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Summary 
This thesis presents a study of the transmission dynamics of nosocom-
ial pathogens in hospital wards, with particular reference to methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-resistant entero-
cocci (VRE). The work makes use of mathematical models, and obvserva-
tional and epidemiological studies. 
Thansmission dynamics of a potential pathogen are first explored using 
a stochastic host-vector epidemic model, where health-care workers' hands 
are assumed to be the vectors. Consequences of changes in patient manage-
ment are presented, and stochastic effects are shown to be essential to an 
understanding of ward dynamics. 
Observations of carer handwashing behaviour and carer-patient. contact 
patterns are described, and the factors associated with hand washing com-
pliance and contact rates explored using statistical models. Patient-carer 
mixing patterns are investigated. Refinements to the host-vector model are 
used to show how different aspects of observed contact patterns may both 
increase and decrease the spread of nosocomial pathogens. For contact pat-
terns typical of intensive care units, the model predicts that infection rates 
will increase as the staff-to-patient ratio decreases, so understaffing may 
result in more cross-infection even if handwashing levels do not change. 
The effect of antibiotic treatment on the spread of resistant strains is 
studied using a two-strain model. Changing patterns of antibiotic use are 
shown to be capable of causing large and rapid changes in ward prevalences 
of resistant strains. 
To investigate possible fitness costs, growth kinetics of methicillin-sensitive 
and methicillin-resistant S. aureus strains are compared. No evidence for 
differences in growth rates is found, though there is a suggestion that MRSA 
stains may have longer lag periods. 
Finally, a Markov chain Monte Carlo (MCMC) approach is developed to 
enable model parameters to be estimated from the incomplete data typical 
of ward-based epidemiological studies. The approach is used to estimate 
parameters using S. aureus and VRE transmission data. With the latter 
data, transmission rates were related to patient antibiotic use. All antibiotic 
combinations considered were associated with increased acquisition rates, 
the effect being strongest for cephalosporins. 
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Chapter 1 
Introduction 
1.1 Hospital-acquired infections 
It has been estimated that there are in the region of 100,000 hospital ac-
quired infections (HAls) in England and Wales each year, and about two 
million in the United States (Glynn et al., 1997; CDC, 1992). At anyone 
time about one patient in ten has an HAl (The Hospital Infection Working 
Group of the DoH and PHLS, 1995). These infections are not only harmful 
to the affected patients, but also, indirectly, to others through the financial 
burdens they place on health services (Casewell, 1995; Mehtar, 1995; Coello 
et al., 1993). In 1993 the direct excess cost of a methicillin-resistant Staphy-
lococcus aureus (MRSA) infection was estimated to be nearly £2,500 per 
patient due to increased patient stays and antibiotic usage (Mehtar, 1995). 
A more recent and more detailed study found that patients presenting with 
HAls during their stays incurred costs almost three times greater than those 
who didn't, even after adjusting for possible confounding by age, sex, diag-
nosis, co-morbidities, and speciality (Plowman et al., 1999). The absolute 
increase was estimated at over £3000 per case, mostly attributable to the 
extra overheads and nursing care resulting from the increased length of stay. 
Applied to the NHS throughout England, this was estimated to represent an 
1 
annual cost of just under a billion pounds annually, £930 million of which 
was incurred during the patients' hospital stays, the rest post-discharge. 
The same study, again after adjusting for potential confounders, found that 
patients with an HAl were seven times more likely to die in hospital than 
uninfected patients. The authors estimated that a 10% reduction in the 
incidence of HAls throughout England would translate into the release of 
resources valued at £93 million and free up over a third of a million bed 
days. 
The problem may not have increased in scale, but in recent years the 
urgency of the matter has risen following the detection and transmission of 
strains of MRS A with intermediate vancomycin resistance (Hiramatsu et al., 
1997b,a; Hiramatsu, 1998). As antibiotic resistance continues to spread 
amongst bacterial populations and the range of therapeutic options dimin-
ishes, the prevention and control of infection, rather than treatment, must 
become increasingly important. 
1.2 Infection control and Semmelweis 
Much of current hospital infection control practice and much of the best 
evidence of its efficacy descends from the pioneering work of Ignaz Phillip 
Semmelweis (Carter and Carter, 1994; Rotter, 1997). Working as an assis-
tant in the maternity clinic in Vienna General Hospital between 1846 and 
1849, Semmelweis became alarmed by maternal mortality that sometimes 
amounted to 20% of patients in a month, much of it attributable to what 
was known as "childbed" or "puerperal fever". The clinic had two sections, 
but one side-the side Semmelweis worked on-had mortality rates four 
to five times greater than the other. Confused by this discrepancy, he at-
tempted to make the sections as similar as possible in every respect, even 
considering the psychological effects of the bell-ringing that accompanied 
the priest's visits. However, nothing seemed to make any difference until 
2 
hospital officials instigated a halving of the number of medical students in 
Semmelweis's section. This change was followed by a marked reduction in 
mortality, which fell from between 10 and 20% to below 5%. Not until the 
forensic expert Professor Kolletschka died from septicaemia after a student 
pricked him with a knife during an autopsy could Semmelweis understand 
this change. He saw that the disease from which his friend had died "was 
identical to that from which so many maternity patients died" and guessed 
that "the autopsy knife had been contaminated by cadaverous particles". 
The medical students in the first section routinely examined the cadavers 
before examining patients and must have also spread the lethal particles. 
The hypothesis explained many aspects of childbed fever, not least the fact 
that rates seemed to go up when Semmelweis was present. "Only God 
knows the number of patients who went prematurely to their graves be-
cause of me", he declared. "I have examined corpses to an extent equalled 
by few other obstetricians." Subsequently Semmelweis insisted that every-
one in his section wash their hands in a chlorine solution on entry to the 
labour ward. The change was indeed followed by substantial reductions in 
mortality. When there was a further outbreak of puerperal fever in which 
11 out of 12 exposed patients died, apparently as a result of everyone ex-
amining one "highly interesting" patient on the ward before visiting other 
patients, all patient examinations were required to be preceded by the same 
handwashing protocol. Similar reductions in mortality were subsequently 
found at other institutions following the same interventions, and laboratory 
experiments added further credence to the hypothesis. Unfortunately, this 
work preceded Koch's studies and the general acceptance of the germ the-
ory of disease by several years, and despite an initial positive reaction and 
vociferous campaigning by Semmelweis, it fell into disfavour. By 1879, how-
ever, Pasteur had collected blood from victims of puerperal fever in Parisian 
hospital morgues, and identified Leeuwenhoek's animalcules-streptococcal 
3 
chains-in the cultures. Attending a lecture that year on puerperal fever he 
interrupted the obstetrician (who was dismissing the far-fetched idea that 
micro-organisms could be responsible): "The cause of this disease is doctors 
who carry a germ from a sick patient to a healthy one .. .! shall show you the 
microbe" (Friedman and Friedland, 2000). 
1.2.1 Beyond Semmelweis 
Since Semmelweis's time, a vast body of knowledge has been accumulated 
about pathogenic bacteria (the "cadaverous particles"), but there have been 
only limited gains in our understanding of contact transmission (Wong, 
2000) and little progress in assessing the relative importance of different 
transmission routes and the factors influencing transmissibility. Contempo-
rary discussions of the role of airborne transmission and of fomites in the 
spread of hospital pathogens are not very different from those taking place 
in the 1840s (Carter and Carter, 1994; McGowan Jr., 1981; Bauer et at., 
1990). 
Indeed, in writing the revised national guidelines for the control of MRSA 
in hospitals, after extensively reviewing the evidence for different interven-
tions, the authors were forced to conclude that few of their recommenda-
tions were supported by well-designed experiments or epidemiological stud-
ies (Working Party Report, 1998). 
Recent systematic reviews of the literature have found the same lack of 
strong evidence for most infection control activities. While there is evidence 
to support the consensus view that implicates the contaminated hands of car-
ers in the transmission of pathogenic organisms (Larson, 1988; Pratt et al., 
2000a; Working Party Report, 1998), specifics-such as choice of handwash-
ing agent, handwashing technique, glove use etc-have only a limited basis 
in scientific evidence (Pratt et al., 2000b). The importance of staff carriage 
of MRSA is also often debated, but another systematic review found that 
4 
crucial evidence regarding the role of staff carriage was lacking. The avail-
able literature did not enable any decisive conclusion about its importance 
to be reached (Nicholson et al., 1997). 
The most important difference between our time and that of Semmelweis 
is the use of antibiotics. Their introduction in the late 1940s revolutionised 
medical practice, and led many to think that the problem of infectious dis-
eases had been overcome. That antibiotic resistance might ruin this dream 
was, however, foreseen from the beginning of the antibiotic era. As early as 
1946 Alexander Fleming said: 
It is to be hoped that penicillin will not be abused as were the 
sulfonamides ... There is probably no chemo-therapeutic drug to 
which in suitable circumstances the bacteria cannot react by in 
some way acquiring 'fastness' [resistance]. (cited in Mazel and 
Davies, 1998) 
However, though the link between antibiotic use and bacterial drug-
resistance might seem incontrovertible, another recent systematic review 
again had to conclude that there was no strong evidence relating antibiotic 
use to resistance levels in hospitals (Standing Medical Advisory Commit-
tee, sub-group on Antimicrobial Resistance, 1998). The authors found the 
literature to be dominated by retrospective studies and swamped with un-
systematic reviews and editorials. 
As the reviews mentioned above suggest, much of the hospital infection 
literature remains anecdotal in nature and consequently likely to be subject 
to large reporting and publication biases. 
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1.3 Directions of future research 
1.3.1 Interventional studies 
There are a number of obstacles to conducting well-designed experimental 
studies of the nosocomial transmission of pathogenic bacteria, and some 
authors have even claimed that randomized controlled trials (RCTs) are 
not feasible in this field (Standing Medical Advisory Committee, sub-group 
on Antimicrobial Resistance, 1998). In contrast to Semmelweis's interven-
tions, contemporary studies have to compare different hand decontamination 
agents or increase hand washing compliance. The latter is hard to do, and 
the effects of interventions may be difficult to monitor. Changing hand-
washing agents may also change handwashing compliance (Rotter, 1997), 
and as the effects are likely to be smaller so sample sizes need to be larger. 
Interventions are made at the level of the ward or hospital rather than the 
individual, so cluster-randomized designs are required (Ukoumunne et at., 
1999). However, these obstacles can be overcome, as has been shown by a 
recent cluster-randomized controlled trial of the effect of hand washing in-
terventions in the community (Carabin et al., 1999). In principle, similar 
studies should be possible in hospital settings. Such interventional studies 
are in fact essential not only for assessing the control measures, but also for 
estimating the true socio-economic costs of HAIs. As Plowman et al. (1999) 
admit, their estimates on costs of HAls may be biased; confounding factors 
other than those considered may lead to patients who are more likely to ac-
quire infections to have longer stays or greater mortality. Their analysis, as 
with all other such analyses, provides no way of disentangling the increased 
length of stay resulting from the infection from the increased chance of an 
infection resulting from an increased length of stay. A controlled trial that 
reduced the number of infections in one group would be required to provide 
an unbiased estimate of the true costs. 
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1.3.2 Mathematical modelling 
The potential value of population-level thinking in tackling the problem 
of nosocomial infections has recently been emphasised (Starr et at., 1997; 
Massanari, 1997). Mathematical models are fundamental tools for such an 
approach, allowing the systematic exploration of the consequences of cur-
rent knowledge, beliefs and assumptions regarding the transmission process. 
The UK Standing Medical Advisory Committee sub-group on Antimicro-
bial Resistance (1998) recently concluded that "Mathematical modelling in 
bacterial population genetics ... has the potential to provide answers unob-
tainable in any experimental situation." . Equally important, however, may 
be the role of mathematical modelling in providing questions. By helping 
to define the problem more precisely, modelling can expose important areas 
where our knowledge is lacking. Also, by allowing the exploration of the in-
teractions of a number of factors, mathematical models may help to propose 
interventions most likely to have the greatest impact. They should also aid 
in the design of the experiments required to confirm or refute the efficacy of 
such interventions. 
1.4 An overview of the thesis 
The unifying theme of this thesis is a population-level approach to hospital-
acquired infections. This is undertaken through mathematical modelling, 
observational studies, laboratory investigations, and population-level anal-
yses of hospital transmission data. 
PopUlations may be studied at many different levels: populations of 
pathogens within a host; patients within a ward or a hospital; individuals 
within a community. The focus of this thesis is on the transmission dynamics 
of pathogens, or potential pathogens, within single hospital wards. 
Chapter 2 first presents a simple model for the transmission dynamics 
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of a potential pathogen, such as Staphylococcus aureus, in a single hospital 
ward. Hand-borne spread is assumed, and carer behaviour explicitly mod-
elled. The emphasis is placed on results from simulation studies with the 
stochastic version of the model. These are used to explore the effects of 
lengths of patient stays, carer handwashing behaviour, the rate of detection 
of colonized patients, as well as properties of the organism itself. 
Chapter 3 describes an observational study in a surgical/medical ward. 
The aim of this was to collect data for model parameter estimation, and 
to assess the need for refinements to the model. Three sets of data are 
presented: 
• Carer hand-washing behaviour 
• Patient-carer contact patterns 
• S. aureus transmission data 
The factors associated with handwashes by carers before and after pa-
tient contacts and important sources of heterogeneities in patient-carer con-
tact patterns are explored with statistical models. The S. aureus cross-
infection data are used to measure the amount of normally undetected 
asymptomatic transmission between patients. Further analysis of these 
transmission data appears in chapter 8. 
Chapter 4 then presents modifications to the basic model motivated by 
the results of chapter 3. In particular, the model is adapted to allow for 
non-homogeneous mixing between patients and carers and heterogeneities 
in patients themselves. The effects of carer-patient contact patterns appro-
priate to intensive care units (ICUs) are also considered. 
Chapter 5 provides an introduction to the second half of the thesis. 
This is concerned with the problem of antibiotic resistant bacteria and the 
relation between antibiotic use and their spread. This chapter provides a 
brief literature review, with emphasis on the nosocomial transmission of 
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drug-resistant S. aureus strains. Where possible, published data are used 
to estimate parameters required in transmission models. 
Chapter 6 then reviews the recent modelling literature relating drug-
resistance to drug use and presents a simple two-strain model for the trans-
mission of a potential pathogen such as S. aureus. Pre-existing drug-
resistant and sensitive strains are assumed, and transmission and persis-
tence of the organisms are related to antibiotic-consumption. Some results 
for the deterministic model are presented, though the emphasis is again on 
the stochastic treatment. Future modelling directions are discussed. 
Chapter 7 describes a laboratory study intended as a rough assessment of 
an important model parameter: the cost of resistance from the perspective of 
the bacterium. This is assessed through a comparison of the growth kinetics 
of methicillin-resistant and methicillin-sensitive S. aureus strains. 
One of the biggest problems with stochastic models such as those pre-
sented in this thesis lies in estimating parameter values from available data, 
particularly when the epidemic process is only partially observed and the 
data leave substantial uncertainty in the true underlying process. Chap-
ter 8 shows how recent developments allow these problems to be overcome. 
Parameter estimates for transmission rates are obtained using simulated 
data, transmission data from chapter 3, and data from a large study of the 
nosocomial transmission of vancomycin-resistant enterococci (VRE). These 
latter data are used to relate the transmission rate to instantaneous patient 
antibiotic use. 
Finally, chapter 9 summarises the most important results from previous 
chapters, relates these to the overall state of knowledge about the spread of 
HAls, and proposes directions for future research. 
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Chapter 2 
A basic single-ward model 
2.1 Introduction 
Until recently there had been little attempt to study the transmission dy-
namics of nosocomial infections within a quantitative framework. Little use 
has been made of mathematical models in comparison to their role in un-
derstanding community-based epidemics (Anderson and May, 1991; Isham 
and Medley, 1996). In part this may be due to the small populations af-
fected. This means that stochastic effects can be dominant and the usual 
deterministic approximations are of limited utility. 
Although stochastic epidemics have been the subject of much theoretical 
study (Bailey, 1975b), there have been surprisingly few attempts to relate 
this work directly to applied situations. The diversity of infection control 
practice and policies found in hospitals may in part reflect the lack of such a 
quantitative framework. The development of appropriate, validated models 
should aid the design of cost-effective control strategies. 
What work there has been on modelling nosocomial infection has mostly 
occurred in the last four years. This has concentrated on the competitive in-
teractions between antibiotic resistant and sensitive strains, and has largely 
ignored stochastic effects. These types of models are discussed in detail in 
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chapter 6. 
This chapter follows on from earlier work in modelling the nosocomial 
transmission of a hand-borne pathogen in a hospital ward, and presents 
a simple mathematical for the spread of an organism such as S. aureus. 
Because the population is small a stochastic approach is adopted: the timing 
of events is determined by a chance process and only integer values are 
allowed for the number of patients and carers (Bailey, 1975b). For simplicity 
a single strain is considered in this chapter. 
In the earlier work the mathematical properties of the model were ex-
plored, and particular attention was given to the quasi-endemic solution 
(Cooper, 1996). Here, the implications for the management of nosocomial 
infections are studied using essentially the same model (there are only minor 
differences). The effects of changing parameter values relating to both the 
management of patients and the properties of the pathogen are investigated. 
This work has been reported in Cooper et al. (1999). 
2.2 Methods 
2.2.1 Model Perspective 
There is a large body of evidence to suggest that a high proportion of hospital 
infections result from the transfer of pathogens on the hands of health-care 
workers (HCWs) (Larson, 1988; Casewell and Phillips, 1977; Knittle et ai., 
1975; Cookson et ai., 1989; Lingnau and Allerberger, 1994; Wolinsky et al., 
1960). Here, a single strain of a hand-borne pathogen, such as S. aureus, 
for which airborne and other transmission routes can be neglected is consid-
ered. The model considers two populations: patients and HCWs occupying 
a single ward. Patients may be admitted and discharged, but bed occu-
pancy is assumed to be 100%. The population of HCWs is also assumed to 
be constant. Carers are uniquely classified as being either transiently con-
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taminated with the pathogen, or entirely free of contamination. Similarly, 
patients are considered to be either colonized or uncolonized. Patients who 
are asymptomatic carriers of a potential pathogen and those who have overt 
infection are grouped into the same compartment; no distinction is made 
between them. Both are assumed to transmit the organism to HeWs with 
equal probability on contact. 
2.2.2 Model Assumptions 
Given the perspective described above, the assumptions which lead to the 
model are as follows: 
1. All transmission from one patient to another is caused by a contact 
from a HeW transiently colonized with the pathogen. It is assumed 
that all such contacts between transiently colonized HeWs and uncol-
onized patients have a given probability, p, of colonizing the patient. 
The possibility of direct patient-to-patient contact is ignored, though 
in certain special cases-such as paediatric wards-it may be an im-
portant transmission route (Riley and Rouse, 1995). However, data 
collected as part of the study described in chapter 3 suggests that it 
is unlikely to be so in more typical wards. 
Airborne transmission and transmission from contact with inanimate 
surfaces are also neglected. For S. aureus, airborne transmission ap-
pears to be of minor significance (Bauer et al., 1990; Mortimer et al., 
1966). Observed patterns of recovery of airborne staphylococci and 
transmission of strains cannot easily be reconciled with a major role 
for airborne spread (Lidwell et al., 1970, 1971). 
The importance of environmental contamination for transmission of S. 
aureus remains unclear (Boyce et al., 1997), but for faecal pathogens 
such as vancomycin-resistant enterococci (VRE) and Clostridium dif-
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ficile it appears more likely to be a significant reservoir (Weber and 
Rutala, 1997; Samore et al., 1996). These transmission routes may 
also become more important in places where there are more suscepti-
ble patients such as burns units and ICUs. 
2. HCWs acquire transient hand-contamination with the pathogen by 
touching colonized patients. It is assumed that aU such contacts be-
tween uncolonized HCWs and colonized patients have a given proba-
bility of colonizing the carer, p'. 
Both direct carer-to-carer transmission and the possibility of HCWs 
becoming colonized from sources outside the ward under consideration 
are ignored. For staff whose work involves moving between wards the 
latter may be important, but here only the within-ward spread of 
nosocomial pathogens is under consideration. 
3. In the absence of reliable data on the carer-to-patient transmissibility 
it is assumed to be equal to the patient-to-carer transmissibility. For 
S. aureus survival time on transiently colonized hands of HCWs is un-
likely to be a limiting factor in its spread if hand washing is practised 
at levels typically found in observational studies. Thansmissibility can 
therefore be considered to be largely a function of the rate of shedding, 
and the number of organisms needed to establish colonization. Host 
factors are likely to account for much of the variation in these val-
ues. For example, there is evidence that patients with heavily infected 
wounds might be expected to shed more bacteria (Burke and Corrigan, 
1961; Selwyn, 1965). This would correspond to an increase in patient-
to-carer transmissibility. Similarly, patients with wounds, eczema or 
taking antibiotics may require far fewer organisms to establish colo-
nization, resulting in an increase in carer-to-patient transmissibility 
(Foster and Hutt, 1960). Different transmissibilities may therefore re-
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flect different wards as much as different strains. 
In principle, the probability of transmission from a colonized patient 
to a HCW can readily be measured by sampling carer hand contam-
ination following patient contacts. Either a hand-wash sampling or a 
contact-plate technique can be used, though the method chosen will in-
fluence the relative values of the carer-to-patient and patient-to-carer 
transmissibilities obtained (Ayliffe et al., 1979). Since the former is 
more sensitive it should lead to a higher value for patient-to-carer 
transmissibility and a hence a lower value for carer-to-patient trans-
missibility. Handwash sampling typically shows roughly twice the fre-
quency of contamination with S. aureus as contact-plate sampling 
(Ayliffe et al., 1975). 
Casewell and Phillips (1977), using a gloved-hand technique, found 
that in 17 out of 47 contacts with seven colonized patients Klebsiellae 
spp were transferred to nurses hands, giving an overall patient-to-carer 
transmissibility of 0.36, or 0.22 per-strain if colonization with multiple 
types is accounted for and contacts assumed to be evenly distributed 
amongst the patients. 
In two other studies HCW hand contamination could be ascribed to 
specific patient-carer contacts. However, in the first a transmission 
probability for single organisms could not be calculated due to a lack 
of typing of the recovered organisms (Sanderson and Weissler, 1992), 
and in the second, samples were only taken following bed-making and 
wound dressing in a burns unit (Ojajarvi, 1980). 
In other studies where carer hand contamination has been measured it 
is not possible to associate the acquisition of the organism on a carer's 
hands with a single patient contact (Ayliffe et al., 1979, 1975; Bauer 
et ai., 1990). To be used for assessing transmissibilities additional as-
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sumptions have to be made about contact rates, hand washing rates, 
prevalence of patient colonization, and the frequency of hand contam-
ination with a carer's own strains. In studies where HCWs' hands are 
sampled at random the frequency of recovery of S. aureus varies be-
tween about 10 and 30%, though values as high as 60% and 70% have 
been recorded in a burns unit and a hospital for skin diseases (Ayliffe 
et al., 1975). 
In contrast to the patient-to-carer transmissibility, estimation of the 
carer-to-patient transmissibility presents many problems. Studies which 
attempt to directly measure the chance of patient colonization when 
inoculated with bacteria cannot easily be related to activities on a real 
ward (Foster and Hutt, 1960; Shinefield et al., 1963). 
It is, however, possible to make an order of magnitude estimate. Stud-
ies from the 1960's and 1970's suggest that new strains of S. aureus 
are acquired by hospital patients at a rate of about 5 per 100 patient 
weeks (Parker et at., 1965; Shooter et at., 1963; Lidwell et al., 1970, 
1971). It is assumed that all these arise from contact with a transiently 
colonized carer, and that about one in ten HCWs have S. aureus on 
their hands at anyone time (Ayliffe et at., 1979, 1975). If each patient 
requires on average five carer contacts per day, and carers decontami-
nate their hands after 40% of such contacts (Larson and Kretzer, 1995) 
then a carer-to-patient transmission probability of about 0.01 can be 
derived. This can be considered to be the mean for all S. aureus 
strains. Acquisition rates for resistant S. aureus strains are typically 
greater than for sensitive strains when the number of sources is ac-
counted for. Lidwell and co-workers found that the acquisition rate of 
tetracycline resistant strains per source was about ten times greater 
than that for sensitive strains, and five times greater than that for 
strains resistant only to penicillin (Lidwell et at., 1966). 
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What data there are therefore suggest the carer-to-patient transmis-
sibility is likely to be smaller than patient-to-carer transmissibility. 
However, the former may be expected to vary more between wards 
than the latter due to different patient susceptibilities. None of the 
above estimates were derived from wards where patients are particu-
larly susceptible to colonization (burns units, ICUs and neonatal units 
etc.), and all the relevant studies were carried out in the 1960's and 
1970's when risk factors associated with infection (such as use of in-
vasive devices) were probably lower than they are today (Casewell, 
1995). Given these uncertainties, for simplicity it was assumed that the 
patient-to-carer and carer-to-patient transmissibilities were the same 
in all the simulations. 
4. HCWs do not become long-term carriers of the pathogen. 
During investigations of MRSA outbreaks, long-term HCW coloniza-
tion has repeatedly been found to be rare (Lingnau and Allerberger, 
1994; Cox et ai., 1995; Thompson et ai., 1982), suggesting that it 
accounts for only a small percentage of patient acquisitions. Lid-
well et ai. (1966) estimated that the rate at which patients acquired 
tetracycline-resistant S. aureus strains from a colonized staff member 
was only about a fifth of the acquisition rate from a colonized patient. 
Other researchers have also found that most organisms acquired by 
patients come from other patients rather than staff (Barber et ai., 
1960; Witte et ai., 1994). The main impact of staff carriage may be 
to occasionally seed new outbreaks, thus enabling persistence of the 
organism for longer than would be possible if patients were the only 
reservoir (Lessing et ai., 1996). In special cases, and for pathogens 
with higher rates of carriage amongst staff (such as the tetracycline-
resistant S. aureus strains of the 1960s and 1970s), long-term carer 
colonization may however account for a substantial number of patient 
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acquisitions (Coovadia et at., 1989; Parker et at., 1965; Lidwell et al., 
1970, 1971) and Casewell (1986) considered both patients and staff to 
be significant sources during MRSA outbreaks. Also, if MRSA has 
been endemic in a setting for a long time higher levels of staff colo-
nization may be likely. Staff colonization lasting for an intermediate 
length of time, arising from close-contact activities such as changing 
dressings of heavily contaminated wounds, may also be important in 
the case of S. aureus (Cookson et at., 1989). 
5. The population of patients is considered to be homogeneous. 
Each patient is considered to be equally likely to contact a member 
of staff in any time interval, equally likely to become colonized, and, 
if colonized, equally likely to transmit the pathogen to a HCW on 
contact. 
This restriction is an obvious candidate for exploration in a further 
refinement of the model. For example, perhaps one quarter of the 
population appears to be unable to become nasal carriers of S. au-
reus (Williams, 1963), and patients with invasive devices may be both 
more likely to receive contacts, and more susceptible to infection. A 
recent study found that such patients were more than seven times more 
likely to become infected (Glynn et al., 1997). Chapter 4 extends the 
current framework to situations such as these. 
6. The population of HeWs is considered to be homogeneous. 
Variation between HCWs due, for example, to differences in behaviour 
such as handwashing(Gould, 1994) and in the microbial skin flora (Rey-
brouck, 1983) are neglected. Though again, chapter 4 presents a frame-
work for addressing this sort of question. 
7. The detection of colonized patients is assumed to be a random process, 
and the mean time to detection to depend only on a constant level of 
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surveillance activity. 
In practice, surveillance activities might increase during an outbreak, 
and the mean time to detection decrease. There are also likely to 
be higher detection rates for patients with clinical infections than for 
asymptomatic carriers. Since the infection-to-colonization ratio may 
differ in different settings the detection rate may also be expected to 
vary substantially according to setting (Lidwell et al., 1966; Cox et at., 
1995). 
8. Once detected, colonized patients are assumed to be removed from the 
ward and so are no longer a source of infection. Colonized patients 
who are not detected are removed from the ward at the same rate as 
uncolonized patients. 
9. Each time a HCW washes his or her hands any contamination present 
is removed. 
In fact real handwashes may vary in their effectiveness at removing 
potential pathogens, depending on both technique and the disinfec-
tant used (Kj0len and Andersen, 1992). However handwashing, even 
with less than optimal agents, may be expected to lead to very large 
reductions in the transient flora. Studies such as those by Bonilla et al. 
(1997), where high levels of hand contamination are observed before 
handwashing, and only very low levels after, appear to confirm this. 
2.2.3 Model Structure 
At any point in time the model's state is determined by the number of 
colonized patients in the ward and the number of contaminated HCWs. The 
sizes of the carer and patient populations are assumed constant so these also 
define the number of uncolonized patients and uncontaminated HCWs. 
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Figure 2.1: Flow diagram of the model illustrating the rates of transitions 
between the four compartments. See table 2.1 for an explanation of the 
parameters, and table 2.2 for details of the events represented by the arrows. 
Table 2.1 lists the parameters used in the model and their default values, 
chosen to be realistic, where relevant data existed. For some of the results, 
the parameter values are varied. Table 2.2 shows the possible events and 
their rates. 
At the start of all the simulations all patients are uncolonized and all 
HCWs are uncontaminated, so an epidemic can only occur once an in-
fected/colonized patient is admitted. 
Mathematical details of the model are given below. The model is illus-
trated diagrammatically in figure 2.1. 
The model is constructed as follows: 
• Let x be the number of susceptible patients, and y the number of 
colonized patients (i.e. those who either have infections or are asymp-
tomatic carriers). Let the total number of patients in the ward be a 
constant n, so x + y = n. 
• Similarly, let the total number of carers be n', x' of whom are not car-
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rying the pathogen, and y' of whom are temporarily colonized, where 
x' +y' = n'. 
• The removal rate for patients not known to be carrying the pathogen 
is p. This includes removals due to death, transfers to other wards, 
and discharges. 
• The detection rate of patients colonized with the pathogen is 1'. Since 
colonized patients are assumed to be removed from the ward, this 
represents the additional removal rate for colonized patients. 
• The rate at which temporarily colonized carers are cleared is t-t'. This 
is effectively the handwashing rate of carers. 
• It is assumed that each patient requires a contact from a carer in a 
given time interval with a given probability, and that all these require-
ments are met and no superfluous contacts are made. Let c be the 
mean number of contacts required by a patient each day, p the prob-
ability that a patient becomes colonized on contact with a colonized 
HCW, and p' the probability that a HCW becomes colonized on con-
tact with a colonized patient. Taking f3 = cp and f3' = cp', the rates at 
which contacts which can potentially result in colonization are made 
are /3x (for patient colonization) and {3'y (for staff colonization). Since 
a fraction y'ln' of the former contacts will be with colonized carers, 
and x'ln' of the latter with susceptible carers, the rates for patient 
and carer colonization will be {3xyl ln' and {3'x'yln' respectively . 
• The proportion of patients newly admitted to the ward who are car-
rying the pathogen is a (0:$ a :$ 1). 
Given these rates, the differential equations for the deterministic version 
of the model can he written: 
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dt 
dy' 
dt 
y' 
a(p,x + p,y + --yy) + f3x, - (p, + --y)y 
n 
, x' " 13 y- - p, y 
n' 
(2.1 ) 
(2.2) 
The basic model is a well-studied host-vector model, and is very simi-
lar to the most simple models of the transmission of malaria. In this case, 
instead of mosquitoes biting humans, the vectors are hospital staff touch-
ing patients. The mathematical properties of the deterministic version of 
this model are well understood and have been extensively studied (Bailey, 
1975a; Aron and May, 1982), while the stochastic version continues to be 
the subject of research (Nasell, 1991) 
For this system of equations, the basic reproduction number, Ro-the 
mean number of secondary cases arising from one primary case in a com-
pletely susceptible population (Anderson and May, 1991)-is given by 
Ro = (n - 1)1313' 
(p, + --y)(n'p,' + 13') (2.3) 
In the deterministic version of the model, the introduction of one colo-
nized patient will lead to an outbreak if and only if Ro ~ 1. 
2.2.4 Stochastic model 
In the stochastic model the numbers of susceptible and colonized patients 
and susceptible and colonized staff are now represented by discrete random 
variables X(t), Y(t), X'(t) and Y'(t) respectively. Again, X(t) + Y(t) = n 
and X'(t) + Y'(t) = n'. What were rates in the deterministic model must be 
interpreted probabilistically in the stochastic model. Thus, the probability 
of a colonized carer being cleared of the pathogen (i.e. the probability that 
one such carer washes his or her hands) in a short time interval bot is given 
by p,' tlt. 
The transition probabilities can be written as: 
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Pr{[Y(t + ~t), Y'(t + ~t)] = [i + l,j]1 [Y(t), Y'(t)] = [i,j]} = 
(n - i) . . (3--J~t + a(JLn + "(z)~t + o(~t) 
n' 
Pr{[Y(t + ~t), Y'(t + ~t)] = [i,j + 1]1 [Y(t), Y'(t)] = [i,j]} = 
(3'i (n' ~ j) ~t + o(~t) 
n 
Pr{Y(t + ~t) = i-I I Y(t) = i} (JL + "()(1 - a)i~t + o(~t) 
Pr{Y'(t + ~t) = j - 11 Y'(t) = j} JL'j~t + o(~t) 
All other transitions have probability o(~t). 
Note that in the stochastic model even if Ro < 1 there will always be 
some probability of an outbreak following the introduction of a colonized 
patient. Conversely, if Ro > 1, the introduction of a colonized patient may 
result in no secondary cases at all. Consequently the interpretation of Ro is 
not as clear as it was in the deterministic model. 
Because colonization and decolonization in carers occur on a much shorter 
timescale than they do amongst patients a good approximation to the pro-
cess can be made by assuming that the probability of there being a given 
number of colonized HCWs on the ward at one time depends only on the 
number of colonized patients at that time. For this approximating process 
an analogous and closely related value, R~, can be defined as 
R' _ (3(n - 1)111 
0- n'(p + ,) (2.4) 
where y'l is the mean number of colonized HCWs given that there is one 
colonized patient. Then it can be shown that the mean number of colonized 
patients, Y(t) increases with time if and only if R~ > 1 (Cooper, 1996). 
A Monte Carlo simulation program was written in Turbo Pascal (Bor-
land, 1990) using standard methods (Renshaw, 1991) and run on IBM com-
patible personal computers (486 and 586 processors) to determine the be-
haviour of the stochastic model. The random number generator used here 
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was the ran3 function taken from Press et al. (1989). The program listing 
is available from the author, and is published in an earlier form in Cooper 
(1996). 
2.2.5 Handwashing rate-handwashing frequency relation-
ship 
The handwashing frequency of scenario 4 is defined to be the probability 
than a HCW washes his or her hands before a patient contact. This is 
derived from the handwashing rate, J.L', using the formula: 
(J.L' + C~/) 
J.L' (2.5) 
(See, for example, Cox and Miller (1965) for a derivation). Since, in 
practice, hand washes do not generally occur at random, but are usually as-
sociated with patient contacts, this is a more meaningful parameter, and cor-
responds more directly with the observed hand decontamination frequency. 
2.2.6 Model Scenarios 
The behaviour of the stochastic version of the basic model was examined by 
running simulations for different parameter values, where each run simulated 
transmission on the ward for a period of 365 days. To examine the effects 
of different management policies on transmission, parameter values were 
chosen and varied in turn from their default values (table 2.1) within five 
different scenarios. For each of these, three abstracted results are presented, 
each calculated as the mean of the 1000 simulation runs: 
• The successful introduction rate on a ward was defined to be the 
number of "outbreaks" per year. An outbreak was defined to be an 
event when a secondary case of patient colonization arose due to cross-
infection following the introduction of a colonized patient to a ward in 
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Parameter Meaning Default value 
n N umber of patients 20 
n' Number of health care workers (HCWs) 3 
J1. Patient removal rate 0.10 Iday 
J1.' Handwashing rate 14.0/day 
'Y Detection rate of colonized patients 0.10/day 
a Proportion of admissions already colonized 0.01 
c Patient-carer contact rate 5/day 
p Carer-patient transmission probability 0.1 
p' Patient-carer transmission probability 0.1 
(3 Carer-patient transmission rate ((3 = cp) 0.5 
(3' Patient-carer transmission rate ((3' = cp') 0.5 
Table 2.1: Parameters and their default values. The default values for the 
parameters n, n', J1., J1.' and c are taken to approximate observed values in 
a general medical ward (Cooper, 1996). The low value for n' is a weighted 
average across all nursing shifts. The numerous peripatetic HCWs are likely 
to account for much of the inter-ward transmission, but relatively little intra-
ward transmission, and are therefore not included in this estimate of n'. It 
is far harder to obtain values for p, and p'. The choice of these parameter 
values is discussed in the text. 
Event 
Patient removal (when no colonization detected) 
Detection of colonized patient and removal 
HCW handwash 
Removal of contamination from hands of HCW 
Carer-patient contact 
Carer-patient transmission 
Patient-carer transmission 
Admission of uncolonized patient 
Admission of colonized patient 
Rate of event 
J1.(x+y) 
'YY 
J1.'(x' + y') 
J1.' y' 
c(x + y) 
(3xy'ln' 
(3'yx'ln' 
(1 - a)(J1.x + J1.y + 'YY) 
a(J1.x + J1.y + 'Yy) 
Table 2.2: Events and their rates. Here x represents the number of uncol-
onized patients and y the number of colonized patients. y' represent the 
number of HCWs who are carrying the pathogen on their hands, and x' 
represents the number of HCWs free of hand contamination. 
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which no patients or HCWs were colonized. This measure is intended 
to reflect surveillance data. 
• The ward-level prevalence was calculated as the percentage of days per 
year on which at least one colonized patient was present on the ward 
at the beginning of the day. 
• Yearly colonized patient-days were calculated as a percentage of the 
total patient-days per year. This measure is most closely related to 
measures of morbidity and economic cost of infections. 
The scenarios are defined as follows. 
• Scenario 1: n·ansmissibility 
In order to assess the impact of changing transmissibility results are 
given for different values for the patient-to-carer and carer-to-patient 
transmissibilities. In line with the above discussion, these parameters 
are varied between 0 and 0.3. This corresponds to changing Ro from 
o to 5.09, with Ro = 1 when these parameters are 0.133. 
For the remaining scenarios, results are presented for three different 
transmissibilities. Patient-to-carer and carer-to-patient transmissibil-
ities are taken as 0.07, 0.10 and 0.13. For these parameters, Ro takes 
the values 0.28, 0.57, and 0.96 respectively, assuming other parameters 
take their default values. 
• Scenario 2: Probability of Colonization at Admission 
The probability of a patient being colonized on entry to the ward 
was varied between 0% and 10%. This is meant to reflect the differ-
ent prevalences of infection and carriage in the community. In terms 
of management, the introduction of effective screening procedures for 
patients entering wards (and consequent isolation and control of trans-
mission) would reduce this parameter. 
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• Scenario 3: Duration of Patient Stay 
The mean lengths of patient stays in the ward were varied between 4 
and 20 days. Because of the assumption that bed occupancy is 100%, 
a shorter duration implies a greater turnover of patients on the ward, 
each discharge being immediately replaced by an admission. Conse-
quently, increasing patient turnover is likely to increase the likelihood 
of colonized patients being admitted, but decrease the probability that 
they will transmit infection during their stay. 
• Scenario 4: Handwashing Frequency 
By varying the rate at which HCWs are assumed to wash their hands, 
the frequency with which decontamination occurs prior to patient con-
tact was varied between 0 and 100%. For a value of 100% there should 
be no transmission, and transmission should be maximal for 0% hand-
washing. 
• Scenario 5: Infection Detection 
To investigate the effect of different levels of surveillance activities in 
the ward, the mean time taken for a colonized patient to be detected 
was varied upwards from three days. Because of the time required for 
routine microbiological procedures it is unlikely that a shorter time-to-
detection could be feasible unless PCR-based methods were used. The 
greater the expected time to detection, the greater the chance that a 
colonized patient will be discharged before colonization is detected. 
2.2.7 Results 
Figure 2.2 shows three sample runs selected from 100 simulation runs with 
the default parameter set. The runs were selected to illustrate the extremes 
of behaviour. All three were made using the same parameter values in a 
ward initially free of colonized patients and carers. The different outcomes 
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Figure 2.2: Sample simulation runs from the model, all using the default 
parameter values (given in table I) which give an Ro value of 0.57. These 
runs were selected to illustrate the high degree of variability that occurs in 
the stochastic model. In the following graphs, all parameters are set to their 
default values, unless otherwise stated. 
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shown are therefore due entirely to stochastic effects. Although the appar-
ent patterns of colonization in the three wards are completely different, and 
attempts might be made to explain the differences on behavioural or biolog-
ical grounds, the properties of the organism and the practices in the wards 
are identical. 
• Scenario 1 : Transmissibility 
Figure 2.3 shows how increasing patient-to-carer and carer-to-patient 
transmissibilities has a dramatic impact on the successful introduc-
tion rate, ward-level prevalence, and colonized patient-days. As the 
transmissibilities increase, the mean number of outbreaks increases 
rapidly, and then declines to a value of 1 as the pathogen becomes 
almost endemic on the ward, as indicated by the prevalence graph. 
The number of colonized patient-days is also highly sensitive to small 
changes in the transmissibilities. The non-linear nature of these re-
sults indicates that a small change in transmissibility can induce large 
epidemiological changes, assuming that carer-to-patient and patient-
to-carer transmission are equally affected. The error bars show that 
there is wide variation about these means due to stochastic effects. 
Thus, for the highest transmissibility, 5% of wards have a prevalence 
of nearly 100%, while another 5% have a prevalence of less than 40%. 
• Scenario 2 : Probability of Colonization at Admission 
The results presented in figure 2.4 show that for relatively low preva-
lences, the successful introduction rate increases linearly with the prob-
ability of admitting a colonized patient. As this probability is increased 
further, the ward-level prevalence becomes very large and outbreaks 
tend to merge into each other, so that the successful introduction rate 
plateaus and decreases. The number of colonized patient-days also 
increases linearly over the range of values investigated suggesting that 
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are equal. Ro = 1 when the transmissibility is 0.133. Error bars indicat 
the range of values obtained by excluding the 5% highest and lowe t values . 
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halving the rate of introduction of the pathogen on any ward will po-
tentially halve the costs associated with infection providing Ro < 1. 
• Scenario 3 : Duration of Patient Stay 
The results are shown in figure 2.5. For all three values of transmis-
sibility, the successful introduction rate decreases as the lengths of 
patient stays increase. This can be accounted for by a lower rate of 
patient turnover leading to a decreased number of colonized patients 
being admitted to the ward. Consequently, increasing turnover will 
increase the number of outbreaks, but note that doubling the turnover 
(e.g. decreasing stay duration from eight to four days) less than dou-
bles the number of outbreaks. This non-linear behaviour is due to 
the fact that discharge of shorter stay patients is more likely prior to 
transmission occurring. 
In contrast, the ward-level prevalence of the pathogen behaves differ-
ently with length of stay depending on the pathogen's transmissibility. 
For strains oflow and intermediate transmissibility, it increases slightly 
as length of stay decreases. However, the highly transmissible strain 
has a more or less constant prevalence, despite the increased rate of 
successful introduction. Again, this is due to the positive and negative 
effects of patient turnover on transmission. 
The mean number of colonized patient-days behaves differently again, 
and for less transmissible strains is almost constant. More highly trans-
missible strains are more susceptible to reduction by increasing patient 
turnover, though for the parameters chosen here the effect is small. If 
the mean time to detection of colonized patients is considerably larger 
than the default value used here, then both the colonized patient-
days and ward-level prevalence of the more transmissible strains show 
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marked reductions as a result of decreasing the lengths of patient stays. 
• Scenario 4 : Handwashing Frequency 
Figure 2.6 shows how the three statistics vary with the hand wash-
ing frequency. The seemingly contradictory result that the success-
ful introduction rate increases sharply as the handwashing frequency 
increases above zero can be explained in a similar manner to the de-
crease in incidence in figure 2. With very low handwashing levels, the 
pathogen is endemic on the ward, and incidents of cross-infection can-
not be resolved into discrete outbreaks. For relatively small increases 
in handwashing frequency, the prevalence falls rapidly to below 20%, 
and outbreaks appear as distinct events, separated by periods where 
the ward is entirely free of the pathogen. As the hand washing fre-
quency increases above zero to the relatively low values of 0.2 or 0.3 
there is also a rapid decrease in the colonized patient-days. Very little 
difference is made to the overall number of colonized patient-days by 
further increasing the handwashing frequency beyond about 0.4. 
• Scenario 5 : Infection Detection 
The effect of changing surveillance effectiveness is shown in figure 2.7. 
Surprisingly, the reduction in infection surveillance, ,,/, leads to only a 
small increase in the successful introduction rate. This would suggest 
that the detection and removal of colonized patients is not as impor-
tant in influencing outbreak incidence as patient turnover or rate of 
introduction of colonized patients. Consequently, increasing infection 
surveillance is expected to have almost no effect on outbreak surveil-
lance data. Ward-level prevalence and colonized patient-days are much 
more sensitive to changes in infection surveillance, and the effect in-
creases with increasing transmissibility. Consequently, surveillance is 
expected to have a more dramatic effect on clinically and economically 
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important measures of infection as transmissibility increases. 
2.3 Discussion 
2.3.1 Stochasticity 
The principal conclusion to be drawn is that stochastic models are essential 
for the interpretation and analysis of nosocomial infections. The patterns 
shown in figure 2.2 represent apparently very different epidemiological sit-
uations, and yet the differences are entirely due to chance. Although these 
patterns were selected, they are representative of the heterogeneity intro-
duced into surveillance of nosocomial infections at the level of the ward. It 
is quite likely that an outbreak of the size depicted in figure 2.2C would 
attract specific attention, and causes be sought, but the transmission pa-
rameters are identical to those in an adjacent ward that had no infection 
problem (Figure 2b). This result may also have important implications for 
interpretation of the hospital infection literature, much of which consists 
of outbreak reports and describes interventions that are claimed (or im-
plied) to have controlled the outbreaks. Clearly, it is essential to consider of 
stochastic effects and publication bias that may result from selecting only 
the "interesting" outbreaks from a whole distribution of possible outbreaks 
patterns. 
2.3.2 Changing admission colonization probability 
The results also highlight several important consequences for management 
of organisms such as S. aureus. In particular, alterations in patient man-
agement and infection control can have non-linear, and sometimes counter-
intuitive, effects on different measures of infection. It was found that re-
ducing the proportion of patients who are already colonized on admission 
to be an effective way of controlling the spread of infections providing Ro 
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is less than one. This gave a linear reduction in colonized patient-days over 
the whole range of parameter values studied. Of the management strategies 
considered, reducing the proportion of new colonized admissions to the ward 
is the most effective across a wide range of different situations. Note that 
even if Ro < 1, and without community transmission, if enough patients dis-
charged from the ward are readmitted within a short enough space of time, 
then the number of patients colonized on admission would be expected to 
increase, as patients acquiring the organism in earlier episodes on the ward 
are readmitted before having time to lose the organism. 
2.3.3 Changing duration of stay 
The results suggest that while a decrease in the lengths of patient stays is 
always likely to result in a greater incidence of outbreaks, the ward-level 
prevalence and the number of colonized patient-days may increase or de-
crease depending on the transmissibility of the pathogen and other parame-
ters. For the parameter values chosen here the effect is very small. However, 
for a highly transmissible strain in a ward with lower levels of surveillance 
(i.e. larger mean times to detection of colonized patients) reductions in the 
lengths of patient stays can be accompanied by substantial reductions in 
these two statistics. 
2.3.4 Transmissibility 
One weakness of any modelling approach is the paucity of direct informa-
tion on the most influential parameter: transmissibility. Small changes in 
the transmissibility of a pathogen can result in large changes in the observed 
prevalence and in the total number of colonized patient-days. Such changes 
could be due to changes in hospital procedures, or due to the evolution of 
the pathogen, perhaps as the result of the adaptation of bacteria to their 
resistance genes (Schrag and Perrot, 1996; Lenski, 1997). Note that unlike 
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the transmissibility of the pathogen, the susceptibility of the patient popu-
lation is, at least to some extent, a management decision. The tendency to 
hospitalise only the most severely ill could be expected to result in a more 
susceptible population due to reduced immune response, higher antibiotic 
usage, higher levels of catheterisation, higher levels of usage of invasive de-
vices and so on. All of these factors should result in an increase in the value 
the carer-to-patient transmission probability. However, it is not clear how 
the probability of transmission from a patient to a carer should be affected, 
although it seems likely that individuals with infections lead to more trans-
mission than asymptomatic carriers. In the absence of reliable information 
on these two parameters it was assumed they were equal in all our simula-
tions. As a result the graphs cannot be considered as exploring the results 
of changing patient susceptibilities alone. 
2.3.5 Handwashing 
The importance of hand washing in the control of hospital infections has 
been repeatedly emphasised (Larson, 1988). The model results support this. 
Since it was assumed that all transmission occurs via the transiently colo-
nized hands of HeWs and handwashing was assumed to reduce carriage to 
zero this result is not unexpected. What may be surprising is how large 
the reductions in the ward-level prevalence and colonized patient-days are 
as the hand decontamination frequency is increased above zero to relatively 
low values. For the parameter values chosen here, increasing the hand de-
contamination frequency above about 40% makes very little difference to 
the prevalence and intensity. 
Note, however, that the handwashing frequency used in the model cannot 
be taken straight from values observed in observational studies. In the model 
it is assumed that each hand wash is 100% effective at removing pathogens. 
This is clearly not the case in practice (Kj01en and Andersen, 1992). To be 
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realistic, the handwashing frequency in the model should perhaps be much 
lower than frequencies found in studies, which are typically in the region of 
40% (Larson and Kretzer, 1995). 
2.3.6 Infection surveillance 
Finally, the effect on transmission of the level of surveillance activities on 
the ward (measured as the mean time taken to detect a colonized patient) 
was considered. In contrast to the handwashing graph (scenario 4), where 
increased levels of handwashing cause rapidly diminishing reductions in colo-
nized patient days as the hand washing frequency increases above fairly small 
values, colonized patient-days and ward-level prevalence varied almost lin-
early over the whole range of parameter values examined. Note that it has 
been assumed that the mean time to detection is constant. In practice one 
may expect it to decrease in an outbreak situation as surveillance activi-
ties increase. This effect is likely to mean that surveillance activities are in 
practice much more effective than the results presented here suggest. The 
patterns shown suggest that once handwashing rates are at some reason-
able level, increasing resources should be directed at improving detection 
for greatest effect. 
2.3.7 Measurement of infection 
Three indices of infection on a ward over one year have been considered. It 
clearly matters how infection is measured, in that some management tools 
had opposite effects on different measurements (e.g. successful introduction 
rate and colonized patient-days in Figure 5). In particular, it is apparent 
that the successful introduction rate becomes meaningless if a pathogen be-
comes endemic on wards; if all patients are infected the incidence of new 
infection is zero. Other measures may be more meaningful in different situ-
ations. For example, in an ICU, where colonization is more likely to result 
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in clinically important consequences, the probability of a patient becoming 
colonized during their stay may be a more accurate measure of the problem. 
2.3.8 Extensions 
Here, a highly simplified model for the transmission of a single pathogen 
within a single ward has been presented. The intention has been to make the 
model as simple as possible, whilst retaining some of the essential aspects 
of transmission. To this end a number of simplifying assumptions in the 
construction of the model were made. Clearly, a set of different assumptions 
will produce a different model, with potentially different results. 
Mathematical models are seldom realistic enough to allow explicit pre-
dictions to be made. The value of this type of model lies rather in improving 
understanding of the non-linear interactions between a small number of pro-
cesses. Improved correspondence between model and reality requires the in-
clusion of the next set of important processes. Thus the complicating factors 
of patient heterogeneities, non-homogeneous mixing patterns and antibiotic 
use are considered later in chapters 4 and 6. 
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Chapter 3 
An observational study 
This chapter describes a one month prospective observational study aimed 
at collecting data for estimation of model parameters. The study was con-
ducted in a 15 bed mixed medical/surgical ward. Detailed observations 
of patient-carer contacts and carer hand washing behaviour were made and 
analysed using Poisson and logistic regression models. To measure trans-
mission of MSSA and MRSA between patients, consenting patients were 
swabbed for S. aureus and a combination of typing methods used to iden-
tify cases of cross-infection. Carer hand contamination with S. aureus was 
assessed using finger-plate sampling following patient contacts. 
3.0.9 Background 
Transmission 
Between the late 1950s and early 1970s a number of prospective studies were 
carried out in which all patients in a given ward were swabbed at regular 
intervals, enabling asymptomatic and symptomatic transmission to be de-
tected (see chapter 5). Such large-scale prospective ward-level studies do 
not appear to have been repeated since the early 1970s. Recent prospective 
studies that have been published have lacked sufficient detail for parame-
41 
ter estimation (see chapter 5). Instead, the hospital infection literature has 
been dominated by outbreak reports or retrospective surveys. The former 
are unlikely to be representative of the normal state of affairs in hospital 
wards, and both usually have insufficient reporting detail to be of much 
use (denominators are rarely reported, and the reasons and frequency of 
screening are not usually given). As a consequence, it is not clear how much 
normally undetected transmission of S. aureus occurs on wards. 
Both hospital populations and standard practices have changed substan-
tially over the past 20-30 years and hospital S. aureus strains may exhibit 
very different behaviour to earlier strains (Casewell, 1995). There is a need 
to conduct similar studies again, but now with the benefit of more accu-
rate and reliable typing methodologies, together with more sophisticated 
statistical analysis. 
Handwashing and contact patterns 
If the assumption that most transmission of S. aureus between patients 
occurs via the transiently colonized hands of health-care workers is justified, 
then the hand decontamination behaviour of the carers must be crucial to 
the transmission dynamics. 
Although there have been many observational studies on hospital wards 
aimed at collecting data relevant to infection control, most of these have con-
centrated solely on the handwashing practices of health-care workers (Lar-
son and Kretzer, 1995), usually with the objective of producing an overall 
hand washing "rate". Prior to this study, there appears to have been little 
attempt to relate handwashing compliance to factors associated with carers, 
patients and contact-types using a statistical model. 
Heterogeneity in the rates at which patients are contacted by carers and 
associations of contact rates with other patient risk factors for the acqui-
sition of S. aureus strains can have important impacts on the pathogen's 
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transmission dynamics (see chapter 4). The transmission dynamics will also 
be affected by who makes the contacts. For example, transmission patterns 
on wards where required patient contacts are repeatedly made by the same 
carer would be expected to differ from those on wards where they are evenly 
distributed amongst the different carers. However, literature searches failed 
to reveal any studies that attempted to measure patient-carer contact rates 
and contact patterns. 
3.0.10 Aims 
The aims of this study were therefore: 
• To investigate how much transmission of S. aureus (MSSA and MRSA) 
actually occurs between patients during the normal running of a typ-
ical medical/surgical ward. 
• To measure handwashing compliance in carers, and to determine the 
factors associated with poor compliance and sources of heterogeneity 
in hand washing rates. 
• To measure carer-patient contact rates, the epidemiologically impor-
tant factors associated with high contact rates, and to explore hetero-
geneities in these rates. 
• To investigate carer-patient contact patterns and look for departures 
from the assumption of homogeneous mixing made in chapter 2. 
• The current study was intended as a pilot, and an important aim 
was to evaluate the effectiveness of data collection methods, and to 
determine the form larger scale studies should take. 
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3.1 Method 
3.1.1 Study Environment 
Prior to the study, approval from ethics committee and ward staff was ob-
tained and the broad aims of the study were explained to the permanent 
ward staff. 
The study was based on a 15-bed mixed medical surgical ward and lasted 
for 1 month. After a preliminary period of two weeks where different data 
recording techniques were assessed, patient data and swabs were collected 
between the 6th of July and the 7th of August 1998. Observations of patient-
carer contacts and handwashes on the ward were all carried out between the 
13th of July and the 6th of August 1998. 
The ward was divided into three areas: one bay of four beds containing 
exclusively female patients (beds 1-4); one bay ofthree beds directly opposite 
the nurses station containing both male and female patients (beds 5-7); one 
side room (bed 8); and one bay of seven beds containing only male patients 
(beds 9-16, there was no bed 13). 
Two sets of data were collected: patient-carer contact data and asso-
ciated handwashing and transmission data. A nurse was employed for the 
duration of the study to take swabs, obtain patient consent, and jointly 
conduct ward observations with the author. 
3.1.2 Contact pattern data 
The contact pattern data consisted of recordings of direct contacts be-
tween patients and health care workers (HCWs). Patient-carer contacts 
were recorded in observation periods that lasted for lengths of time decided 
beforehand; typically 1.5 hours, but going up to 7.5 hours for overnight 
observation periods. Observation periods are illustrated in figure 3.1. 
Contact details were recorded on form CR1 (see appendix A for this and 
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other forms) and included the purpose of the contact, the patient and carer 
involved, the time of the contact, whether or not gloves were worn, whether 
or not an apron was worn, and whether or not it was preceded or followed 
by handwashing. All contacts were classified as one of the following: 
• Contact type I - Simple Touch 
This included casual contacts between the patient and carer, and tak-
ing pulse, blood pressure, temperature, etc. 
• Contact type II -Extensive Touch 
More prolonged contacts between the patient and carer including phys-
ical examination, physiotherapy, being helped to wash etc. 
• Contact type III-Complex Touch 
All contacts (short and long) between the patient and the carer where 
an invasive or semi-invasive procedure was carried out. This included: 
changing a wound dressing; inserting or adjusting a catheter; inserting 
or adjusting a drip. 
Where curtains were drawn the nature of the contact was assessed either 
by noting the equipment taken behind the curtain or by asking staff. In most 
cases there was no ambiguity as to the nature of the contact. In a few cases 
a guess as to the extent of the contact had to be made, and in such cases 
this was indicated on the recording form. A contact was considered to end 
when the carer left the patient or contacted a potentially contaminated site 
outside the patient's immediate environment. Carers present on the ward 
during the observation period were listed in form Cl and were identified by 
unique codes. Where possible this was completed from ward records before 
the observation period, though changes during the observation period were 
often required. It was found to be possible to observe contacts on patients 
in a1115 beds in the ward by moving around the ward, rather than viewing 
from a fixed location, except during the busiest observation periods. 
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3.1.3 Patient data 
For all patients entering the ward during the study period, or present on 
the ward at the beginning of the study, details were recorded on form PI. 
Additional data were collected during each day of the study period for each 
patient on the ward. These data were entered directly into form P2. 
3.1.4 Carer data 
Details of which nurse was on which shift and in which nursing team were 
kept for each day. The named-nurse l for each patient was also recorded. 
These data were entered in form CI. 
3.1.5 ICU observations 
11.5 hours of ward observations were also conducted in the Intensive Care 
Unit (leU) on the 17th and 18th of June, 1999. In this case only con-
tact details between patients under observation and HCWs were recorded. 
No other patient or carer details were noted. In contrast to observations 
based in the medical/surgical ward, consistently identifying staff members 
presented some problems: staff were not known to the observer beforehand 
and observations were carried out over only two days. It was found that 
these problems could be overcome by associating a unique ID code with a 
description of staff footwear, thus allowing identification of staff even when 
they were behind drawn curtains. 
3.1.6 Transmission data 
Staphylococcus aureus isolates (both sensitive and resistant strains) were 
collected from those patients who had provided written consent and agreed 
to be swabbed. The aim was to collect swabs from patients on admission 
IThe nurse with primary responsibility for that patient's care (Dooley, 1999) 
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to the ward, twice per week, and immediately prior to discharge or transfer. 
Nasal swabs were requested from all the nursing staff who were present on 
the ward during the study period, and as many of the other carers who 
worked on the ward during this period as was practicable. Transmission of 
S. aureus from patients to the hands of carers was investigated by taking 
finger streaks immediately before and after different procedures. No swabs 
were taken in the lCU. 
Transmission data were analysed by fitting them to a transmission model 
using an MCMC approach. This is described in chapter 8. 
Cultivation and identification 
Patient swabs were taken from the nose, axillae and throat. Carer swabs 
were taken only from the nose, usually by the carers themselves by cir-
cling the swab through both nostrils consecutively while applying even pres-
sure. All swabs were taken using sterile synthetic-tipped transport swabs 
(F108C, Bibby Sterilin, Staffordshire) which were used to inoculate salt 
broths (CM435, Oxoid, Basingstoke), pooling nose, throat and axillae swabs 
taken at the same time from a patient. 
After overnight incubation at 37°C the broths were used to inoculate 
mannitol salt agar (MSA) plates (CM85, Oxoid), and MSA plates supple-
mented with 5 mgjL oxacillin. These were incubated at 37°C and examined 
after 24 and 48 hours. S. aureus colonies were identified by colonial mor-
phology, ability to ferment mannitol, and coagulase production. Further 
confirmation of their identity was later provided by detection of the coagu-
lase gene and from colony morphology on Baird Parker medium. S. aureus 
colonies were then stored temporarily on nutrient agar slopes before being 
transferred onto tryptone soy agar (TSA, labM, Lancs) plates supplemented 
with 5% defibrinated horse blood (CS Microbiology, Buckingham). Colonies 
with distinct morphologies from each plate were subcultured and stored in 
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Tryptic Soy Broth (TSB, Difco laboratories, Detroit) with 10% glycerol at 
-70°C. Isolates obtained from the ward during the period of study as a 
result of routine hospital procedures were processed similarly. Initial cul-
turing, identification of S. aureus colonies, and transferring to slopes was 
carried out jointly with clinical microbiology staff at the hospital. 
Finger streaks were taken from both hands of carers before and after they 
touched patients believed to be carrying S. aureus by pressing fingers and 
thumbs firmly onto a blood agar plate (Oxoid). After overnight incubation 
at 37°C, colonies resembling S. aureus were subcultured onto MSA and 
MSA supplemented with oxacillin, and then processed as for the rest of the 
isolates described above. 
Antibiotic susceptibility testing 
All isolates were tested for antimicrobial susceptibility by the disk diffusion 
method on Mueller-Hinton agar according to National Committee for Clin-
ical Laboratory Standards (NCCLS) guidelines (1997). The following an-
tibiotics were used: penicillin; sulphamethoxazole; vancomycin; teicoplanin 
(30JLg); ciprofloxacin; doxycycline (30U); hydrochloride; gentamicin; to-
bramycin (lOpg); neomycin (30/-,g); kanamycin (30/-,g); streptomycin (10 
U); chloramphenicol; spiramycin (100JLg); fusidic acid (lOJLg); rifampicin; 
mupirocin (5pg); tetracycline; minocyc1ine (30JLg); clindamycin; erythromycin; 
and lincomycin (15JLg) (all from Oxoid, UK). NeCLS breakpoints were used 
(1997), except in the cases of doxycyc1ine,tobramycin, kanamycin, strepto-
mycin, spiramycin, fusidic acid, minocycline, and lincomycin for which the 
French breakpoints were used (Courvalin and Soussy, 1996). Swedish break-
points were used for teicoplanin (Ringertz et al., 1997). A zone diameter of 
less than 20mm around the 5pg mupirocin disk was considered to indicate 
at least low-level resistance, while strains that grew without a zone of inhi-
bition around a 200pg mupirocin disk were considered to possess high-level 
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resistance. 
Oxacillin resistance (equivalent to methicillin-resistance) was determined 
by screening on TSA plates supplemented with 10mg/L oxacillin (Sigma 
Chemicals Co., St Louis) (NCCLS, 1997) and confirmed by the detection of 
the mecA gene as previously described (Murakami et at., 1991). 
Molecular typing 
Molecular typing was based on polymorphisms of the coagulase and protein 
A genes, and randomly amplified DNA (RAPD). 
DN A preparation 
Genomic DNA was isolated using a Wizard Genomic DNA Purification Kit 
(Promega, WI), with a number of modifications to the manufacturer's in-
structions. In short, tryptic soy broth (TSB, Difco, Detroit) was inocu-
lated with a single colony, and incubated overnight with vigorous shaking 
at 37°C. 1 ml of the culture was transferred to a 1.5 ml micro centrifuge 
tube and centrifuged at 13000 x 9 for three minutes. Supernatant was re-
moved and cells resuspended in 48011-1 of 50mM EDTA before adding 12011-1 
of 40mg/ml lysozyme and incubating at 37°C for 20 minutes. The sample 
was centrifuged at 13000g for three minutes, the supernatant removed and 
the cells resuspended in 60011-1 of nuclei lysis solution, then incubated at 
80°C for 5 minutes. 311-1 of RNase solution was added to the samples, mixed 
by inversion, and incubated for 15 minutes at 37°C. After cooling to room 
temperature, adding 200 11-1 of protein precipitation solution, vortexing, and 
incubating on ice for 5 minutes, the samples were centrifuged at 13000 x 9 
for three minutes in the cold room and the supernatant removed and added 
to 600 11-1 of room temperature isopropanol. These samples were then mixed 
by inversion, centrifuged at 13000 x 9 for two minutes and the supernatant 
discarded. The DNA pellet was washed with 70% ethanol which was aspi-
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rated off after centrifuging for 2 minutes at 13000 x g. Samples were vacuum 
dried for 30 minutes before rehydrating by incubating with 100 ",,1 of DNA 
Rehydration Solution for one hour, and stored at -20°C. 
Arbitrary primed PCR (AP-PCR) 
Typing based on Randomly Amplified Polymorphic DNA (RAPDs) closely 
followed a previously described protocol (Murchan et al., 1998). 50 ",,1 of 
reaction mixture was used, containing 0.5",,1 of Tag DNA polymerase; 2.5",,1 
of MgCb; 0.1",,1 of each of dATP, dCTP, dGTP and dTTP; and 5",,1 of Tag 
PCR buffer, all as supplied by Gibco BRL (Gaithersburg, MD). To this 2",,1 
of DNA template and 0.5mM of primer were added. Primers used were: 5'-
TCA CGA TGC A-3' (AP4) and 5'-GTG GAT GCG A-3' (AP7). Cycling 
was performed in a Touchdown thermo cycler (Hybaid, Middlesex) and PCR 
reaction conditions were: predenaturation at 94°C for five minutes; 5 cycles 
of 94°C for 20s, 35°C for 30s, 72°C for 90s; 30 cycles of 94°C for 20s, 55°C 
for 30s and 72°C for 30s; then one minute at 72°C. Amplified DNA was 
stored at -20°C. PCR-products were separated by electrophoresis on 1.5% 
agarose gels (Gibco BRL) with ethidium bromide using a 1kb molecular 
weight marker and photographed under UV light. 
Detection of protein A and coagulase gene polymorphisms 
Typing based on restriction fragment length polymorphism (RFLP) of the 
protein A gene was similar to previously described methods (van Belkum 
et al., 1997; F'renay et al., 1994). The reaction mixture differed from that 
used for the AP-PCR only in the following respects: only 1J.Ll of each DNA 
template was used; only 1J.Ll of MgCb was used; the primers used were 5'-
GCT AAA AAG CTA AAC GAT GC-3' and 5'-CCA CCA AAT ACA GTT 
GTA CC-3' (Gibco BRL). PCR conditions were as follows: 35 cycles of 
denaturation at 95°C for one minute, annealing at 50°C for one minute, and 
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chain extension at 72°C for one minute 30 seconds; followed by 5 minutes at 
72°C. PCR products were digested using the restriction endonuclease Rsal 
(Gibco BRL) according to the manufacturer's instructions, and examined 
using electrophoresis with a 1.5% agarose gel and a 1KB molecular weight 
marker. 
RFLP analysis of the coagulase gene closely followed the methods of 
Goh et aZ. (1992), but used only the two primers: COAG3, 5'-AAA GAA 
AAC CAC TCA CAT CA-3'; and COAG2, 5'-CGA GAC CAA GAT TCA 
ACA AG-3'. Otherwise, the reaction mixture was as for the protein A 
gene. PCR conditions were: 40 cycles of 95°C for 30s, 55°C for 2 minutes, 
72°C for four minutes; followed by 5 minutes at 72°C. PCR products were 
digested using the restriction endonuclease AZul (Gibco BRL) according to 
the manufacturer's instructions, and then analysed as described above. 
3.1. 7 Statistical analysis 
Handwashing data 
Handwashing data were recorded as a binary responses associated with each 
carer-patient contact, so logistic regression was used to construct a descrip-
tive model of the probability of any particular carer washing their hands for 
a given contact. Two distinct models were constructed: one for pre- and 
one for post-contact hand decontamination. 
The data collected can be considered to have a hierarchical structure: at 
the lowest level are observations of handwashing behaviour associated with 
each contact. These can be considered to be clustered within two overlapping 
higher levels: the different observations periods; and the different carers. 
If such clustered observations are correlated, then the assumptions of a 
standard logistic regression are violated: the residuals are no longer inde-
pendent, and type I errors are more likely than the a value would suggest 
(Hox, 1995). One potential solution would be to include a dummy vari-
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able for each observation period and each carer. However, a more economi-
cal and informative approach is to use the multilevel modelling framework, 
which considers the higher level units themselves to be samples from a larger 
population (Goldstein, 1995). Thus, when constructing the model, both in-
tercepts and slopes were allowed to vary randomly across the levels, and 
estimates for both fixed and random effects were obtained. 
MLwiN v.1.0.2 (Goldstein et at., 1998) was used for initial model explo-
ration and fitting using second order penalized quasilikelihood (PQL) when 
this converged, and first order PQL or marginal quasilikelihood (MQL) oth-
erwise. Second order PQL has been shown to provide much better estimates 
than 1st order PQL or MQL when fitting multilevel models with binary re-
sponses (Goldstein and Rasbash, 1996), but recent simulation studies have 
shown that it still underestimates the true values of higher order variances 
in such random effects logistic regression models, and gives standard errors 
which are too low (Draper and Browne, 2000). The final parameter esti-
mates were therefore obtained using Markov Chain Monte Carlo (MCMC) 
methods, which have been shown to outperform the quasilikelihood based 
methods for this type of model (Draper and Browne, 2000). In particu-
lar, Metropolis sampling as implemented in the program WinBUGS v.1.2 
(Spiegelhalter et at., 1999) was used to obtain posterior distributions to 
the parameters for the previously selected models. Diffuse priors were used 
throughout. 
Explanatory variables considered in the regression are listed in table 3.1. 
Following data exploration with a standard logistic regression analysis 
the following interactions were also considered in the regression: [carer type] 
* [contact type]; [carer type]* [activity level]; [carer type]*[day]. 
During model construction variables significant at or near to the five per 
cent level were added to the model in a stepwise fashion. The approximate 
Wald hypothesis test was used to determine significance. Random effects 
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Level Variable Coded as 
Contact contact type baseline category is for type 1 contacts 
binary variables for type 2 and type 3 contacts 
MRSA status of patient 0 - not known to be colonized 
1 - known to be colonized 
sex of patient 
sink adjacent to bed 
Carer carer type 
Observation time since start of study 
period Activity level 1 
Activity level 2 
Activity level 3 
time of day 
observer 
ward sister present 
o - female; 1 - male 
0- no; 1 - yes 
baseline category is nurse 
binary variables for: 
doctor 
health care assistant 
student nurse 
student doctor 
other (eg. physiotherapist, phlebotomist etc) 
time in days, mean-centred 
mean-centred, continuous value 
mean-centred, continuous value 
mean-centred, continuous value 
1 - observation period stopped before midday 
o otherwise 
Baseline category is data recorded by observer 1 
binary variables for two observers and observer 2 
baseline category is for no sister present 
binary variables for: 
ward sister present and active 
acting ward sister present and active 
Activity levels 1, 2, and 3 give three distinct measures of the level of ward activity, 
and are defined as follows: 
• Activity level 1 The nurse-to-patient ratio, defined as the ratio of the number 
of patients seen to be contacted during the observation period to the number 
of nurses observed to make contacts. 
• Activity level 2 The ward contact rate of a given observation period, defined 
as the number of contacts made by nurses per hour. 
• Activity level 3 The ward contact rate per nurse. i.e. activity level 2 divided 
by the number of nurses making the observed patient contacts. 
Table 3.1: Variables considered for inclusion in the logistic regression. 
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were also retained only if significant at or near to the five per cent level. 
Contact data 
Contact rates: Count data corresponding to the number of contacts re-
ceived by each patient in each observation period were analysed using a 
Poisson regression model. Since some patients might be expected to require 
more contacts than others, and some observation periods might be expected 
to be busier than others (reflecting the time of day, ward rounds, day of 
week, staffing levels etc), the multilevel framework is again appropriate. In 
this case there are again two overlapping classifications. The response vari-
able (number of contacts of one patient in one observation period) can be 
considered to be clustered within higher level units corresponding to either 
the patients or the observation periods. 
Again, MLwiN was used for model selection, and WinBUGS for final 
parameter estimates, using diffuse priors. 
Model construction was carried out in a similar manner to that for the 
logistic regressions. Explanatory variables considered for inclusion in the 
model were chosen for epidemiological relevance and are listed in table 3.2. 
Contact patterns: To formally test the assumption that patient contacts 
are not preferentially met by certain nurses, patient x carer contact matrices 
for each of the observation periods where all beds were observed were formed. 
Cell ij of such a table records the number, Cij, of contacts made by nurse j 
on patient i in the observation period. The null hypothesis is that the Lj Cij 
contacts received by patient i are distributed across the columns (the carers) 
according to multinomial distribution, where each contact has a probability 
of ~i: c;:j of being met by carer j. Because the Cij were mostly ones and 
twos, asymptotic techniques were not appropriate. Instead, exact tests of 
the null-hypothesis were performed using StatXact (1997). This program 
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Level 
Patient x Obs. period 
Patient 
Observation period 
Variable 
Patient taking antibiotics 
Operation in last 24 hours 
Operation in last week 
(and not in last 24 hrs) 
length of ward stay to date 
Catheter present 
Other line presentt 
sex 
In(age) 
admitted from home 
transferred from another ward 
In( days in hospital in last year) 
time of day 
Coded as 
0- no; 1 - yes 
0- no; 1 - yes 
0- no; 1 -yes 
time in days (1-89) 
0- no; 1 - yes 
0- no; 1 - yes 
o - female; 1 - male 
in years, mean-centred (26-91) 
0- no; 1 - yes 
0- no; 1 - yes 
(1-186) 
1 - obs. period stopped before midday 
o otherwise 
Table 3.2: Variables considered for inclusion in the patient contact Poisson 
regression. Ranges of non-categorical variables (before taking the logarithm) 
are shown in parentheses. 
t Any line excluding catheter, oxygen line, or nasogastric tube. 
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enumerates all possible contingency tables consistent with the marginal to-
tals, and returns the probability (the exact p-value) of getting a likelihood 
less than or equal to that of the actual data. 
3.2 Results 
3.2.1 Data collected 
Of the 685 carer-patient contacts observed, carers were seen to decontam-
inate their hands before the contacts on 36.1% of the occasions, and after 
the contacts 39.1% of the time. 
A total of 88 hours and 40 minutes of ward observation were conducted 
over 45 observation periods. The number of beds under observation varied 
between observation periods: for 66.7 hours (and 30 observation periods) all 
15 beds were observed; for 1.5 hours and 1 observation period 14 beds were 
observed; for 11.8 hours and 8 observation periods 9 beds were observed; 
for 8.4 hours and five observation periods only 8 beds were observed; and 
for 0.25 hours and one observation period two beds were observed. In total, 
the 45 observation periods give a total of 1195.6 observed patient hours. 
Figure 3.1 shows the distribution of observation periods throughout the 
day. Over the one month study period there were 54 patients recorded on 
the ward (some patients who stayed less than 24 hours may not have been 
included). The mean age was 65 (range: 26 to 91). Over the same period 
71 different HCWs were observed to make contact with patients. Of these 
26 were nurses, student nurses or health-care assistants. The others-the 
peripatetic HCWs-were not known to the observers, and it is likely that 
some of these may have been counted twice in the above figure. 
Patients were not necessarily in their beds during the observed hours. In 
many cases, though the beds were theoretically occupied, the patients were 
physically absent. Often they were in the operating theatre, on weekend 
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Figure 3.1: Distribution of ward observation periods. 
leave, smoking in the corridor, having limbs fitted , or undergoing physio-
therapy. In the analysis (as only within-ward transmission is under consid-
eration) , such beds were considered to be occupied. A bed was consid red to 
be empty only if it could have been occupied by a newly-admitted patient. 
During these observation periods a total of 690 contacts were observed. 
These comprised 483 type 1 contacts, 118 type 2 contacts, and 89 type three 
contacts . Only 5 patient-to-patient contacts where observed, though it is 
likely that some may have gone unobserved during the observation periods 
as a number of the patients would often smoke together in an area just 
outside the ward. 
Table 3.3 gives a breakdown of contact types made by three carer cat-
egories: doctors (including medical students); nurses (including student 
nurses and health-care assistants); and others. 
Patient-carer contact rates obtained in the different observation p riods 
are illustrated in figure 3.2. Contact rates showed considerable variation 
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Figure 3.2: Distribution of observed contact rates by time of observation 
period. One observation period was undertaken to assess the feasibility of 
conducting observations during a ward round. This gave a conta t rate of 
240 /patient /day, and is not shown in the figure. See also section 3.2.3. 
Doctors 
Nurses 
Other 
Contact type 
Type 1 Type 2 Type 3 
64 19 15 
394 93 61 
25 6 13 
Table 3.3: Frequency of contacts by carer category. Note that medical 
students and student nurses are included in the doctors and nurses categories 
respectively 
58 
throughout the day, with peaks at about 9am and 4pm, and considerably 
lower contact rates in the early hours of the morning. 
3.2.2 Handwashing 
When analysing these data in the multilevel logistic regression, models with 
only one level of clustering were first considered. Level 1 consist.ed of the 
individual cont.acts, and the clustering at level 2 was considered to corre-
spond to either the carer, observation period, or patient. When level 2 was 
taken as the observation period, there was found to be highly significant 
variation between observation periods in handwashing frequency, both for 
handwashes before and after patient contacts. No significant level 2 variation 
was found when the higher level unit was taken as the patient, for both pre-
and post-contact handwashes. When level 2 was taken to be the carer, once 
the different carer types were accounted for in the model, no significant 
variation between carers remained for handwashes after patient contacts. 
However, the variation between carers for handwashes before contacts was 
just significant at the five per cent level. Because of this, a cross-classified 
model for pre-contact handwashes was considered (Goldstein, 1995): level-l 
contacts were considered to be embedded within both carers and observa-
tion periods, which constituted overlapping level 2 units. After fitting such 
a cross-classified model in MLwiN with 2nd order PQL, the variation be-
tween carers was found not to be significant (P > 0.1), while that between 
observation periods was significant at the 10%, but not 5% level. As a re-
sult of this, only level 2 clustering corresponding to the different observation 
periods is considered in the following analysis. 
The model for pre- and post-contact handwashes is then given by equa-
tions 3.1 to 3.3, where i corresponds to the patient-carer contacts, j corre-
sponds to the observation periods, and Yij is 1 if there was a handwash for 
the ijth contact, and 0 otherwise. b is the vector of slope parameters cor-
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responding to the vector of explanatory variables Xij- Uj is the departure of 
the intercept for the jth observation period from the mean, a. Normal score 
plots of these level 2 residuals indicated good agreement with the assumption 
that they follow a normal distribution. 
Yij '" binomial( 7rij, 1) 
logit(7rij) = a + Uj + bXij 
Uj '" N(O,a~) 
(3.1 ) 
(3.2) 
(3.3) 
Final parameter estimates, obtained using WinBUGS, are given in ta-
ble 3.4. Those variables listed in table 3.1, but not appearing in table 3.4, 
were not significant in the final model. 
3.2.3 Contact rates 
When constructing the multilevel Poisson regression model for the contact-
count data, two different 2-level hierarchies were first considered. In both 
cases level 1 corresponded to observations on one patient in one observation 
period. Level 2 was taken as the patient in the first case, and the observation 
period in the second. In both cases, even after including all the significant 
explanatory variables, there was found to be significant level 2 variation in 
the intercepts (though not in any of the slopes). Both models showed fairly 
good agreement with the assumption that level 2 residuals are normally dis-
tributed, though the former was a little leptokurtotic. Both models also 
exhibited large and significant extra-Poisson variation, indicating that nei-
ther classification alone could suffice, and that instead both classifications 
should be used. 
Level-2 residual plots also indicated that one observation period was 
clearly an outlier (residual equal to 4.9 standard deviations of the level 2 
observation period residuals) . This corresponded to the shortest observation 
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Parameter Estimate 95% credible interval 
Pre-contact handwashes 
intercept (a) -1.10 {-1.48, -0.74} 
contact type 2 2.13 {1.62, 2.65} 
contact type 3 3.08 {2.44, 3.76} 
doctor -1.51 {-2.21, -0.83} 
health care assistant -1.04 {-1.70, -0.41 } 
other -1.20 {-2.26, -0.18} 
(day since start of study) x nurse t -0.07 {-0.12, -0.04 } 
a~ (level 2 intercept variance) 0.57 {0.17, 1.24 } 
Post-contact handwashes 
intercept (a) -0.99 {-1.34 , -0.66} 
contact type 2 2.42 {1.89, 2.98} 
contact type 3 3.07 {2.41 , 3.76} 
doctor -1.98 {-2.71 , -1.29} 
health care assistant -0.74 { -1.34, -0.16} 
(day since start of study) x nurse t -0.06 {-0.10, -0.02} 
(day since start of study) x other t 0.16 {0.05, 0.29} 
a~ (level 2 intercept variance) 0.45 {O.ll , 1.03} 
Table 3.4: Coefficients from the random effects logistic regression. t For 
computational reasons, the "day since start of study" variable was mean-
centred before performing the analysis by subtracting 13.90. Intercept esti-
mates thus correspond to nurses washing their hands before or after type I 
contacts on this day of the study. Estimates were obtained using WinBUGS, 
using a run of 44,000 samples and burn-in of 1000 for the pre-contact data 
and 50,000 samples with a burn-in of 10,000 for post-contact data. Diffuse 
priors were used: (N(O, 10-6 ) for slope parameters, and r(O.OOl, 0.001) for 
precessions. 
61 
period (25 minutes), where only two beds were being observed, both at the 
time being visited by a ward round. This observation period in fact fell 
on the first day of the study, and was conducted to assess the feasibility of 
observing contacts during a ward round. It was therefore excluded from the 
subsequent analysis. 
A three-level cross-classified model was therefore constructed, including 
all those explanatory variables that were significant in the two-level models. 
This three-level model is defined by equations 3.4 to 3.8. 
Cjk rv poisson(/1-jk) 
10g/1-jk = a + bXjk + logtj + Uj + Uk + Ajk 
Uj rv N(O,a~.) 
J 
Uk '" N(O,a~k) 
Ajk '" N(O, aD 
(3.4) 
(3.5) 
(3.6) 
(3.7) 
(3.8) 
Here Cjk represents the number of contacts received by patient k during 
the jth observation period. b is again the vector of slope parameters corre-
sponding to the explanatory variables Xjk. Uj and Uk are the random effects 
for the observation periods and patients respectively. Ajk is the patient 
by observation period random effect which models extra-Poisson variability. 
Because different observation periods had different lengths, offsets log(tj) 
are included, where tj is the duration in minutes of the jth observation 
period. 
Estimates for the elements of b significant in either of the 2-level models 
are given in table 3.5. 
The rate ratios shown in table table 3.5 indicate how the per-patient 
contact-rates change with the explanatory variables. For categorical vari-
ables the contact rate is multiplied by the rate ratio: thus patients taking 
antibiotics are estimated to be contacted at 1.89 times the rate of patients 
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Parameter Estimate 95% credible interval Rate ratio 
Fixed effects 
intercept (a) -5.39 {-5.92, -4.90 } 
patient taking antibiotics 0.64 {0.31 , 0.98 } 1.89 
Operation in last 24 hours 0.55 { 0.07, 1.02 } 1.74 
In(days on ward) -0.12 { -0.28 , 0.03 } 0.88 
Sex 0.34 {-O.lO , 0.80 } lAO 
In(Age) (mean centred, mean=4.16) 0.71 {-0.02 , 1.42 } 2.03 
Catheter 0.04 {-OA3 , 0.51 } 1.04 
Other Line 0.40 {0.03, 0.77 } 1.49 
Random effects 
a~. (observation period) 0.26 {0.O9, 0.53 } 
] 
a~k (patient) 0.15 {O.Ol, 0.41 } 
a~ (extra-Poisson) 0.60 {O.36, 0.90 } 
Table 3.5: Parameter estimates for the multilevel Poisson regression model 
of patient-carer contact rates. Variables that were not significant in ei-
ther of the 2-level models are not shown. Rate ratios are defined as 
Exp{parameter estimate), and are discussed in the text. Estimates were 
obtained using WinBUGS, using a run of 100,000 samples and burn-in of 
10,000. Diffuse priors were used: N{O, 10-6 ) for slope parameters, and 
r(0.001,0.001) for precisions. 
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not taking antibiotics, other factors being equal. For non-categorical vari-
ables, the rate ratios give the factor by which the contact rate changes for 
a proportional change in the variable. Thus, increasing the number of days 
a patient has spent on the ward by a factor m is estimated to result in an 
increase in the contact rate by a factor equal to the rate ratio raised to the 
power In(m). So, for example, doubling the time spent on the ward is esti-
mated to decrease the contact rate by a factor of 0.92 (0.88In(2)). Similarly, 
doubling the age is estimated to increase the contact rate by a factor 1.63. 
In fact the 95% credible intervals for both age and time spent on the ward 
contain zero. However both might be expected to be determinants of the 
contact rate a priori, and both intervals only just include zero, so they have 
been left in the model. 
3.2.4 Contact patterns 
Nurse-patient associations 
Of the 25 patient-carer contact tables examined (corresponding to the ob-
servation periods where all beds in the ward were being observed and with 
sufficient contacts to make an assessment), six showed departures from ho-
mogeneity significant at the 5% level. An upper bound for the probability 
of this given that the null hypothesis can be calculated from the binomial 
distribution to be 0.0012. Thus, there is very strong evidence to suggest 
that a patient's contacts are not equally likely to come from each nurse, 
even when allowing for different nurses' contact rates. 
Two potential sources of this heterogeneity were considered: nursing 
teams and named nurses. Firstly, all nurses were assigned to one of two 
teams (known as the red and blue teams). The blue team were primarily 
responsible for the care of patients in beds 1-7, and the red team for beds 
8-16. Though all patients were in fact cared for by members of both teams, 
this team structure clearly provided a significant source of heterogeneity. 
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Beds 1-7 Beds 8-16 Total 
Blue Team 103 56 159 
Red Team 93 156 249 
Unknown team 4 0 4 
Totals 200 212 412 
Table 3.6: Patient-nurse contacts classified by team membership of nurses 
Table 3.6 gives breakdown of the distribution of contacts to different beds 
by team membership. Thus, blue team nurses made just over 1.8 time as 
many patients contacts on beds 1-7 as on beds 8-16, while red team nurses 
made almost 1.7 times more contacts on beds 8-16. 
To see how much of the heterogeneity this team structure accounted for, 
patient x nurse contact tables were again constructed as described above. 
However, data from each observation period were split into two tables: con-
tacts on beds 1-7; and contacts on beds 8-16. When analysed as described 
above for the whole ward data the null hypothesis (the multinomial distri-
bution) could be rejected in only 3 out 43 cases. The upper bound for the 
probability of this is now (from the binomial distribution) 0.167, and no 
longer provides sufficient evidence to reject the null hypothesis The exact 
likelihoods of each of the 43 tables could be combined, and a Monte Carlo 
sampling strategy used to estimate the chance of getting this or a lower like-
lihood. Unfortunately, while StatXact does support Monte Carlo sampling, 
sampling across multiple tables has not been implemented so no attempt to 
detect residual heterogeneity was made. 
The other possible cause of heterogeneity considered arises from the re-
cently introduced practice of "named nursing". A patient's named nurse is 
allocated when the patient is admitted to the ward, and is considered to be 
responsible for that patient from admission to discharge (Dooley, 1999). 
Fifty-five patient-named nurse pairings were identified from the hospital 
computer systems (PAS), and 39 of these were confirmed at ward-level. Of 
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these, 23 pairs were seen to be present on the ward during the same observa-
tion periods. Two of these pairs corresponded to a long-stay patient whose 
named nurse changed mid-way through the study. To avoid the considerable 
complications this would have caused, all observations for this patient were 
excluded from the analysis. 
Every patient's named nurse belonged to the team with primary re-
sponsibility for that patient's care. The patient-carer contact rates of the 
21 named-nurse-patient pairs were therefore compared with contact rates 
for the 120 nurse-patient pairs for nurses who weren't named nurses, but 
who nonetheless belonged to the same team. In both cases, only observa-
tion periods where the presence of both patient and carer was confirmed 
and the patient was under observation were used. Contact rates were then 
calculated as the ratio of the total number of contacts observed between 
each pair, and the total time they were present during the same observation 
periods. Mean daily contact rates {and standard errors} for named-nurse-
patient pairs, and non-named-nurse-patient pairs were 5.71{1.30} and 6.24 
(0.88) respectively. Clearly these differences are not significant. Variances 
however did differ significantly between the two groups (P=0.007). How-
ever, the non-named-nurse-patient contact rates did contain one obvious 
outlier (with a contact rate of 64.0 days-I). When this point was excluded 
the non-named-nurse-patient contact rate was reduced to 5.75, and the 
difference between the variances of the two groups was no longer significant 
at the 5% level {P=0.056}. Overall, no evidence was found to suggest that 
named-nurses contacted their patients at rates differing from those of other 
members of the same nursing team. 
Contacts in the ICU 
Patient-carer contact rates recorded in the leU are shown in table 3.7. The 
overall mean contact rate per patient was 144 contacts/day {total number 
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of contacts observed/total patient-days observed). 
In contrast with the situation in the medical/surgical ward, a large pro-
portion of each patient's contacts in the leU came from a nurse specifically 
assigned to that patient's care. The last column in table 3.7 gives the pro-
portion of contacts for each patient that came from this nurse. Of all the 
patient-carer contacts observed, 60% came from the patient's assigned nurse 
The remaining contacts were divided between other nurses (principally for 
procedures requiring more than one nurse), and other carers (doctors, phys-
iotherapists etc). 
3.2.5 Transmission data 
Patient carriage 
Details of all the patient swabs are given in tables 3.8 and 3.9. Of the 46 
swabs that were taken as part of routine microbiological screening, the 18 
routine screens for carriage usually only looked for MRSA strains, and would 
have failed to detect MSSA carraige. 
Of the 50 patients who stayed on the ward during the observation period, 
swabs could not be obtained from 32 due to either refusal or inability of the 
patients to provide informed consent to take part in the study. No swabs at 
all (including routine swabs) were obtained from 18 of these patients. 
Staff carriage 
Table 3.10 gives the breakdown of the number of staff working in the ward 
during the study who were swabbed. Those carers present on the ward 
during the study who weren't swabbed either refused to take part in the 
study, were not present long enough for there to be an opportunity to swab 
them, or were present on the ward for too short a period time to merit 
swabbing. None of the four carers found to be carrying S. aureus were 
colonized with MRSA. 
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Patient Observation Period Duration of # Contacts from #Contacts from Total contact Proportion of contacts 
ob. period (hrs) assigned nurse others rate (per day) from assigned nurse 
1 1 2.5 14 5 182.4 0.74 
2 1 2.5 5 3 76.8 0.63 
3 1 2.5 12 8 192 0.60 
4 1 2.5 9 0 86.4 1.00 
5 2 3.0 8 4 96 0.67 
6 2 3.0 5 6 88 0.45 
7 2 3.0 6 10 128 0.38 
8 2 3.0 14 9 184 0.61 
9 3 3.0 9 9 144 0.50 
0:. 10 3 3.0 5 4 72 0.56 
00 3.0 10 6 128 0.63 11 3 
12 3 3.0 15 9 192 0.63 
13 4 1.5 7 10 272 0.41 
14 4 1.5 9 2 176 0.82 
15 4 1.5 8 5 208 0.62 
16 5 1.5 4 3 112 0.57 
17 5 1.5 5 5 160 0.50 
18 5 1.5 9 7 256 0.56 
19 5 1.5 6 2 128 0.75 
Table 3.7: Contact rates in the ICU 
Site swabbed 
Carriage site Wounds All sites 
Routine swabs 18 (3) 28 (11) 46 (14) 
Study swabs 47 (10) 47 (10) 
Total 65 (13) 28 (11) 93 (24) 
Table 3.8: Number of swabs taken, both as part of the study, and for rou-
tine purposes, as part of normal hospital procedure. Numbers in brackets 
indicate S. aureus positive swabs. The carriage sites swabbed as part of 
the study were nose, throat and axillae. Routine swabs included swabs of 
throat, nose, axillae, ear, hairline, perineum, penis, sputum, or combinations 
of these. 
Site swabbed 
Carriage site Wounds All sites 
Routine swabs 7 (3) 15 (6) 20 (8) 
Study swabs 18 (4) 18 (4) 
Total 24 (5) 15 (6) 32 (10) 
Table 3.9: Number of patients swabbed, both as part of the study, and for 
routine purposes, as part of normal hospital procedure. Numbers in brackets 
indicate the number of patients from whom S. aureus was recovered. 
N umber on ward 
Number swabbed 
Nurse 
19 
14(3) 
Student nurse 
4 
3(0) 
Doctor 
30 
1(0) 
Med. student 
3 
1(1) 
Other 
24 
o (0) 
Table 3.10: Number of carers swabbed. Numbers in brackets indicate the 
number from whom S. aureus was recovered. No carer was swabbed more 
than once. 
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Approximate fragment size (bp) 
RFLP type 500 450 400 320 240 160 
A + + + 
B 
C + + + + + 
D + + 
E + 
F + + 
G + + + 
H + + 
I + + 
J + 
Table 3.11: RFLP patterns of AZul-digested coagulase gene PCR products 
(ignoring undigested fragments). 
3.2.6 Typing of strains 
From the 24 S. aureus positive swabs, after separating strains growing 
with distinct morphologies from each swab (or each pooled nose, throat and 
axillae swab) 50 isolates identified as S. aureus were selected for typing. 
Four of these (3b, 6, 22b and 36a) subsequently failed the Baird Parker test, 
and are not included in the rest of the analysis here. 
Coagulase gene polymorphisms 
Each S. aureus isolate produced a coagulase gene PCR product between 
approximately 500 and 900 bp. After digestion with AluI nine distinct RFLP 
patterns were identified (table 3.11 and figure 3.3). 
Protein A polymorphisms 
45 of the isolates produced an amplicon ranging from about 340 to 660 
bp following the protein A peR. The number of 24bp repeat elements in 
the amplicon was estimated by subtracting 53bp (the unrepeated part of 
the amplicon (UhIen et al., 1984)) from the estimated size of the variable 
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396 
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Figure 3.3: 
lkb ABC C G J 
tion of coagulase gene amplicons obtained from S. aureus strains isolated 
from patients and carers. Nine distinct patterns were observed. Before 
digestion amp Ii cons were between approximately 500 and 900bp. 
RFLP type approx. restriction fragment sizes (bp) estimated number of 24bp repeats 
A 450 17 
B 240 7 
C 330 12 
D 300 10 
E 150 4 
F 260 9 
G 130 3 
Table 3.12: RFLP patterns of RsaI-digested protein A PCR products ob-
tained from S. aureus strains isolated from patients and carers. The am-
plicon sizes correspond to fragments containing the 24-bp repeats in the X 
region of the spa gene. 
A A B c D E F B G A A E D 
Figure 3.4: RFLPs from the RsaI dig stion of protein A gene amplicons ob-
tained from S. aureus strains isolated from patients and carers. Seven dis-
tinct patterns were observed, containing between three and 17 24bp repeat 
in the variable size fragment. Three isolates produced no PCR products. 
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D 
A A A CAD 0 E F G 0 C 0' E lkb 
Figur 3.5: RAPD products obtained using the AP7 primer with S. au-
reus strains isolated from patients and carers. Eight distinct patterns w re 
observed and seven isolates produced no produ ts. 
size fragment produced by the RsaI digestion of prot in A amplicon and 
dividing by 24. The was always a fragment of about 220bp. The sev n 
distinct patterns observed are detailed in table 3.12 and shown in figur 3.4. 
RAPDs 
Eight di tinct RAPD patterns were observed. These have b en lab 11 d A-
H. All of these came from PCRs using the AP7 primer. AP4 ould not 
reliably be made to produce RAPD products. 
Seven of the isolates produced no discernible RAPD produ ts, or bands 
too faint to determine a pattern type. Figur 3.5 displays a sel ction of 
the RAPD products using AP7, including the most commonly occurring 
patterns. 
Antihiograms 
Six different resistance patterns w re found: 
• A. Penicillin, Ciprofioxacin, Spiramycin, Erythromycin, Oxacillin 
• B. Penicillin, Ciprofioxacin, Erythromycin Oxa illin 
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• C. Penicillin 
• D. Sensitive to all antibiotics tested 
• E. Penicillin, Erythromycin 
• F. Penicillin, Erythromycin (intermediate), Oxacillin 
The presence of the mecA gene was confirmed in all strains showing 
resistance to oxacillin. 
Summary of typing results 
Table 3.13 summarises the phenotyping and genotyping results for the whole 
ward. 
The results show that patients 1 and 2 were carrying indistinguishable 
MRSA strains. Isolates 19b and 8 also gave identical types under all four 
typing methods, suggesting that strains carried by patients 10 and 7 were 
related. Isolates 35 (from a nurse's hands) and 36b (from a different nurse's 
nose) also typed identically under all methods, suggesting a common source. 
Isolate 4a shared a coagulase type, RAPD type and antibiogram with 8 and 
19b though differed in the protein A type. The number of protein A repeats 
has been reported to occasionally vary between strains otherwise typing 
identically (Hoefnagels-Schuermans et al., 1997). It therefore seems likely 
that isolates 8 and 19b are epidemiologically related. 
Isolate 11 differs from isolates recovered from patients 1 and 2 only in 
the protein A type and antibiogram. However, unlike those isolates, it was 
not an MRSA, but was in fact sensitive to all antibiotics tested. Poston 
et al. (1993) have reported that mec and spa are linked, and can sometimes 
be co-eliminated. It is conceivable that in this case mec could have been 
eliminated and a mutation in the spa locus occurred, but without further 
information they should be assumed to be different strains. 
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Type codes 
Isolate # coa RFLP protein A RFLP RAPO antibio ram swab date patient # swab sites strain ID 
la A A A 8/7/98 1 NTA 1 
14a A A A B 8/7/98 1 NTA 1 
14b A A A B 8/7/98 1 NTA 1 
23 A A A B 15/7/98 1 NTA 1 
2410 A A B 15/7/98 NTA 
24b A A A B 15/7/98 NTA 
24c A A A 15/ 7/98 1 NTA 
26 A A A B 21/ 7/98 1 NTA 
27b A A A B 21/ 7/98 1 NTA 
2810 A A A B 21/ 7/98 1 NTA 
2710 A A B 21/ 7/98 1 NTA 
28b A A B 21/7/98 1 NTA 
1510 G B F 8/7/98 1 NTA 
2 A A A B 6/8/98 2 NTA 
Sa A A A B 28/7/98 2 W 1 
9 A A A B 6/8/98 2 NTA 1 
1710 A A A B 8/7/98 2 NTA 1 
17b A A A B 8/7/98 2 NTA 1 
1810 A A B 8/7/98 2 NTA 1 
29 A A A B 21/7/98 2 NTA 1 
3110 A A A B 28/7/98 2 NTA 1 
32b A A A B 30/7/98 2 NTA 1 
3310 A A A B 30/7/98 2 NTA 1 
2510 A A A B 15/7/98 2 NTA 1 
3210 A A A B 30/7/98 2 NTA 1 
33b A A A 30/7/98 2 NTA 1 
34 A A A B 30/7/98 2 NTA 1 
310 B B C C 5/8/98 3 W 3 
11 A C A 0 24/7/98 4 W2 4 
410 B 0 0 C 29/7/98 4 WI 5 
8 B E 0 C 28/7/98 7 W 5 
10 E F E C 06/7/98 8 WI 6 
13 E F E C 28/7/98 8 W2 6 
12 F F E E 28/7/98 8 W2 7 
1610 0 F 0 08/7/98 9 TA 8 
19b B E 0 C 13/7/98 10 NTA 5 
19,. F G C 13/7/98 10 NTA 9 
21 I B C C 14/7/98 11 NTA 10 
7 0 G 0' 0 21/7/98 11 S 11 
2210 G B E C 14/7/98 M1 N 12 
2010 G B 0' C 13/7/98 Nl N 13 
3010 F 0 A C 21/7/98 N2 N 14 
30b F 0 C 21/7/98 N2 N 14 
35 J 0 H C 5/8/98 N3 N 15 
36b J D H C 5/8/98 N4 N 15 
36c J 0 C 5/8/98 N4 N 15 
Table 3.13: Phenotyping and genotyping results for all isolates. Codes 
for swab sites are: N (nose), T (throat), A (axillae), W (wound/ulcer), 
S(sputum). RAPD types followed by a prime had the same bands, but in 
different relative intensities to the type without the prime. 
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Figure 3.6 provides a schematic illustration of all the ward strains and 
S. aureus colonization and transmission episodes on the ward during the 
study. For each day of each patient's stay on the ward, patients are classi-
fied as being either colonized with S. aureus, uncolonized, or of unknown 
colonization status. The colonization status was arrived at by making the 
following assumptions 
• Once colonized, a patient is assumed to remain colonized with the 
same strain in the absence of treatment. 
• If the first swab of a patient gives a S. aureus strain type not found 
among patients or staff on the ward prior to that date, then the patient 
is assumed to have been colonized with that strain on admission to the 
ward. Similarly, positive swabs taken within three days of the patient's 
admission or of the start of the study are assumed to be present when 
the patient entered, or at the beginning of the study if that occurred 
first. 
• If the first swab of a patient gives a strain previously found among 
patients or staff, it is assumed that the strain was acquired by cross-
infection. 
• Negative swabs of carriage sites (nose, throat and axillae) are assumed 
to indicate that the patient was not colonized with any strain up to 
the date when the swab was taken, when other swabs (wound swabs) 
don't contradict this. 
• Negative wound swabs, or routine MRSA screening swabs are assumed 
to provide no evidence for non-carriage of S. aureus. 
• For patients for whom MRSA was successfully eradicated, it is as-
sumed that patients are of unknown colonization status between the 
last negative and first positive swab. Two consecutive negative swabs 
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carer colonized 
carer uncolonized 
carer status unknown 
Patient colonization status 
colonized uncolonized unknown 
o 
5 
1 
1 
11 
1 
3 
4 (1) 
o 
Table 3.14: Numbers of finger streaks taken from carers by colonization 
status of patients and carers. Plates were taken before and after all contacts, 
and from the left and right hands. S. aureus positive numbers are given in 
parenthesis. 
following earlier positive swabs were assumed to indicate the loss of 
the carriage. 
Finger streaks 
For logistic reasons it proved impossible to take as many finger streaks as 
had been hoped from carers following contacts with patients known to be 
colonized with S. aureus. Instead, additional finger streaks were taken be-
fore and after contacts with patients of unknown colonization status, as well 
as with those who had screened negative for S. aureus carriage. Table 3.14 
details these swabs. Of the 104 finger plates made (26 occasions, before and 
after contact, left and right hands) only one yielded S. aureus. This was 
obtained from a nurse who had screened negative for S. aureus carriage, 
following an assisted wash (contact type 2) of a patient of unknown colo-
nization status. From table 3.13 it can be seen that this strain (isolate 35) 
has an identical type to one carried by nurse N3 (isolate 36). Interestingly, 
nurse N3 had helped the same patient take their tablets one hour earlier. 
Since the finger plates taken before the contact were negative, and finger 
plates were taken immediately after the patient contact, it appears that the 
patient became transiently contaminated from N3, and then passed on the 
organism to N4. 
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Figure 3.6: Ward stays and colonization status of patients. Arrows indicate 
patient stays. Green line segments indicate periods where patients were 
uncolonized. Other colours indicate carriage of particular strains (indicated 
by the circled numbers). Black and broken line segments indicate periods 
of unknown carriage status. 
77 
3.3 Discussion 
3.3.1 Observational method 
The observational approach used here has a number of potential problems. 
There may be ambiguity about when one contact ends and another begins, 
when handwashing is appropriate, and what level a particular contact is. 
Some contacts and handwashes may simply be missed. This last point may 
be particularly important when wards are crowded, and lines of vision are 
obscured. A further problem is the Hawthorne effect: the modification of 
the subject's behaviour as a consequence of being observed. In this study 
carer-patient contacts and carer handwashes were recorded by two observers. 
Initially recording was carried out jointly in order to ensure agreement be-
tween the two observers, though following this period no attempt was made 
to check inter-observer reliability, though checks on consistency were made 
to ensure that certain contacts were always classified the same way. Other 
handwashing studies have generally not assessed inter-observer reliability, 
but when this has been done good agreement between independent observers 
has been found (Pittet et al., 1999). In the current study it was felt that 
there were only a small number cases where there was ambiguity, and in the 
logistic regression no evidence of systematic differences between observers 
was found. 
The original intention had been to record contact patterns and ward 
activities using closed circuit television cameras (CCTV) in the ward, and 
ethics committee approval had been granted for this provided all patients 
and ward staff who might be filmed provided written consent. However, 
a preliminary survey found that about a quarter of patients asked would 
not consent to be filmed, and many others were not capable of providing 
informed consent. Also, one nurse out of the 19 asked would not consent to 
be filmed. Patients and carers could not be filmed without their consent, so it 
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would have only been possible to film for about a third of the time (less if the 
non-consenting nurse was present). Due to these difficulties, it was decided 
to abandon the use of CCTV for the current study. CCTV has, however, 
been used previously to conduct ward observations (Brown et al., 1996), 
though solely for the purpose of recording carer hand washing practices. In 
that case the ward was a neonatal unit and patient privacy therefore not 
a major concern. Despite the privacy problems, CCTV does offer many 
advantages over direct observations: observations can be conducted in less 
time by fast-forwarding; data extracted from tapes can easily be validated 
at a later date by other investigators; it eliminates the extra risk of missing 
contacts during the busiest periods; carer behaviour is perhaps less likely 
to be affected as it easier to forget about the presence of a camera than a 
person (and carers may be misled as to the purpose of the cameras, as in 
the study by Brown and co-workers); potential biases due to the fact that 
not all beds could be observed during the busiest periods will be eliminated. 
Careful positioning of cameras should also be able to eliminate the problem 
with direct observations that a mass of bodies in the ward obscures the view 
to patient beds. For situations where consent is not required for CCTV use, 
this may therefore be preferable to direct recording of contacts. 
Asking the patients to record the contacts themselves was also attempted, 
but it was immediately obvious that this would introduce large biases into 
the results. Those patients who required the most care were those least able 
and willing to record their own contacts, and patients who initially recorded 
their own contacts were unable to continue doing so post-operatively. The 
alternative of asking carers to record contacts was also rejected. It proved 
extremely unpopular with the nurses, who said they wouldn't have time, 
didn't think they would be able to accurately recall the numbers of patients 
contacted, and were unwilling to record contacts using simple push-button 
counting devices (which may also have provided a potential cross-infection 
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source). Other researchers have relied on self-reporting by those making the 
contacts (Edmunds et al., 1997). However, reported contact rates were not 
verified by other means, and the reliability of such methods may be open to 
question. 
One other possibility, that may in the future be the best way to collect 
these sorts of data, is to use electronic devices attached to each carer and 
patient that transmit information between each other using the conductivity 
of the skin. These could be used to record contacts, the identity of the person 
making the contact, contact duration, time etc, while maintaining patient 
and carer privacy. Such devices work on changes in capacitances, and so 
should still work if latex gloves are used (and could possibly even detect 
their use). However, at the moment such devices are in the prototype stage 
(Zimmerman, 1996), but could in the near future prove invaluable for such 
contact-tracing studies. 
3.3.2 Patient consent 
A major problem with this study was the very low number of consenting 
patients. Only 18 out of 50 patients consented to be swabbed. Reasons 
for non-consent were: too ill (3 patients); lack of English and no transla-
tors available (4); unconscious (3); too confused (5); lack of opportunity to 
request consent (5); psychotic (1); consent refused (11). 
13 of the consenters were male, compared to 18 of the non-consenters, 
and the mean age of consenters was 63.3 compared to 65.4 for non consenters. 
Neither of these differences are statistically significant at the 5% level, but 
such a low consent rate does suggest that bias due to underlying illness etc 
may be important. Fortunately, this will only affect the transmission results, 
as contact patterns were recorded regardless of consent. 
The requirement of patient consent may represent one of the reasons 
why studies where all patients entering a ward are systematically swabbed at 
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regular intervals have rarely been carried out in recent years. This represents 
a major problem for assessing the amount of transmission and hence the 
impact of any control measures. One solution may be to implement routine 
admission and weekly swabbing as part of the standard practice for hospital 
wards being studied, thus circumventing the need for patient consent. An 
alternative approach appropriate to intensive care settings-that adopted by 
Talon et al. (1995)-is to obtain consent from relatives rather than patients 
themselves. 
3.3.3 Handwashing 
In contrast to previous studies (reviewed by Larson and Kretzer, 1995), data 
were recorded and analysed to allow handwashing to be related to contact 
type, carer details, and factors related to the observation period. One recent 
study has presented a comparable analysis, using a logistic regression model 
to explore the factors associated with hand washing (Pittet et at., 1999). 
Unlike that study, in this study HeWs were assigned unique IDs, allowing 
heterogeneity in handwashing frequencies between carers to be explored. 
The estimated handwashing frequency of about 40% was similar to that 
reported elsewhere. However, it was found to vary enormously according 
to the type of contact made: simple contacts had the lowest hand washing 
frequency, while more prolonged contacts and invasive or semi-invasive pro-
cedures the highest, both before and after patient contacts. These effects 
were large and highly significant. The finding that doctors washed their 
hands far less frequently than nurses was also in accordance with previous 
studies. Again, this effect was large and highly significant. An important 
difference to previous studies is that in this case the difference cannot sim-
ply be attributed to different types of contacts being made, as these are 
included in the regression. In fact, it was found that doctors and nurses 
made similar proportions of type 1, 2 and 3 contacts. More surprising is the 
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finding that health care assistants were less likely to wash their hands before 
and after contacts than nurses. However, since there were only three health 
care assistants observed, this difference should be treated with caution. The 
finding that other HeWs were less likely to wash their hands before (but 
not after) contacts is also surprising. However, since none of these HeWs 
were based on the ward it is possible that hand washes occurred before they 
entered the ward and were therefore unobserved. 
The hand washing frequency of nurses was found to decrease slightly 
with time from the start of the study. One possible explanation of this 
is that nurses washed their hands more often at the start of the study, 
knowing that they were being observed, but as they became used to the 
observers, levels fell. It is interesting that the opposite pattern was seen in 
other HeWs (physiotherapists, phlebotomists etc): there was a suggestion 
that these carers increased their handwashing frequency during the study. 
Since these carers weren't informed that a study was taking place at the 
beginning, but may have become aware of the fact later on, this observation 
is consistent with the hypothesis that the presence of observers accounted 
for the difference. 
After accounting for the type of HeW, the type of contacts made, and 
the observation period, no further variation in handwashing frequency was 
found between individuals. This is also somewhat surprising, but should not 
be taken to mean that such variation does not exist. It does however suggest 
that poor handwashing compliance is a problem amongst HeWs in general, 
rather than a few poorly-performing individuals. Interventions aimed at 
increasing compliance should not be aimed only at the individuals consid-
ered to be the worst offenders, but rather at groups of carers as a whole. 
There was, however, found to be significant variation in handwashing fre-
quency according to the observation period. In an attempt to find plausible 
sources for this heterogeneity the following factors were considered: time of 
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observation period (AM or PM); observers present; presence or absence of 
influential staff members (ward sisters); activity levels on the ward. None 
were found to approach significance. Since there was some evidence of het-
erogeneity between carers when heterogeneity between observation periods 
was not considered, it seems likely that the composition of the staff on duty 
during different observation periods may in fact account for some of this 
heterogeneity. 
Some of the negative findings in this study are particularly interesting 
(though again must be interpreted cautiously, as effects may have been real 
and important but too small to detect): carers were found to be no more 
likely to wash their hands if a sink was adjacent to the bed, or if the pa-
tient was known to be MRSA positive. Furthermore, during the study it 
became known to the staff that there were three MRSA positive patients on 
the ward. Alcohol hand scrub was placed next to each bed, and there was a 
visit from the infection control team. Despite these measures, hand washing 
frequencies before and after these interventions did not differ significantly. 
This is consistent with other studies based on didactic interventions (Larson 
and Kretzer, 1995). In contrast to the findings of Pittet et ai. (1999), hand-
washing frequency was not found to be influenced by the activity level on 
the ward. This was true for all three measures of activity level used. This 
has a direct bearing on the discussion of staff-patient ratios, and is discussed 
further in chapter 4. 
3.3.4 Contact patterns 
This study represents one of the first attempts to systematically record and 
analyse patient-carer contact rates, and factors associated with these rates. 
Of particular interest are the results that patients who were taking an-
tibiotics had contact rates almost twice that of those who weren't. For 
pathogens transmitted by direct contact this could represent one previously 
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unconsidered explanation for the association of antibiotic use with the acqui-
sition of such organisms. If antibiotics provide an additional risk themselves, 
this observation can have important implications for the transmission dy-
namics (see chapter 4). Note that some of the additional contacts of patients 
taking antibiotics may be related to the administration of the antibiotics 
themselves. Patients having had an operation in the last 24 hours also had 
substantially higher contact rates. After these two factors had been ac-
counted for, the presence of a line (apart from a catheter, nasal-gastric tube 
and oxygen line) was found to be associated with a more modest increase in 
contact rate. There was also a suggestion that men had higher contact rates 
than women, and that contact rates increased with age. These observations 
may partly explain some of the reported risk factors for acquiring hospital 
pathogens (for example Asensio et al., 1996). 
After accounting for these factors, there remained significant heterogene-
ity in contact rates associated with the observation period, suggesting that 
other factors not included in the model affected the contact rate. Clearly 
time of day is likely to be one factor, as patterns of ward activity change 
greatly throughout the day. 
About half as much heterogeneity again could be explained by remaining 
variation amongst the patients due to factors not included above. However, 
by far the largest source of additional variation in contact rates was asso-
ciated with term for extra-Poisson variation. Factors likely to lead to the 
aggregation of contacts that this extra variation represents may include the 
fact that some procedures require more than one contact, or may involve 
more than one contact if the carer is interrupted (as was sometimes ob-
served). Also, some procedures may require more than one carer, again 
leading to aggregation. The most important factor for aggregation, how-
ever, is likely to be underlying illness, which may clearly vary considerably 
within individual patients from day to day. For some periods patients were 
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not actually present in the ward during the observations, and contact rates 
were then recorded as zero, again leading to aggregation. 
3.3.5 Hand contamination 
Measurements of hand contamination can enable the estimation of the patient-
to-carer transmissibility, an important model parameter (see chapter 2, sec-
tion 2.2.2). Consequently the possibility of using random sampling of carers' 
hands to plot the change in contamination levels as a function of time was 
considered, thus enabling an estimation of the parameter based on a knowl-
edge of the contact rate and hand washing frequency. However, simulation 
studies suggested several hundred swabs would be required to obtain even a 
very rough estimate of the parameter. Because of this it was decided to sam-
ple hands directly after contacts with S. aureus colonized patients instead. 
The frequency of detectable hand contamination found this way appears to 
be low when compared to other studies with different organisms (Casewell 
and Phillips, 1977), but in fact only six streaks were taken following contact 
with known S. aureus carriers, so the sample is very small. Also, the finger 
streak method used is known to be about half as sensitive as the gloved 
hand method (Ayliffe et al., 1975). 
Hand-sampling following individual contacts should, however, be far 
more informative than the more common practice of taken random hand 
samples (Ayliffe et al., 1979, 1975; Bauer et al., 1990) Indeed, it has been 
pointed out elsewhere that the low prevalences of hand contamination typ-
ically found when carers' hands are sampled at random follows from a con-
sideration of the transmission dynamics, a result confirmed by the above-
mentioned simulation studies (Austin et al., 1999b). However, lack of time 
amongst carers can make the collection of such data difficult. 
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3.3.6 Typing 
The utility of the protein A gene for typing may be questioned, based on the 
above observation that organisms apparently coming from a single strain 
appeared to change their protein A type on one occasion. Indeed, while 
some researches have reported the number of 24bp repeats to be stable 
over long periods of time (Frenay et al., 1994), others have found it to be 
variable in otherwise identical strains (Trzcinski et al., 1997; van Belkum 
et al., 1997; Hoefnagels-Schuermans et ai., 1997). In this study, the protein 
A type was interpreted as providing evidence of a common source for strains 
when isolates had the same type, but different protein A types were not 
assumed to provide evidence of different sources. 
The ward MRSA strain in this study had a surprisingly large number of 
24bp repeats (17). This is potentially interesting in light of the link reported 
by Frenay et al. (1994) between the number of repeats and epidemicity. 
However, van Belkum et al. (1997) found no correlation between protein A 
repeats and the ability of a strain to colonize the nose, and suggested that 
no single lineage has an increased propensity for nasal colonization. Poston 
et al. (1993) found that the protein A gene didn't seem to be linked to ad-
hesion properties of S. aureus to cells they tested. Hoefnagels-Schuermans 
et ai. (1997) also found no connection between spreading behaviour and 
number of 24bp repeats in 43 MRSA strains, although in their isolates the 
number of repeats only ranged from nine to eleven. Any such link must 
therefore be considered to be highly speculative. 
3.3.7 Further analysis 
Further analysis of some of the data collected in this study is carried out else-
where. The ward transmission data are considered further in chapter 8 and 
the consequences of patient heterogeneity and patient-carer contact patterns 
are examined in more detail in chapter 4. 
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Chapter 4 
Extensions to the basic 
model: patient and contact 
pattern heterogeneity 
4.1 Motivation 
In previous chapters it was assumed that contact patterns between patients 
and carers were homogeneous; that each patient contact was equally likely 
to be met by each of the carers on the ward, and that all patients required 
contacts at the same rate. 
The data described in chapter 3 contradict this assumption. The follow-
ing sources of heterogeneity were identified: 
• Some patients require more frequent contacts than others; 
• On some wards nurses work in teams, where one team is more likely 
to contact one particular group of patients; 
• On reus at anyone time most of a given patient's contacts will be 
made by one particular nurse. 
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Other factors, such as antibiotic use and the type of required contacts 
may contribute to further heterogeneity and cause some patients to be more 
likely than others to acquire an organism when contacted by a transiently 
colonized carer. Similarly, carers may be more likely to become colonized 
on contact with certain colonized patients, again as a result of the types of 
contact and other host factors (Cookson et at., 1989). 
Such heterogeneity is important because it may impact on the dynamics 
of hospital infections, affecting the chance of an organism becoming estab-
lished in a hospital, the endemic level given that it becomes established, and 
the chance of stochastic fade-outs occurring given this endemicity. Conse-
quently, such heterogeneity may have implications for a number of patient 
management issues including: segregation of different classes of patients into 
different wards, or parts of wards; carer-to-patient ratios; nursing teams; and 
cohort nursing. 
In this chapter the assumption of homogeneous mixing is relaxed, and 
structure is allowed in the contact patterns between patients and carers. 
Heterogeneity between the patients is also considered. 
4.2 Method 
The modelling framework of Hasibeder and Dye is adopted (Dye and Ha-
sibeder, 1986; Hasibeder and Dye, 1988), and adapted so that it is applicable 
to the small populations under consideration. General results are presented, 
and this framework is then used to explore three different aspects of contact 
pattern heterogeneity: nursing teams (partial cohorting); "named-nurses" 
and ICU-type contact patterns, where each patient is assigned a single nurse 
who is responsible for a disproportionate amount of their care; and patient 
heterogeneity (some patients need more contacts than others; some patients 
are more susceptible to colonization than others). In each case threshold 
conditions for invasion are first considered and (where possible), deter min-
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istic endemic levels are calculated. Finally, stochastic effects are explored 
through simulation experiments using standard methods implemented in a 
C++ program available on request from the author. 
4.2.1 Modelling framework 
The basic host-vector framework of chapter 2 is retained, but each patient is 
now assumed to belong to one of 9 groups, and each carer to one of g' groups. 
The mixing patterns between the different groups are now determined by 
the parameters lij,where 1 ~ i ~ 9 and 1 ~ j ~ g'. lij represents the 
proportion of the contacts of patients in group i that are made by carers in 
group j. Clearly, Lj lij = 1. 
In the deterministic formulation, the system can then be described by 
the equations 
dyj 
dt 
(4.1) 
(4.2) 
Here Yi and yj are the number of colonized patients in group i and colo-
nized carers in group j respectively, and Xi and xj the number of uncolonized 
patients and carers in these groups. f3i represents the product of the rate 
contacts are made on patients in group i and the probability of transmission 
to uncolonized patients on contact with colonized carers. f3j is the same, 
except that transmission is now to uncolonized carers from colonized pa-
tients. As before, a gives the proportion of patients who are colonized on 
admission. J.L is the patient discharge rate and IJ' the carer hand washing 
rate. ni and nj represent the number of patients and carers respectively 
in patient group i and carer group j. Since both of these are assumed to 
remain constant Xi and xj are given by ni - Yi and nj - yj, and the system 
is completely determined by the above equations. 
89 
In the case where a = 0, these equations are analogous to those obtained 
by Dye and Hasibeder (1988) for modelling vector-borne disease transmis-
sion dynamics in a heterogeneous population. In this case, however, there is 
the important difference that it is assumed that the host (patient) contact 
rate doesn't change with vector (carer) density. Since these contacts are 
driven by patients' needs, this is a natural assumption, given that there are 
adequate staffing levels, and is supported by reports of nursing workload 
falling with decreases in the number of patients (Farrington et at., 1998). 
Another important distinction is that in this case a finite (and small) 
population is being considered, and Yi and yj take only integer values. In 
contrast, Dye and Hasibeder were considering large populations where the 
deterministic and continuous treatment is more readily justified. 
When considering the basic reproduction number, Ro, in a stochastic and 
individual-based framework the formulation from the mean-field model may 
need to be modified. Expressions for approximations for Ro for the current 
model are derived which are closely related to those obtained by Dye and 
Hasibeder for the deterministic model. Limitations of these approximations 
are considered in the discussion. 
4.2.2 Sources of heterogeneity 
In the next section deterministic and stochastic results are presented for 
three different scenarios: 
• Nursing teams (g = g' = 2). 
Two nursing teams are considered, each with primary responsibility 
for one group of patients' care. Both groups of patients are assumed 
to require contacts at the same rate. This corresponds to the contact 
patterns observed in the observational study presented in chapter 3. 
The situation where patients in one of the groups are more susceptible 
to colonization is also considered. 
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• Patient heterogeneity (g = 2; g' = 1) . 
All nursing staff are assumed to have equal responsibility for treating 
all patients, but some patients are assumed to require more contacts 
than others. Again, the motivation comes from ward-based observa-
tions of contact patterns. The situation where patients requiring more 
contacts are more susceptible is also considered. This is also motivated 
by the observation in chapter 3 that patients taking antibiotics also 
had much higher contact rates . 
• Assigned nurses (g' = n'). 
In this case a disproportionate amount of a given patient's care comes 
from one assigned nurse. Though no evidence was found for this from 
the observations on the medical/surgical ward presented in chapter 3, 
in some cases a patient's named nurse may tend to have a dispropor-
tionate role in their care (Dooley, 1999). Contact patterns on ICUs 
also follow this pattern, with each nurse typically assigned to one or 
two patients and contributing only occasionally to the care of other 
patients. In this case carer groups consist of only a single individual 
while patient groups may range from a few individuals on most wards 
to a single individual on an ICU. 
4.3 Results 
4.3.1 The basic reproduction ratio 
Following Diekmann et al. (1990), the basic reproduction ratio for the model 
with non-homogeneous mixing and patient heterogeneity is considered to be 
the dominant eigen-value of the next-generation matrix for the linearized 
process. Rather than taking the approach given in the example of Diekmann 
et al., the more natural approach of Macdonald (see Bailey, 1975b, and 
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references therein) is adopted, and the new cases amongst hosts (patients) 
are considered to constitute the next generation, rather than the transient 
colonization of vectors (carers). 
The epidemic process is approximated by making two simplifying as-
sumptions. Firstly it is assumed that the expected number of transiently 
colonized carers at anyone time depends only on the number of colonized 
patients at that time. That is, transient effects can be ignored for the carer 
colonization process. This assumption is justified by the fact that carer 
colonization and loss of colonization occur on a much faster timescale than 
patient colonization: while a patient's length of stay is typically of the order 
of several days, the duration of transient colonization of carers will typically 
range from a few hours to minutes. 
The second assumption is that all carers contacted by colonized patients 
are uncolonized, and all patients contacted by colonized carers are uncol-
onized, unless they are themselves the source of the transmission under 
consideration. In most situations this will be a reasonable assumption at 
the start of an outbreak. Observations have shown the prevalence of hand 
colonization with S. aureus amongst staff to be low. Limitations of this 
assumption are considered in the discussion 
Because of these assumptions, only approximations to the basic repro-
duction number are obtained here. In practice, for most realistic parameter 
values, they represent upper bounds to the true values. 
With these assumptions, if the patient is assumed to belong to group 
i, and the carer to group j, then from equations 4.1 and 4.2 a colonized 
patient will have a mean length of stay of 1//-£, and during this time each 
susceptible carer will become transiently colonized with this strain according 
to a Poisson process with intensity f3hij/nj. Assuming that every carer 
contacted by the index patient is uncontaminated gives the upper bound for 
the mean number of carers colonized by this patient: f3hij/(/-£nj). 
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Similarly, the rate a susceptible patient becomes colonized from a colo-
nized carer is (3,ij Inj. The mean number of patients colonized before the 
hand contamination is cleared will therefore be at most (3iTij I (J.l' nj). 
Putting these two expressions together gives an expression for the mean 
number of secondary cases of patient colonization in patient group k caused 
by one colonized patient in group i. If i = k this is: 
(3i ~ (3h'D(ni - 1) 
J.l7 J.llnj (4.3) 
and if i =1= k it is given by 
(4.4) 
The expected number and distribution of new cases in the patient groups 
(Yl) caused by initial cases (Yo) is then given by Yl = WYo, where W is 
the next-generation matrix. 
The diagonal elements of Wij of Ware given by expression 4.3 above and 
the off-diagonal elements Wik are given by expression 4.4. 
If Ai are the eigenvalues of W, and ( = max(Ai) then, if w( is the 
corresponding eigenvector Yo will approach k(nw( for some constant k. 
The condition for the number of colonized patients to increase, initially, 
is therefore ( > 1, and the initial course of the epidemic is determined 
by the dominant eigenvalue. W is a square non-negative matrix, and as 
long as it is also irreducible it can be shown that ( must be real and non-
negative (Hasibeder and Dye, 1988). If W is not irreducible the patients 
may be divided up into two or more groups of patients each having no 
chance of causing infections in other groups (however indirectly). In such 
cases the patients belong to two or more distinct populations and the ward 
may be divided into two or more subwards, each having an irreducible next 
generation matrix. These subwards are then independent and are the units 
to which the analysis should be applied. 
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4.3.2 Nursing teams 
In this case there are two nursing teams and two groups of patients. It 
is assumed that contact patterns between these groups are symmetrical: 
patients in group 1 get the same proportion of contacts from carers in group 
2 as patients in group 2 get from carers in group 1. Then "Iii = 1- k, i = 1,2, 
and 'Yij = k, i f; j. Here 0 ::; k ::; 1, and k represents the proportion 
of contacts that patients in one group get from one group of carers (so if 
k = 0.5 the mixing is homogeneous). 
If both groups of patients and both groups of carers have the same sizes 
(nl = n2 = n/2 and n~ = n~ = n' /2), and the same contact rates and 
susceptibilities to becoming colonized ((31 = (32 = (3 and (31 = (32 = (3') , 
then the dominant eigenvalue, (, of the matrix W is given by 
(3(3' (2k2 2k + l)(n 2) ,-------------( = - - + 1(4k4 - 8k3 + 4k2)n2 - (4k2 - 4k + 2)2(n - 1) 
J-tJ-t'n' V 
(4.5) 
Figure 4.1 shows how this changes with k, and figure 4.3 presents corre-
sponding simulation results. 
If the ni -1 term in expression 4.3 is replaced with ni, then all the terms 
in k in equation 4.5 cancel and the dominant eigenvalue is given by 
(3(3'ng 
2J-tJ-t'n~ 
which is the basic reproduction number for the continuous deterministic 
model. Thus the only effect of the team structure on the invasibility criterion 
is caused by the small reduction in the number of susceptibles becoming more 
important as there is more separation between the two groups of patients. 
Unless the number of patients in each group is very small, this effect is likely 
to be of little importance. 
When the two patient groups have different properties, so that one is 
more susceptible to colonization than the other (as might, for example, 
happen when pre-operative and post-operative patients are separated on 
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Figure 4.1: Two groups of patients, two groups of carers. (i the dominant 
eigenvalue of the next-generation matrix W defined in section 4.3.2 and rep-
resents the approximation to the basic reproduction number for this model 
(and is given by equation 4.5). k is the mixing parameter, and repr sents 
the proportion of the contacts made by carers of a single team on patients 
of a single group. Other parameters are: nl = n2 = 10; nJ. = n2 = 2; f31 = 
/32 = 0.5; /3~ = f32 = 1; p. = 0.1 ; p.' = 20; (J = O. The brok 11 line shows the 
value of Ro for the model, obtained by replacing the ni - 1 terms with ni in 
expression 4.3. 
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Figure 4.2: Two groups of patients, two groups of carers. ( is the dominant 
eigenvalue of the next-generation matrix W in section 4.3.2. 'fransmission 
parameters and contact patterns are as in figure 4.1 except that patients in 
one of the groups are now assumed to have twice the probability of becoming 
colonized on contact with a colonized carer as patients in the other (f31 = 
1.0, f32 = 0.5). 
a ward), then the heterogeneity in contact patterns has the opposite effect 
(see figure 4.2): grouping the high risk patients together increases the ability 
of the pathogen to invade. 
Prevalence 
In general it is not possible to obtain an equilibrium solution to the deter-
ministic equations for this 2 x 2 model, or for more complex models. In 
the symmetric case, however, where the parameters are the same within the 
patient and carer groups, and where the mixing matrix with elements "Iij is 
also symmetric, then it is easy to show that the equilibrium solution doesn't 
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Figure 4.3: Simulation results from the stochastic model described in sec-
tion 4.3.2 with two patient groups and two carer groups. Parameters and 
mixing patterns are the same as those listed in figure 4.1. Means are based 
on 10,000 simulation runs, and 95% confidence intervals for these means are 
shown. 
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change with k and is identical to that in the case of homogeneous mixing 
(this follows from the fact that for one value of k, the mixing patterns will in 
fact be homogeneous mixing). The same conclusion is reached for all such 
symmetric mixing patterns, where the ratio of the number of carers to the 
number of patients within each group doesn't change. 
In the case where one of the patient groups is more susceptible to becom-
ing colonized than the other, then in the deterministic model the prevalence 
in each group will vary as shown in figure 4.4, where the deterministic equi-
librium has been determined numerically using Maple (Waterloo Software, 
1996). As expected, the effect of increasing the separation between the 
groups is to increase the prevalence in the high risk group and decrease it in 
the low risk group. The mean of the quasi-stationary solution to the stochas-
tic process would be expected to be close to these deterministic means. 
4.3.3 Patient heterogeneity 
In this scenario there are two groups of patients but only one group of carers. 
One of the patient groups receives a disproportionate amount of the total 
number of contacts. The total patient contact rate (and hence the work 
rate of the carers) is assumed to remain constant. In this case W is a 2 x 2 
matrix. The dominant eigenvalue, " is easily calculated, and the solid line 
in figure 4.5 shows how this changes as the contact rates in the two patient 
groups diverge. Increasing the proportion of contacts received by group A 
patients from 50% (homogeneous mixing) to 97.5% results in a substantial 
increase in ,. However, the graph suggests that the effect is only likely to be 
important if one group of patients accounts for a very large proportion of the 
total contacts. Even when one group of patients receives three quarters of all 
contacts, the increase in , is fairly small. If patients in the group requiring 
more contacts also have a greater chance of becoming colonized on contact 
with a colonized carer then the effect of the heterogeneity becomes far more 
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Figure 4.4: Prevalences from the deterministic model of two groups of pa-
tients, two groups of carers, where patients in one group (broken line) are 
twice as susceptible as patients in the other group (solid line). Parameters 
are the same as those used in figure 4.2. 
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Figure 4.5: Effect of patient heterogeneity on (, the dominant eigenvalue of 
the transmission matrix Win s ction 4.3.3. Two groups of patients, A and B, 
and one group of carers ar assumed. While th proportion of contacts from 
ach patient groups varies, the total patient contact rate remains the same. 
For the solid line, though the contact patterns differ the other parameters 
are the same as for figure 4.1. The broken line uses the same parameters 
except that patients with a higher contact rate are also assumed to be twice 
as susceptible. 
important. This is shown in the broken line in figure 4.5, where group A 
patients are assumed to have twi e the probability of becoming coloniz d on 
contact with a colonized car r. Figme 4.6 presents corresponding simulation 
results, and emphasises that such effects an greatly incr ase the ability of a 
pathogen to persist, particularly when higher contact rate in some patients 
are accompanied by a gr ater susceptibility to colonization. 
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Figure 4.6: Simulation results from the stochastic models des ribed in se -
tion 4.3.3 (and corresponding to t.he two models in figure 4.5). There ar 
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the effc t of het rogen ity in contact patt rns alone, and heterogeneity in 
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simulat.ion runs, and 95% confidence int.ervals for the means ar shown. 
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4.3.4 Assigned nurses ("named nurses" and leu contact pat-
terns). 
In this scenario the contact pattern can be described in the same framework 
described above, except that now there is only a single carer in each carer 
group. The number of patients in each group may be one or more and a 
single nurse is assigned to each patient. If k represents the proportion of 
required contacts a patient receives from nurses other than the single nurse 
assigned to them, then using the same notation as before "Iij = k / (n' - 1) if 
i =1= j, and "Iii = 1 - k. Consequently, from equations 4.3 and 4.4, providing 
n' > 1, the off-diagonal elements of the matrix Ware now given by 
(
2k - k 2 k2 ) 
n' - 1 (n' - 1)2 
and the diagonal elements by 
The eigenvalues of an n x n matrix with diagonal elements b and off-diagonal 
elements a are (n - 1)a + band b - a. Since all the elements of matrix W 
are non-negative, the former is the dominant eigenvalue. In the case where 
/3i = /3, Vi and /3k = /3', Vk, then substituting in the Wij gives the dominant 
eigenvalue 
/3/3' [ n' k2 ] (=- 2k+n-1--- . 
ILIL' n' - 1 
(4.6) 
To be able to make comparisons between different staff/patient ratios it 
is necessary to express the above using the handwashing frequency fHW (the 
probability of a hand wash after each patient contact) rather than rate IL'. 
To do this IL' is replaced with UHwcn)/n(1- fHW) in the above equation, 
where c is the rate that each patient makes contacts. 
Figure 4.7 then shows how ( changes with k for different values of n' 
in a 20 bed ward with a constant carer handwashing frequency. Simulation 
results are presented in figure 4.8 showing how such mixing patterns can 
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translate into reductions in the time to extinction of a pathogen following 
its introduction on a ward, and a reduction in the colonized patient days. 
Clearly the greatest sensitivity to n' occurs when n' = n so that each patient 
may have a single nurse assigned to them. In the extreme case where each 
nurse contacts only one patient (so k = 0) clearly no transmission is possible, 
while when k = (n' - l)/n' (will be maximal, and the mixing patterns 
will be identical to the homogeneous mixing case. The figure illustrates that 
contact patterns such as these may be effective control strategies when the 
nurse to patient ratio is very high (such as in an ICU), but at the ratios 
normally seen in other wards it is unlikely to make a noticeable difference 
unless an extremely high proportion of patients' contacts come from their 
assigned carers. This has special relevance for staff-patient ratios: even if 
the carer hand washing frequency stays constant, decreasing the staff-patient 
ratio will cause the basic reproduction number to increase. The magnitude 
of this effect increases with the fidelity of carers to their assigned patients. 
In the case of homogeneous mixing (k = (n'-l)/n'), (does not change with 
the staff-patient ratio, while for contact patterns typically seen in the ICU 
the effect is likely to be large. 
4.4 Discussion 
4.4.1 Patient heterogeneity 
In the deterministic model of Dye and Hasibeder the heterogeneity in con-
tact patterns could only increase the basic reproduction number. In this 
case it has been shown, both through individual-based approximations to 
the basic reproduction number in a multi-group setting and simulation re-
sults, that heterogeneity can also, in some circumstances, make it harder for 
a pathogen to become established in the population. The most extreme ex-
ample of this is in the leU setting, where non-homogeneous mixing can have 
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Figure 4.7: Assigned nurses and the basic reproduction number. Here ( is 
the approximation to the basic reproduction number in the stochastic mod 1 
described in section 4.3.4, where for each patient one nurse is responsible 
for a disproportionate number of their contacts. The mixing paramet r 
k represents th proportion of each patient's conta ts coming from nurs s 
other than the nurse assigned to them. Parameters used were: n = 20; 
{3 = 0.5; {3' = 1; c = 10; J.l. = 0.1; (7 = O. c rep res nts the patient contact rate. 
J.l.' is varied to keep the handwashing frequencY,!JIw, constant and equal to 
0.286. 
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a dramatic influence on the ability of a pathogen to invade and persist. The 
difference from the continuous deterministic result can only be accounted 
for by taking into account effects at the level of the individual; in particular 
the replacement of the ni term in expression 4.3 with ni - 1 due to the fact 
that the source if infection cannot, by definition, be susceptible. In the con-
tinuous approximation of Dye and Hasibeder the population that any single 
infected interacts with is, conceptually, infinite and individual-based effects 
therefore do not come into play. 
4.4.2 Implications for management and control 
Staff-patient ratios 
A number of authors have reported infection rates increasing as staff-to-
patient ratios decreased (Fridkin et at., 1996; Archibald et at., 1997; Haley 
and Bregman, 1982; Vicca, 1999). The postulated cause is usually a de-
crease in the handwashing frequency and/or thoroughness associated with 
the increasing workload. There has been one report of hand washing that 
seemed to demonstrate that this did in fact occur (Pittet et al., 1999). 
The observational study described in chapter 3, however, failed to demon-
strate an association between three different measures of carer workload 
and hand washing frequency (though no attempt to measure handwashing 
technique was made). The results of this chapter suggest that, whether or 
not decreased handwashing frequency and/or effectiveness does occur with 
increasing workload, there are likely to be other causes of the association 
between lower carer-to-patient ratios and higher infection rates. In particu-
lar, section 4.3.4 showed that the association would be expected to increase 
with departures from homogeneous mixing patterns. Thus, in a ward where 
patients and carers mixed homogeneously, changing carer-to-patient ratios 
could only affect the infection rate through reduced infection control mea-
sures or other indirect effects. For contact patterns typically seen in reus, 
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however, even if handwashing frequency and effectiveness didn't change, the 
infection rate would still be expected to show an inverse relationship with 
the carer-to-patient ratio. This suggests that in such situations increasing 
the staff-patient ratio may be an effective control measure. Indeed, closing 
of wards to new admissions has just this effect, and may, in addition to the 
important aspect of reducing the influx of susceptibles, account for some of 
the success of this method of controlling outbreaks (Farrington et at., 1998). 
Patient heterogeneity 
The results from section 4.3.3 show that patient heterogeneity can have the 
effect of making it easier for the pathogen to invade even when carers behave 
homogeneously. For contact rate heterogeneity the effect was small, but dra-
matic increases in the persistence of the pathogen were seen when increased 
contact rates were associated with greater susceptibility. Results from chap-
ter 3 suggest that this is indeed likely in practice. Patients taking antibiotics 
had contact rates almost twice as great as other patients. There may also be 
associations between transmissibility from patients to carers and contact fre-
quency. For example, Burke and Corrigan {1961} found that patients with 
infected wounds were much greater dispersers than those without. These 
patients would also be expected to require more contacts. Though no data 
on the subject are presented here, it also seems likely that the same high-
risk patients will tend to have longer stays. In this respect, with a relatively 
small number of patients responsible for a large amount of the transmission, 
the situation is analogous to the "core groups" of individuals considered 
important for the dynamics of sexually transmitted diseases {Hethcote and 
Yorke, 1984}. 
The results of section 4.3.3 then have implications for the management 
of a heterogeneous group of patients. For example, the separation of pre-
operative and post-operative patients has been proposed as an infection con-
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trol measure (Lidwell et ai., 1970; Shooter et ai., 1963). Acquisition rates of 
resistant strains have been found to be much higher amongst post-operative 
than pre-operative patients in the above studies. However simulation results 
suggest that the effect of grouping high risk patients together in this way is 
likely to increase the ability of a pathogen to persist. Fewer colonized patient 
days are seen when high and low risk patients are mixed. In this respect, 
the low risk patients offer some protection for the high risk patients, but at 
the expense of having greater risk of acquiring the organisms themselves. 
Overall, the total risk to patients is lower, but clearly ethical questions may 
arise in this situation. 
4.4.3 Individual-based considerations 
In section 4.3.1 it was suggested that the expression derived for Ro was an 
upper bound to the true value. This is because, in considering the number 
of secondary cases arising from the primary case, it was assumed that each 
contact of the primary case was uncolonized. No account was taken of the 
reduction in susceptibles attributable to the primary case itself. 
Ro is normally defined as the mean number of secondary cases arising 
from a primary case in a completely susceptible population. In heteroge-
neous populations, rather than giving the mean number of secondary cases, 
Ro gives the "typical" number of secondary cases; that is the mean number 
of secondary cases that is approached in the exponential phase of the epi-
demic, before non-linear effects due to the reduction of susceptibles become 
important (Diekmann et ai., 1990). When considering an individual-based 
model, however, where each individual is in contact with only a finite (and 
generally small) number of other individuals, the reduction in the number of 
susceptibles can be important even for the primary case. In the individual-
based SIR model discussed by Keeling and Grenfell (2000) this is particularly 
important, as once contacts of the index case become infected they cannot 
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be re-infected. For the present model, this effect of susceptible contacts be-
ing "used up" applies both to the carer contacts of the index patient and 
to the susceptible patients contacted by carers. The effect may be expected 
to be less important than in the SIR model, however, as both patients and 
carers once colonized will not in general remain colonized for the rest of the 
stay of the index patients: carers decontaminate their hands, and patients 
are replaced by new susceptible patients. But overall, the effect will act to 
reduce the actual mean number of secondary cases below that predicted by 
the expression given in section 4.3.1. 
To see how important this is likely to be for the Ro estimates, the effects 
on the level of carer hand contamination and on the expected number of 
patients colonized by a carer are considered. 
If Pij(t) represents the probability of a single carer in group j being 
colonized at time t as the result of a single colonized patient in group i 
initially colonized at t = 0 then 
{3' "'t . 
Pij(t + 8t) = Pij (t)(l - ,.l8t) + (1 - Pij (t)) i.f:L8t + o(8t). 
n· J 
which gives 
where Pij(O) = O. This has solution 
( ) {3~"Yij ( ([' {3hij]) Pij t = " (./, 1 - exp -t J-L + -,-
njJ-L + fJi"Yij nj 
so 
1. ( ) {3hij 1m Pij t = " {3' 
Hoo njl-' + i"Yij 
On many wards, the expected time before a carer becomes colonized as 
a result of contact with one colonized individual will be much larger than 
the expected persistence of hand contamination (assuming the handwashing 
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frequency, patient-carer contact rate, and patient-to-carer transmissibility 
values obtained from the study in chapter 3 are typical). Consequently 
" (3' J-L nj» ('Iij' 
which implies that 
The one situation where this second assumption may be hardest to justify 
is in ICUs, where one carer repeatedly touches the same patient, and very 
high contact rates are seen. In this case, the approximation for Ro may be 
a significant overestimate. 
Considering the colonization of patients by carers, if a patient is colonized 
at a rate r by one colonized carer then they will be colonized with probability 
r'/(r+J-L') before the carer's colonization is cleared (as before J-L' is the rate the 
carer loses the hand carriage). In the continuous version the r term doesn't 
appear in the denominator because an infinite susceptible population is being 
considered, and the rate any single patient is colonized is vanishingly small. 
For finite populations, when J-L' is large compared to r, there will be little 
difference to the usual derivation of Ro used in section 4.3.1. 
Clearly, reconciling individual-based considerations within the setting of 
a heterogeneous population represents a significant challenge. Exact results 
represented by simple formulae will rarely be obtained. For this reason, 
approximations were used here. In populations as small as those considered 
here, which are both dominated by stochastic effects and for which non-
linear effects are likely to be important from early in the course of the 
epidemic, the basic reproduction ratio cannot be as important as it is in large 
populations (though even in very large populations stochastic effects cannot 
be ignored, as the number of cases at the start of an epidemic will be small). 
Despite these caveats, the approximation to the basic reproduction ratio 
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does represent a readily computable quantity that provides an indication 
of an important aspect of the model's behaviour. As a tool to explore the 
effects of different model parameters it can also motivate an exploration of 
the parameter-space through simulation experiments which remain, for all 
but the simplest of models, the most reliable way of studying their behaviour. 
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Chapter 5 
Antibiotic resistance: a 
review of the literature 
The previous analysis is now extended by taking into account antibiotic 
use. This chapter starts by reviewing the literature relating antibiotic use 
to resistance, with particular emphasis on S. aureus. The aim here is 
to inform decisions about model choice, and where possible use published 
results to obtain parameter estimates. Subsequent chapters then present 
mathematical models (chapter 6), laboratory comparisons of growth rates 
of sensitive and resistant strains (chapter 7), and a preliminary analysis of 
data relating the acquisition of VRE to antibiotic consumption (chapter 8). 
Recently there have been excellent reviews of the problem of bacterial 
antibiotic resistance, both from perspective of the UK (Standing Medical 
Advisory Committee, 1998) and globally (Baquero and Blazquez, 1997). It 
is not the intention of this chapter to duplicate this work. However, section 
5.1 presents essential background on drug resistant bacteria. Section 5.3 
then goes on to critically review published attempts to relate consumption 
of antibiotics to acquisition of resistant organisms. This is considered at 
the community level, in hospital wards, and at the level of the individual. 
Section 5.4 then reviews studies of direct relevance to S. aureus and its 
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transmission in hospitals in some detail. Where possible reported results 
from these studies are used to arrive at provisional estimates for the new 
model parameters. 
5.1 An overview of antibiotic resistance 
Antibiotics have been the mainstay of treatment of bacterial infectious dis-
eases for over 50 years. During this time the resistance profiles of both 
pathogenic bacteria and commensals forming part of the normal flora of the 
skin, intestinal tract, and upper respiratory tract have undergone dramatic 
changes. Bacterial strains isolated before the start of the antibiotic era have 
been found not to possess any acquired resistance determinants (Hughes 
and Datta, 1983). Thus, before the 1940s the vast majority of bacteria 
would have been susceptible to all antibiotics (except, of course, those to 
which they possess innate resistance). Penicillin was first used clinically in 
1941(Abraham et ai., 1992). Levels of resistance to penicillin in S. aureus 
as high as 80% were already being reported in hospitals in 1958 (Ridley 
et al., 1970). By the mid-1980s over 80% of S. aureus isolates from almost 
any part of the world were penicillin-resistant (O'Brien, 1986). Now only 
about 10% of S. aureus strains recovered from hospitals are sensitive to 
penicillin (Standing Medical Advisory Committee, 1998). A similar picture 
is found in the faecal flora (Levy, 1997). For example, in one study over 
60% of individuals without a recent history of antibiotic use were found to 
have at least 10% of the E. coli sampled from their faecal flora resistant to 
one of seven antibiotics tested (Levy et al., 1988). 
Antibiotic resistance is not distributed evenly amongst bacterial strains, 
but tends to be clustered, so strains resistant to one antibiotic are more 
likely to also be resistant to other unrelated drugs (Goldstein and Acar, 
1996; Livermore and Yuan, 1996). Such unrelated resistance is caused both 
through single plasmids encoding diverse mechanisms, and also through the 
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independent accumulation of distinct resistant determinants. Such multiple-
resistance poses particularly severe therapeutic problems. This is especially 
true for Gram-positive organisms, for which no novel chemical class of an-
tibiotics has been introduced in last 20 years (Cohen, 1992). For example, 
strains of VRE exist which are resistant to all available antibiotics, and 
recent strains of the more virulent S. aureus have been found with inter-
mediate resistance to glycopeptides, previously the last remaining class of 
antibiotics to which they were all susceptible (CDC, 1997; Hiramatsu et al., 
1997b,a; Navarro Marin, 1996). Even when antibiotics are available to treat 
infections, resistance remains a serious problem owing to the consequent 
reliance on more toxic and expensive antibiotics such as vancomycin, and 
failure of empirical therapy. 
When considering the spread of resistance in bacteria it is important 
to distinguish between the clonal spread of organisms, the spread of resis-
tance genes, and the repeated emergence of resistance arising from mutations 
which are then selected for by antibiotic use. Most resistance genes, whether 
plasmid or chromosomally mediated, are mobile to some extent, and there 
are many accounts of such resistance determinants crossing species or even 
genus barriers (Roberts, 1997; Hall, 1997; Dowson et al., 1990). However, 
the frequency of this varies enormously. Thus the vanA gene encoding for 
vancomycin resistance commonly found in enterococci is readily transferred 
to other strains (Chadwick et al., 1997), and this may account for much of 
its spread in hospitals (Bingen et al., 1991). In contrast, most MRSA trans-
mission is clonal, though there are occasional reports of apparent horizon-
tal transfer of the mecA gene (which confers methicillin-resistance) during 
outbreaks (Dominguez et al., 1994). Only such transmission of pre-existing 
genes is considered in this and subsequent chapters. In some cases resistance 
repeatedly occurs during antibiotic therapy due to the selection of sponta-
neous mutations. Examples include quinolone resistance in Enterobacter 
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and carbapenems resistance in Pseudomonas aeruginosa (Standing Medical 
Advisory Committee, 1998). These processes have important differences, 
and care should be taken when constructing models and drawing conclu-
sions to differentiate between them. For example, while multiple-antibiotic 
therapy may be a good strategy for preventing the emergence of resistance 
through mutations, it may be a poor strategy when resistance genes to the 
antibiotics are already common. 
5.2 Antibiotic resistance in hospitals 
In the UK hospital prescribing accounts for about 20% of all human antibi-
otic consumption and approximately 10% of total antibiotic use (Standing 
Medical Advisory Committee, 1998). However, for the transfer of existing 
resistant genes the concentration of antibiotic use is likely to be more impor-
tant than the total volume, and the prevalence of resistance closely follows 
the gradient of the concentration of antibiotic usage (Levy, 1997). Thus, 
in ICUs, where audits have found that 40-50% of patients receive antibi-
otics in any 24 hour period, the problems are greatest, and resistant strains 
are often endemic. Resistance levels are less severe but still problematic 
on other hospital wards, where self-limiting outbreaks of resistant strains 
are more common than endemicity. Outside rcus, hospital patients are 
about half as likely to receive antibiotics in any given day (Standing Medi-
cal Advisory Committee, 1998). Amongst out-patients resistance levels are 
lower than amongst in-patients (Monnet et al., 1998), and outside hospitals 
a greater prevalence of resistance organisms is found in nursing homes and 
amongst intravenous drug users than in the population as a whole (Cox and 
Bowie, 1999; Muder et al., 1991; Mulligan et al., 1993). Both of these groups 
have higher than average levels of antibiotic consumption (Novick and Ness, 
1984). 
The picture is complicated, however, by the fact that there are likely 
115 
to be different rates of detection in the different groups. Typically, only 
resistant organisms causing disease will be detected. Also, as individuals 
frequently move between the different groups, incidence may he a more ap-
propriate measure than prevalence of the effect when considering the effect 
of antibiotics in the different settings. However, estimating the incidence for 
a commensal is not easy, and the hospital infection literature is often unreli-
able, with patients who have positive swabs within a sufficiently short time 
after admission often being arbitrarily classified as community acquisitions. 
Thus, what appear to be community acquisitions may simply be nosocomial 
acquisitions occurring on earlier hospital stays. 
Another difficulty in assessing the role of hospitals in the spread and 
maintenance of resistance is that much of the resistance seen in hospitals 
(and lCUs in particular) may only be due to selection of pre-existing strains, 
rather than nosocomial acquisition (Silvestri et al., 1999). For organisms 
such as VRE, which may be hard to detect in the absence of antibiotic ther-
apy, and for which much transmission may be accounted for by the mobility 
of the transposon carrying the resistance gene, assessing the importance of 
hospital transmission is particularly difficult (Chadwick et al., 1997). This 
problem is considered further in chapter 8. 
5.3 Relating consumption to resistance 
5.3.1 In large populations 
Resistance data at the national level typically consist of percentages of 
strains resistant to different antibiotics. Strains tested usually come from 
hospitals isolates, though some community isolates are also tested at refer-
ence laboratories. This represents only a small and selective sample of total 
bacterial flora. Different combinations of antibiotics and bacterial species 
are tested in different countries; different sampling procedures are used; 
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test methods and materials differ between regions; and different antibiotic-
resistance breakpoints are used in different countries, so strains classified 
as being resistant in one location will be classified as sensitive in another 
(Baquero, 1990; 'frzciiiski et al., 2000). In light of these difficulties, it is un-
surprising that an NIH task force on antibiotic resistance world-wide should 
report that "available data on global prevalence of resistance to antibacterial 
agents were barely adequate" (O'Brien and the Members of Task Force 2, 
1987). They also claimed that resistance to older antibiotics had stabilized, 
but that new problems were being caused by the transfer of resistance genes 
to new species. Resistance to newer antimicrobial agents was considered 
to be increasing. Because of all these deficiencies in the data it is difficult 
to make meaningful quantitative comparisons between countries. Recent 
surveillance initiatives should mean that in the future better data become 
available (World Health Organization, 1997; Department of Health, 1998). 
There are also difficulties in obtaining reliable data on antibiotic use, 
much of which is not publicly available, apparently for competitive reasons. 
Indeed, a parallel NIH task force, reporting on antibiotic use world-wide, 
described much of the data as "conjectural, anecdotal, or of questionable 
reliability" (Nananda and O'Connor, 1987). 
Despite all these problems, there have been recent attempts to relate 
antibiotic consumption to resistance in large populations. However, even 
with good data there are many obstacles, and predicting the spread of an-
tibiotic resistance remains a major challenge. Thus Baquero (1996) relates 
resistance of respiratory pathogens to drug-use, though points out that the 
analysis will be complicated by factors such as the initial level of resistance in 
the bacterial populations. High quality surveillance data from Finland and 
Iceland coupled with detailed data on antibiotic use have enabled resistance 
in the community to Morexella catarrhalis and Streptococcus pneumoniae re-
spectively to be related to changes in antibiotic consumption using a simple 
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mathematical model (Austin et at., 1999a). The fitted parameters suggest 
that the decay in resistance following reduced prescribing levels is likely to 
be slower than the rise in resistance (assuming antibiotics are prescribed at 
a level high enough to maintain a resistant population). There are, how-
ever, some problems with this analysis. In the Icelandic data, a rapid rise in 
penicillin-resistant pneumococci in children under seven was followed by a 
13% reduction in antibiotic prescribing for this age group. A more gradual 
decrease in penicillin-resistant pneumococci followed. However, for children 
under five years of age the rate of acquisition of pneumococci from the family 
has been estimated to be about 25 times greater than that from the commu-
nity (Auranen et at., 2000). Consequently, much of the acquisition in these 
children is likely to be from individuals experiencing no change in levels of 
antibiotic consumption. These individuals would be expected to have higher 
levels of resistant pneumococci than they would have had if they had also 
experienced a reduction in antibiotic consumption. Furthermore, acquisition 
rates of pneumococci in young children differ by an order of magnitude from 
older age groups (Auranen et al., 2000). Since the model takes no account 
of this important age-structuring, it is difficult to know how to meaningfully 
interpret the parameter estimates. Similar problems can be found with the 
analysis of the Finish data set. 
For the above reasons, caution should be exercised in drawing inferences 
about transmission in the wider community and about long-term dynamics 
from these results. This example also serves to illustrate how difficult it 
can be to measure the effect of the antibiotic use on resistance, even with 
very good data. The Icelandic resistance data consists of only eight yearly 
prevalences, all of these with large confidence intervals. These were used 
to fit a model with four parameters. The authors' reluctance to introduce 
more parameters to the model-as would be required to account for the age 
structuring-is therefore understandable. 
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5.3.2 In small populations 
There have been few attempts to relate the consumption of antibiotics to 
the prevalence of resistant bacteria in whole hospitals, and what evidence 
there is suggests that the relationship is not simple (Monnet et at., 1998). 
Factors such as hospital size can complicate matters (Panlilio et at., 1992) 
and casemix will affect the chance of patients becoming infected, and is 
therefore likely to introduce reporting biases (Glynn et at., 1997). 
At the hospital level, Westh and Rosdahl (1989) found that the level 
of erythromycin-resistance in S. aureus in nine large Danish hospitals was 
significantly associated with erythromycin consumption. In another study, 
Westh and co-workers (1998) compared occurrence of multiply-resistant S. 
aureus strains in 17 hospitals world-wide. They found that use of broad-
spectrum antibiotics was more closely associated with the amount of re-
sistance found than total antibiotic consumption. Monnet and co-workers 
(1998), however, compared eight US hospitals, and found high use of a par-
ticular antibiotic was not necessarily associated with resistance to it. 
At the ward level, there are a number of reports of rapid changes in 
resistance levels following changes in antibiotic usage, and individual wards 
may have markedly different resistance levels to those found in the hospital 
as a whole (Ridley et ai., 1970). For example, Franco and co-workers report 
an intervention in an intensive care nursery (Franco et al., 1973). Faced 
with high prevalence (> 10%) of kanamycin-resistance in enterobacteria, 
they substituted gentamycin for kanamycin. This led to a rapid decrease in 
kanamicin-resistance-accounted for by colonized patients being discharged, 
rather than patients losing resistant organisms-and a significant increase in 
gentamicin resistance in the intestinal flora. After reinstituting kanamycin 
use, there was a rapid rise in kanamycin resistance. 
Conversely, Van der Zwet and co-workers (1999) describe how an out-
break of gentamicin-resistant Klebsiella pneumoniae in a neonatal intensive 
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care unit was apparently controlled by replacing gentamicin with amikacin. 
In a more extreme intervention, Price and Sleigh (1970) apparently con-
trolled a serious outbreak of drug-resistant Klebsiella aerogenes by with-
drawing all antibiotics. A number of other authors have reported control 
of outbreaks of resistant S. aureus strains by altering antibiotic prescribing 
policies (Barber et al., 1960; Ridley et al., 1970; Witte et al., 1994). In chap-
ter 8 a study in which ceftazidime was replaced by piperacillin/tazobactam 
on a ward with endemic VRE is discussed in detail. This change was as-
sociated with elimination of VRE from the ward after a period of several 
months (Bradley et at., 1999). 
However, the interpretation of reports such as these can be complicated 
by the importance of stochastic effects, and the fact that other interventions 
are often made simultaneously. The anecdotal nature of many of the reports 
also suggests that reporting biases may be important. 
5.3.3 In individuals 
Attempts to relate antibiotic consumption to resistance using formal sta-
tistical methods have mostly been inconclusive. For example, Asensio and 
co-workers (1996) used logistic regression to examine the factors affecting 
acquisition of MRSA. Although antibiotic therapy was strongly associated 
with acquisition of MRSA, the analysis failed to demonstrate it to be an 
independent risk factor once ward assignment, time at risk, age, coma and 
invasive procedures were taken into account. They suggested that previ-
ous reports could have overestimated the importance of antibiotic therapy 
"confounded by a prolonged period from admission to isolation of MRSA". 
Hershow and co-workers (1992) also failed to demonstrate a significant 
association of antibiotic use with MRSA acquisition after accounting for 
length of hospital stay, though again, there was a very strong association 
between these variables. A meta-analysis of 20 studies relating VRE acqui-
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sit ion to glycopeptide use reached a similar conclusion, finding only a small 
and non-significant association (Carmeli et at., 1999). 
A number of studies have found MRSA and VRE acquisition to be sig-
nificantly associated with antibiotic consumption, but have not controlled 
for time from admission to MRSA acquisition (Crossley et at., 1979a,b; Pea-
cock et at., 1980; Law and Gill, 1988; Carmeli et ai., 1999). Since length of 
stay and antibiotic use are so closely correlated, these studies could simply 
be reporting the finding that the longer one waits, the more likely some-
thing is to happen. As a result some commentators have even questioned 
whether antibiotic use does actually increase the chance of patients becom-
ing colonized with multiply-resistant strains of bacteria (Thompson et at., 
1982). If it doesn't, one must ask why resistant strains persist in areas with 
high concentrations of antibiotic use, but are found less frequently outside 
these areas. Other possible explanations do exist. Firstly, it is possible that 
patients taking antibiotics have little additional risk of acquiring resistant 
organisms, but, if colonized, transmit them to other patients at a greater 
rate due to overgrowth of the organism. Antibiotic treatment may also pro-
long the carriage of resistant organisms, again leading to more transmission. 
In this case however, since lengths of stays are usually short compared to 
the timescales that individuals remain colonized with commensals such as 
S. aureus, this is unlikely to make much difference. The former mechanism, 
however, is intuitively reasonable. Unfortunately, there is little evidence to 
suggest how important a factor it might be. 
Before rejecting the link between antibiotic use and the risk of acquiring 
resistant bacteria, there are, however, other studies that should be consid-
ered . 
• Knight and White (1958) found that amongst patients taking tetracy-
cline, tetracycline-sensitive strains were almost completely replaced by 
multiply-resistant "hospital" staphylococci within only seven to nine 
121 
days. Untreated patients showed a more gradual increase in resistant 
strains, rising from about 10 to 30% of all carriage strains over 30 days 
of hospitalization. Penicillin was found to cause similar behaviour, 
though at a slower rate. 
• Bonten and co-workers (1998), using a Cox proportional hazards model, 
showed that antibiotic use was significantly associated with acquisition 
of VRE in an intensive care unit. 
• Lidwell and co-workers (1971) used a multiple regression analysis to 
study the factors influencing the rate of nasal acquisition of S. aureus 
in two medical wards between 1965 and 1966. Use of antibiotics (apart 
from penicillin) was highly significantly associated with the acquisition 
rate of tetracycline-resistant strains (though not for other strains). 
Amongst S. aureus carriers, those who received no antibiotics had a 
significantly lower rate of acquisition of tetracycline-resistant strains. 
• In chapter 8, using a model which allows the instantaneous acquisition 
rate to vary according to the antibiotics being taken by a patient at 
a given moment, simultaneous estimates are obtained for acquisition 
rates of VRE amongst patients in a haematology unit for six different 
classes of antibiotic treatment. In all cases, acquisition rates were 
greater when antibiotics were being taken. 
All of these studies use different methods, but they have in common the 
fact that they are all making inferences about the effect of antibiotics on 
the rate of acquisition. Simple logistic regressions do not do this. Trivially, 
length of stay will be strongly associated with acquisition of strainsl. Studies 
1 If patient discharge and strain acquisition can both be thought of as Poisson processes 
with respective rates p. and .>., then the mean length of stay for patients who don't become 
colonized will be l/(p.+ .>.), while for those who do become colonized it will be l/(p. +.>.) + 
1/ p.. 
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that conclude, on the basis of logistic regressions, that length of stay is a 
risk factor for colonization are really stating a tautology. The most plausible 
explanation for the failure of case-control studies to show an association 
between antibiotic use and acquisition of resistant strains is simply that 
antibiotic use and length of stay are so closely related. Logistic regression 
analysis is likely to be a poor tool for disentangling the two. Furthermore, 
the parameter of importance to the transmission dynamics is the rate of 
acquisition. Simply stating that antibiotic use is a risk factor tells us little 
about how the prevalence will change if antibiotic use changes. 
The above studies (with the notable exceptions of those by Lidwell et 
al. and Bonten et al.) considered the problem only at the level of the in-
dividual. The analysis was restricted to what would be appropriate for a 
non-infectious disease. While this may be appropriate for many of the or-
ganisms responsible for nosocomial infections for which the main source is 
patients' endogenous flora, it is clearly not true of S. aureus and VRE, where 
person-to-person spread is important, and the risk to one patient depends 
on colonization status of others (Silvestri et at., 1999). A number of studies 
investigating the transmission of drug-resistant S. aureus within hospital 
populations and presenting data at the population level have, however, been 
carried out, though not with MRSA. From the late 1950s to early 1970s there 
were several large studies where each patient in a ward was swabbed regu-
larly, usually once or twice a week. These studies are considered in detail in 
the next section. 
5.4 Staphylococcus aureU8 
The leading causes of hospital acquired infections are usually reported to 
be S. aureus and E. coli (Jarvis and Martone, 1992; NNIS, 1996; Central 
Public Health Laboratory, 1999). For E. coli a large proportion of these 
are due to endogenous flora, rather than the epidemic spread that is typical 
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for S. aureus, and MRSA in particular (Stamm et aI., 1981; Silvestri et aI., 
1999). A recent report, based on data from 70 hospitals in England and 
Wales between 1997 and 1998, found that 46% of all surgical site infections 
were caused by staphylococci (about four times as many as were caused by 
coliforms, the next highest category). Of these staphylococci, 80% were S. 
aureus, and 67% of those were MRSA (Central Public Health Laboratory, 
1999). Because S. aureus also has the potential to be highly virulent and is 
frequently resistant to multiple antibiotics, it represents probably the most 
troublesome nosocomial pathogen at the moment. For this reason, this 
organism is the primary focus of attention here. 
5.4.1 Drug resistance in Staphylococcus aureus 
MRSA was first reported in patients almost 40 years ago, shortly after 
the introduction of methicillin in 1959 (Jevons, 1961). Numbers increased 
throughout the 1960s in the UK, with increases both in the percentage of 
resistant isolates from individual hospitals, and in the number of hospi-
tals yielding MRSA. However, most of the increase in the second half of the 
decade could be attributed to the former; that is, an increasing prevalence in 
hospitals where MRSA was already established (Parker and Hewitt, 1970). 
During this decade many other countries also reported significant MRSA 
problems (Casewell, 1986). 
In contrast to penicillin-resistance in S. aureus however, the rise in 
methicillin-resistance has not been monotone (O'Brien and the Members of 
Task Force 2,1987). During the early 1970s, MRSA incidence in many coun-
tries actually declined (Shanson, 1981), only to come back up in the second 
half of the 1970s with the emergence of the new-"modern"-MRSA strains 
with different resistance patterns and phage types to most of those from the 
previous decade. It was reported that these strains apparently had an in-
creased transmissibility (Casewell, 1986). Not until the mid-1980s, however, 
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did strains with comparable potential for epidemic spread as the methicillin-
sensitive, tetracycline-resistant, penicillinase-producing strains of the 1950s 
and 1960s emerge (Casewell and Hill, 1986). 
The causes of these changes remain open to question. Speculation that 
epidemic strains may have a greater ability to survive on inanimate or ani-
mate surfaces through enhanced resistance to desiccation and skin fatty acids 
has not been supported by laboratory studies (Farrington et al., 1992). It is 
possible that the changes are due to compensatory mutations ameliorating 
the deleterious pleiotropic effects of resistance genes. Chapter 7 considers 
this question. Much of the change, though, may simply be due to changing 
patterns of antibiotic resistance and antibiotic use. Thus, it has been pointed 
out that the decline in MRSA in the early 1970s coincided with the introduc-
tion of gentamicin, and later increases have coincided with the emergence of 
strains resistant to both methicillin and gentamicin (Shanson and Kensit, 
1976). Tetracycline-resistance in S. aureus is now relatively uncommon in 
the UK. In the 1960s, however, it represented an extremely serious problem. 
This decrease in tetracycline-resistance followed a decrease in tetracycline 
use in the UK hospitals, which now have relatively low levels of usage (Stand-
ing Medical Advisory Committee, 1998). Indeed, the early MRSA strains 
were also resistant to tetracycline, whereas the most common MRSA strains 
now are usually sensitive to it (Shanson and Kensit, 1976; Cox et al., 1995). 
In 1979 Ayliffe et al. reported that a progressive decline in the proportion 
of patients carrying S. aureus resistant to tetracycline, erythromycin, and 
kanamycin was associated with a reduction in the use of tetracycline (Ayliffe 
et al., 1979). Much higher levels of tetracycline-resistance are now seen in 
countries with higher levels of tetracycline usage. Thus, in Poland, where 
tetracyclines are the second most commonly prescribed antibiotics in hos-
pitals, MRSA strains are typically tetracycline-resistant ('Ifzcifiski et al., 
2000). 
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Similar patterns of spread of MRSA have been observed in many other 
countries, but it is interesting to compare these with the markedly different 
experience in Denmark. By the end of the 1960s over 40% of all S. aureus 
strains from blood cultures of hospital patients in Denmark, and 15% of 
all hospital strains were methicillin-resistant (Jessen et ai., 1969; Rosdahl 
and Knudsen, 1991). Most of these strains represented just a few closely 
related clones. By 1984 this figure had fallen to 0.2%, and it has stayed near 
that level since (Voss et al., 1994), despite repeated challenges of MRSA 
strains introduced from patients acquiring them abroad. At the same time 
there was a fall in erythromycin resistance, decreasing from 10% of hospital 
isolates, to only 1-2% over a period of about 20 years (Westh et ai., 1989). 
The cause was a decline in numbers of the closely related strains. This 
started with a decline of those with the most resistance determinants, and 
was followed by a decrease in the resistance of all related types (Westh 
et al., 1992). Rosdahl and Knudsen (1991) reported a correlation between 
decrease in streptomycin and tetracycline consumption and the decline in 
these MRSA strains, which were typically tetracycline and streptomycin 
resistant as well. They suggested that early detection and precautions taken 
when an MRSA strain is introduced has prevented MRSA from becoming 
established in Denmark . 
A high rate of false positives was reported when strains from the 1980s 
were re-tested for methicillin-resistance. Strains from the 1960s and 1970s 
don't appear to have been re-tested for methicillin-resistance, so perhaps a 
little caution should be exercised in the interpretation of these data (Westh 
et al., 1989). 
In recent years hospitals in England and Wales have experienced rapid 
increases in the numbers of MRSA recovered from patients: in 1997 nearly 
32% of S. aureus bloodstream infections were caused by MRSA, compared 
with half that figure in 1995, and less than 5% two years before that. Most 
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of this increase is attributable to three main epidemic strains: EMRSA-
3, 15 and 16 (CDSC, 1998). This has been accompanied by simultaneous 
increases in resistance to other antibiotics such as erythromycin, gentamicin 
and ciprofloxacin. 
In Europe levels of methicillin-resistance now range from below 0.5% 
of all hospital S. aureus strains in Sweden and Denmark, to about 30% 
in France and Spain, generally increasing in numbers from north to south 
(Voss et at., 1994). In the USA, the percentage of MRSA in all hospital S. 
aureus isolates rose from 2.4% in 1975 to 29% in 1991, with significantly 
greater rates of increase in larger hospitals (Panlilio et at., 1992). 
5.4.2 Antibiotic use and Staphylococcu8 aureU8 carriage in 
individuals 
Aly and co-workers (1970) studied the effects on the nasal flora in S. aureus 
carriers of taking the cephalosporin cephalexin orally. Figure 5.1 presents 
a schematic view of their results. They found a lO5-fold reduction in S. 
aureus numbers, and complete loss of carriage in some. The greatest reduc-
tion for most bacterial species was seen three days after stopping antibiotic 
treatment. The reduction in S. aureus numbers was the most striking, 
falling from 38% to 0.6% of the total nasal flora. Two out of seven subjects 
completely lost S. aureus carriage and had not reacquired these organisms 
60 days later (despite the fact that, in one case, they had formed 94% of 
the total nasal count pre-treatment). Similarly, Knight and White (1958) 
treated six nasal S. aureus carriers with erythromycin, and found nasal 
counts diminished from several thousand per swab to all negative cultures. 
After treatment stopped levels increased slowly, returning to pre-treatment 
levels after about three weeks. Similar results were obtained by Martin 
and White (1968) with gentamicin (applied topically) , and Shinefield et al. 
(1966) with oxacillin (applied topically and orally). In all cases, antibiotic 
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therapy suppressed S. aureus nasal carriage in adults to very low or unde-
tectable levels, but most subjects were found to be still colonized with the 
same strain after treatment. 
The effects of such treatment on the chances of an individual becoming 
colonized when challenged with a resistant organism have not been studied in 
detail. Intuitively, one would expect a resistant strain reaching the anterior 
nares of an individual undergoing antibiotic therapy to have a far greater 
chance of becoming established than an organism reaching an individual 
with an undisturbed flora. However, figure 5.1 also suggests that there might 
be a substantially greater chance of becoming colonized for the period after 
antibiotic therapy, when the original flora are recovering to their former 
levels. 
Another effect of the reduced numbers that one might expect is a reduced 
rate of transmission to others from such a source. Indeed, B0e and Soldberg 
found that the reduction in numbers of sensitive strains during antibiotic 
therapy is accompanied by a reduced shedding into the environment (B0e, 
1965, cited by Lidwell et al. (1966)). Similar results are reported by White 
and Smith (1964, cited in Aly et al. (1977)). 
No similar studies have been reported for resistant strains. However, it is 
known that at the temperature of the anterior nares and other staphylococ-
cal carriage sites, the entire population of MRSA will express its methicillin 
resistance. Since this confers resistance to all penicillins, a large selective ad-
vantage for such strains is likely (Parker and Hewitt, 1970; Casewell, 1986). 
5.4.3 Interactions of staphylococcal colonization 
It has been demonstrated in an extensive series of experiments that colo-
nization with one strain of S. aureus (the resident strain) can inhibit the 
acquisition of another strain (the challenge strain) (Shinefield et al., 1974; 
Eichenwald et al., 1965). This was shown to occur both in infants (Shine-
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Figure 5.1: A schematic view of mean nasal bacterial counts before, during, 
and after antibiotic treatment in seven S. aureus carriers. Three of these 
also carried small numbers of gram-negative rods (not shown). Adapted 
from Aly et al. (1970). 
field et al., 1963) and adults (Boris et at., 1964; Shinefield et al., 1966). By 
deliberately inoculating individuals with a strain of low virulence, this ef-
fect has been successfully used to eradicate endemic virulent strains from 
hospital wards, and to treat families with recurrent staphylococcal disease 
(after first using antibiotics to clear the virulent strain) where, owing to 
recolonization with the virulent strain, treatment with antibiotics alone had 
failed (Eichenwald et at., 1965; Boris et al., 1968). 
One objection to all of these studies is that the greater numbers of the 
resident strain compared to the challenge strain could mask the acquisition 
of the challenge strain; only a finite number of colonies can be selected for 
typing from any nasal swab. Ehrenkranz conducted similar experiments to 
those mentioned above, deliberately inoculating individuals with a known 
S. aureus strain (Ehrenkranz, 1966). By using a challenge strain resistant 
to tetracycline and streptomycin and culturing on selective agar containing 
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these antibiotics, he was able to detect the challenge strain when it would 
have otherwise been masked by the resident strain (Ehrenkranz, 1966). No 
relationship between the size of the resident population of S. aureus or eNS 
and minimum inocula of the challenge S. aureus strain able to persist for 
five days was found. However, such selective media may detect even very 
low numbers of bacteria. The result probably only shows that the timescale 
of elimination may be longer than the studies by Shinefield and co-workers 
would suggest. In the series of studies by Shinefield et al. patients were 
repeatedly swabbed for up to 46 weeks. In almost all cases the challenge 
strain did not occur in subsequent swabs when it had not occurred in the 
initial swabs taken a few days after inoculation. If the challenge strain had 
really "taken" but remained at reduced numbers, by chance it would be 
expected to have some subsequent positive swabs. Furthermore, if a strain 
is present in only very low numbers, its importance from an epidemiological 
perspective should be minor compared to the dominant strain. 
Studies have shown that more than one mechanism is likely to be respon-
sible for this "interference". In vitro studies by Bibel and co-workers (1983) 
provide strong evidence that competitive adherence is an important factor, 
and showed that the first bacteria to attach to a nasal epithelial cell are 
able to the reduce the ability of bacteria arriving later to attach . Studies 
by Ribble, however, showed that the filtrate of cultures of one S. aureus 
strain could inhibit the growth of another (Ribble, 1967). More recently it 
has been shown that one S. aureus strain may inhibit the expression of 
virulence factors and other extracellular proteins in another strain, rather 
than effect its growth (Guangyong et al., 1997). Since such proteins may be 
related to the ability to attach to host cells, such behaviour provides another 
explanation for the observed competitive exclusion. 
Other studies have shown that other bacterial species also interfere with 
colonization by S. aureus. Martin and White (1968) treated some nasal 
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S. aureus carriers with gentamicin (active against all staphylococci and 
diptheroids) and others with lysostaphin (which selectively lyses S. au-
reus). Amongst those who carried large numbers of eNS and diptheroids, 
those treated with lysostaphin had a much slower rate of reacquiring S. 
aureus than those treated with gentamicin. For patients who carried lower 
numbers, the acquisition rate changed little with treatment, but was higher 
than that in the first group. More recently it has been shown that implant-
ing Corynebacterium sp. alone (with no prior antibiotic treatment) into 
the nares of S. aureus carriers can eliminate carriage in most individuals 
(Uehara et ai., 2000). 
Such bacterial interference is also important for other bacteria, and may 
be particularly valuable for preventing infections amongst neonates (Sprunt 
and Leidy, 1988; Fuller and Gibson, 1998). 
These results then suggest that the important aspects of the bactericidal 
and bacteriostatic behaviour of antibiotics are twofold. Firstly, there is the 
desirable effect of killing pathogens susceptible to the antibiotic. Secondly, 
there is the undesirable side-effect of suppressing the resident flora. This 
second effect makes it easier for patients to become colonized with new 
strains. If antibiotic concentration is sufficiently high, this will only lead to 
increased colonization by resistant strains. When the chemotherapy ends 
and antibiotic concentrations fall, all strains may have an increased chance 
of colonizing the host. 
5.4.4 Studies on hospital wards 
The most obvious approach to investigating the relationship between antibi-
otic use and the spread of resistant strains on a ward is to record detailed 
transmission data of all strains, by regularly swabbing all patients, and re-
late this to the changing levels of drug consumption. In chapter 8 just 
such a data set for VRE transmission is analysed. Unfortunately, few stud-
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Reference Year Setting Duration # patients swabbing freq. Estimates possible 
(ward type) swabs/week 
(Williams et al., 1959) 1959 surgical 8-9 months 602 1 acquisition rate of penicillin-resistant strains per source 
25 beds and its dependence on initial colonization status 
(Burke and Corrigan, 1961) 1961 surgical 1.5 years 320 admission & limited use as no length of stay data 
discharge 
(Shooter et al., 1963) 1963 surgical 10 months 412 1 force of infection for penicillin and tetracycline resistant strains 
22 beds for pre- and post-operative patients 
(Parker et al., 1965) 1965 medical 15 months 446 2 acquisition rates per source for sensitive and resistant strains 
20 and their dependence on whether patient took antibiotics 
(Selwyn, 1965) 1965 dermatological 2 years 352 1 force of infection 
(Lidwell et al., 1966) 1966 surgical 20 months 714 1 acquisition rates per source for sensitive and resistant strains 
32-34 and acquisition rates per known source 
(Lidwell et al., 1970) 1970 surgical 39 months unknown 1 acquisition rates per source for resistant and sensitive strains 
22 beds 
(Lidwell et al., 1971) 1971 medical 2 years 3327 1 acquisition rates per source for resistant and sensitive strains 
Two 29-bed wards and its dependence on whether patient took antibiotics 
(Talon et al., 1995) 1995 surgical ICU 6 months 157 1 force of infection for sensitive and resistant strains 
and its dependence on initial colonization status 
Table 5.1: S. aureus transmission studies. Phage typing was used to identify cross-infection in all studies except the last, 
which used RFLPs. 
ies have done this for S. aureus in the period since MRSA has become a 
major problem in hospitals, and none permit estimation of the parameters 
of interest. There were, however, a number of studies carried out in the 
1960s and early 1970s which did this. The main concern then was caused 
by the tetracycline-resistant strains, which were also often resistant to many 
unrelated antibiotics. There are some problems in interpreting these data, 
though. Firstly, hospital populations have changed since then, and patients 
are likely to have more risk factors for infection with resistant S. aureus 
strains (Casewell, 1995). Also, the S. aureus strains have changed greatly 
as well. However, there is probably much that can be learned from studies 
of hospital staphylococci from the 1960s, and it has been argued that there 
is little reason why MRSA strains should differ (Casewell, 1986). 
In many of these studies the main interest of the investigators was in 
assessing the role of the design of the ward or other interventions2 . The 
main interest here, however, is in obtaining estimates for the transmission 
rates for sensitive and resistant strains, and their dependence on whether or 
not the patient has taken antibiotics, and whether or not the patient was 
initially colonized with S. aureus. 
The largest and most relevant of these studies are listed in table 5.1. 
The earlier of the studies presented little or no formal analysis of their 
data, but did present their results in largely undigested format enabling 
estimates to be made as indicated below. Later studies tend to present only 
summary statistics. Unfortunately, the original records of the most useful 
of these studies do not survive, so the parameter estimates obtained below 
rely on making inferences, where possible, from the published data. Where 
2None of the main studies that considered ward design were able to conclude with any 
confidence that the changes made significant differences (Shooter et al., 1963; Lidwell et al., 
1970, 1971). One study by Lidwell and co-workers tentatively concluded that segregation 
of patients may have accounted for a low frequency of cross-infections (Lidwell et al., 
1966). 
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possible, maximum likelihood estimates are made, and confidence limits 
obtained using the likelihood ratio test. In most cases these estimates are 
fairly crude and depend on a number of assumptions that may be difficult to 
justify; confidence intervals are therefore likely to underestimate the degree 
of uncertainty. Nonetheless, they do serve as an aid to model construction, 
and give an idea of the area of parameter space in the model likely to be 
worth exploring. They may also be useful in the construction of informative 
priors in a Bayesian analysis. 
Williams and co-workers, (1959) This study was designed to assess 
the importance of self-infection by S. aureus carriers for the aetiology of 
septic lesions. Nasal swabs were taken from patients on admission, and then 
at weekly intervals. Figure 5.2 and table 5.2 present the data of interest 
here; the carriage frequencies of penicillin-resistant and sensitive strains. 
Lengths of patient stays can be estimated from the reported number of 
patients still present at given numbers of weeks post-admission (shown in 
figure 5.2). These show excellent agreement with the negative exponential 
distribution, with a maximum likelihood estimate of the mean length of stay 
(and 95% CI) of 14.9 days (13.8,16.2). Table 5.2 shows data on colonization 
with penicillin-resistant strains classified by initial colonization status. De-
parture from independence of the two classifications is significant at the 5% 
level (p=0.043, G-test 1 df), with patients initially colonized with sensitive 
strains less likely to acquire resistant strains: odds ratio (and 95% confidence 
interval) 0.575 (0.332, 0.997). No significant differences were found between 
initial colonization status and whether or not the patient took antibiotics. 
There are no reason for believing that nasal carriers of penicillin-sensitive 
strains would tend to have longer stays, and there are no significant dif-
ferences in antibiotic consumption amongst non-carriers and carriers. The 
most plausible explanation for the discrepancy is bacterial interference, as 
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described in section 5.4.3. 
It is possible that resistant strains acquired by patients already colonized 
with sensitive strains may have gone undetected due to being masked by the 
sensitive strains. However, if a selective medium had been used for selecting 
the penicillin-resistant strains this would be unlikely to be the cause. The 
authors do not state how penicillin-resistance was detected. 
The authors also reported patient antibiotic use in relation to acquisition 
of drug-resistant staphylococci, and this appeared to be a significant risk 
factor (odds ratio = 1.87, 95% CI = (1.169, 2.996)). However, from the 
data presented it is not possible to determine how much of this difference 
is accounted for by the antibiotic and how much by the increased length 
of stay associated with antibiotic use. As a result, little useful information 
about the effect of antibiotics can be found here. 
Despite having typed the organisms, no data on acquisition rates per 
source are presented. To estimate these the prevalences of the sensitive and 
resistant strains on the ward are needed. A crude estimate of these can be 
made. Since the distribution of lengths of stays is known to be negative 
exponential, patient-discharge can be thought of as a Poisson process. The 
distribution of lengths of stays so far for the patients on the ward at any 
one time should therefore also be negative exponential (though the distri-
bution of total lengths of stays for patients on the ward at anyone time 
will be r(2, 1); long-stay patients will be over-represented). Data presented 
in figure 5.2 provide estimates for Pi(t), the probability that a patient who 
has been on the ward for time, t, will be colonized with a strain i. Thus, 
assuming the probabilities of being colonized do not change after 11 weeks 
for the very few patients who stay that long, the mean prevalence for strain 
i can be estimated to be: 
L Pr(l = t)pi(t) (5.1) 
t=O,l,2 ... 
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where Pr{I = t) is the probability that the length of stay so far, I, for 
any given patient is t weeks. For these data this gives mean prevalences of 
24% for the penicillin-resistant strain, and 23% for the penicillin-sensitive 
strain. 
Of the 353 patients not initially colonized with resistant strains who had 
two or more nasal swabs, there were 98 apparent acquisitions. If patient 
colonization can be assumed to be a Poisson process with rate A (the force 
of infection), and patient discharge is also a Poisson process with rate p" then 
the probability of anyone patient becoming colonized is p = A/ (A + p,). The 
binomial distribution with parameter p gives the likelihood of the observed 
data. The maximum likelihood estimate for A is then 98p,/(353 - 98). Using 
the earlier estimate for p, (1/14.89) , the rate susceptible patients become 
colonized is estimated to be 0.026 /day, with a 95% confidence interval of 
(0.020,0.032). This gives a mean time before becoming colonized of between 
about 30 and 50 days. Since this was in a 25 bed ward, where about 24% 
of patients were colonized with penicillin-resistant strains, there would on 
average be six patient sources. Ignoring other possible sources (Le. long-
term colonized carers) this gives a mean acquisition rate of 4.30 per 1000 
patient days, per source, and a 95% confidence interval of (3.39, 5.4). No 
data for the number of acquisitions of sensitive strains are given. 
One problem with these data is that putative sources of the acquired 
strains were not identified, and some of the apparent acquisitions may there-
fore be caused by initial false-negative swabs before later detection of the 
organism. If patients were already harbouring small numbers of penicillin-
resistant staphylococci these may have been preferentially selected by an-
tibiotic therapy, increasing the chance of detection. Colonized carers were 
also not considered as sources. For both of these reasons the transmission 
rate per source arrived at here may be an overestimate. 
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acquired penicillin-
week 1 carrier state resistant S. aureus 
no S. aureus 77 
penicillin-sensitive S. aureus 21 
didn't acquire penicillin-
resistant S. aureus 
173 
82 
Table 5.2: Number of patients carrying penicillin-resistant S. aureus strains 
by initial nasal colonization status. Data from Williams et at. (1959). 
Shooter and co-workers, (1963) Rates of acquisition of tetracycline-
resistant strains were 0.01 per patient day of exposure for penicillin-resistant 
strains, and 0.005 for tetracycline-resistant strains. Insufficient data are 
presented to estimate acquisition rates per source. 
Parker and co-workers, (1965) The main purpose of this study was 
to investigate the effect of the physical subdivision of wards on the trans-
mission of S. aureus. Nasal swabs were taken from patients in a 20 bed 
ward on admission and then twice weekly. The data presented allow for esti-
mates of the acquisition rates per source for drug-sensitive S. aureus strains 
(8 strain), strains resistant to penicillin only (P), and strains resistant to 
two or more antibiotics, including penicillin (M). Estimates of the affect of 
antibiotic use on acquisition rates for these strains can be made from the 
published data. 
The number of acquisitions of each strain are presented and broken down 
by antibiotic status of patients in table 5.3 .. If.x is the per-patient coloniza-
tion rate (the force of infection), then the probability of a patient becoming 
colonized in an interval ~t is p = 1 - e->.Llt. The log likelihood of there 
being a acquisitions from n patient-intervals (all oflength ~t) is then (from 
the binomial distribution) a In(p} + (n-a) In(1-p} +c, where c is a constant. 
Differentiating with respect to .x and equating to zero gives the maximum 
likelihood estimate for .x, -In((n - a)/n)/~t. 
To estimate the acquisition rates per source for different strains listed in 
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Patient # acquisitions in half week Acquisition rate Acquisition rate 
Strain taking from admission/number swabbed /1000 patient days /patient source 
type antibiotics 1 2 3 4 [first swab ignoredJ 95% CI /1000 patient days 95% CI 
S No 6/256 5/210 3/130 2/79 6.85[6.90J (4.02,10.78) 2.48 [2.50] (1.46,3.90) 
S Yes 3/190 2/175 3/150 1/109 4.15[3.98] (1.99,7.48) 1.50[1.44] (0.72,2.71) 
P No 9/256 9/210 3/130 0/79 9.03 [8.30] (5.70,13.46) 2.55[2.34] (1.61,3.80) 
P Yes 8/190 0/175 3/150 1/109 5.55 [2.64J (2.97,9.30) 1.57[0.75J (0.84,2.63) 
M No 2/256 1/210 0/130 0/79 1.27[0.68J (0.32,3.30) 1.20[0.64] (0.30,3.11) 
M Yes 4/190 3/175 3/150 2/109 5.55[5.32] (2.97,9.30) 5.24[5.02] (2.80,8.78) 
Table 5.3: Numbers of acquisitions and estimated acquisition rates of S. aureus strains sensitive to all antibiotics(S), resistant 
to penicillin (P), and multiply-resistant (M). Acquisition rates are calculated as described in the text. Because some of the 
apparent acquisitions may be due to false negative admission swabs (taken prior to the first weekly swab), rates calculated 
ignoring apparent acquisitions between the first and second swab are also shown. If such false-negatives are important, this 
rate should be lower than the rate based on all the data. Data from Parker et al. (1965). Note that acquisition rates presented 
in table IV of this paper are incorrect and should be multiplied by 2. 
table 5.3 the number of sources for each strain must be estimated. Using 
the same calculations that were used for Williams' study described above, 
mean prevalences of different strains in patients can be estimated to be 
1.06,3.54 and 2.76 for the M, P and S strains respectively. Note that since 
only patient sources are considered these are likely to be overestimates. 
Of 86 apparent acquisitions, a possible source was found for only 28 by 
phage typing, and for 12 of these a member of staff was the only possible 
source found. Furthermore, if the frequencies of the different strain types 
are different in patients and carers, then the relative values for acquisition 
rates of different strains will also be unreliable. Unfortunately, no data are 
given on the strains recovered from carers. 
If apparent acquisitions due to initial false-negative swabs are important, 
then a disproportionate number of acquisitions should appear in swabs taken 
shortly after admission. To compensate for this, in table 5.3 acquisition rates 
have also been estimated by ignoring what appeared to be acquisitions based 
on the first post-admission swab. The large discrepancy between acquisition 
rates for P strains amongst patients taking antibiotics suggests that many of 
these acquisitions are likely to be spurious. There is some evidence that the 
same may be true for acquisitions of P strains amongst patients not taking 
antibiotics. There is also a large discrepancy in estimates for the acquisition 
rate of M strains amongst patients not taking antibiotics, but since there 
were only three acquisitions in this group, the difference does not necessarily 
indicate spurious acquisitions. 
No significant differences in total rates of nasal acquisition of S. aureus 
strains were found between those taking antibiotics and those not, but those 
who received antibiotics acquired multiply-resistant strains between four 
and eight (if the first-weekly swab is ignored) times faster than those who 
didn't. Antibiotic use was associated with a reduction in the acquisition 
rate of both Sand P strains by about half, and the acquisition rate of M 
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Strain 
S 
P 
T 
Acquisition rate per 1000 patient days 
per patient source per patient or staff source 
0.017 0.039 
0.11 
0.63 
0.083 
0.384 
Table 5.4: Acquisitions rates per source for: (i) antibiotic sensitive S. au-
reus strains (S); (ii) penicillin-resistant strains; (iii) tetracycline-resistant 
strains. Acquisition rates per patient source (calculated by the authors) 
are a weighted mean from rates per source in same room and per source in 
other rooms, where weights are the number of sources of each (table 4 in 
the paper). Data from Lidwell et al. (1966). 
strains per source amongst patients not taking antibiotics was found to be 
substantially lower than for S or P strains. This could be due to lower 
numbers of carers carrying these strains, or indicative of a fitness cost of 
resistance. However, the confidence intervals are large, and any evidence of 
a fitness cost is weak at best. 
The assumption made above that each patient is equally susceptible is 
unrealistic, as colonization with one strain will hinder the acquisition of an-
other. Unfortunately, the authors do not say in how many cases a patient 
carrying one strain subsequently acquired another, and prevalences of col-
onization with different strains after different lengths of stay are likely to 
depend on prior antibiotic therapy. Because of this, there is no obvious way 
to adjust the rates in table 5.3. However, acquisition rates per source for all 
patients can be adjusted, if the data illustrated in figure 5.2 is used to esti-
mate the proportion of patients swabbed on each date carrying each strain. 
If it is then assumed that carriage of one strain provides total protection 
against acquisition of another, then the estimates for acquisition rates per 
source (ignoring apparent acquisitions detected on the first post-admission 
swab) are 2.60, 2.03 and 3.79 per source per 1000 patient days, for the S, P 
and M strains respectively. 
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Figure 5.2: Carriage of penicillin-sensitive and resistant strains of S. aureus 
by time spent on the ward. In B, multi-resistant strains are all resistant 
to penicillin and at least one other antibiotic (91% to tetracycline, and 
53% to streptomycin).Data from Williams et al. (1959)(A) and Parker et at. 
(1965)(B). 
Lidwell and co-workers, (1966) This paper describes an investigation 
into whether the subdivision of a ward was effective at preventing staphy-
lococcal cross-infection in a 30 bed surgical ward. Patients were swabbed 
on admission, and at weekly intervals. 71% of the patients received an an-
tibiotic (63% took penicillin, 14% streptomycin and 7% tetracycline. Oth r 
antibiotics were taken by less than 10% of pati nts) . Sources of infecting or 
colonizing strains were identified, where possible, by phage typing. 
A reduction in the S. aureus carriage rate was observed. In the first two 
weeks of patient stay carriage levels fell from 38% to 25%, largely du to 10 s 
of carriage of sensitive strains. This loss continued, though at a slower rate, 
throughout patients' stays. Just over 5% of patients carried tetl'acycline-
resistant strains on admission, and the frequency of carriage of these strains 
increased to no more than 9% with increas d length of stay. 
The total apparent acquisition rate was estimated to be 34.4 per 1000 
patient weeks, or 13.3 per 1000 patient w cks for multiply-resistant staphy-
lococci. The authors considered about 25% of th se acquisitions to be spu-
rious (most of these were sensitive strains). Estimates of acquisition rat s 
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Strain 
84/85 
tet-R, not 84/85 
not 84/85 
Acquisition rate per 1000 patient days 
per patient source per patient or staff source 
1963-4 1967 1963-4 1967 
9.03 
4.91 
4.05 
14.47 
4.63 
5.41 
7.64 
2.73 
1.21 
11.46 
2.98 
1.13 
Table 5.5: Acquisition rates per source for: (i) S. aureus of phage type 
84/85, resistant to penicillin, tetracycline, erythromycin and neomycin; (ii) 
tetracycline-resistant strains apart from 84/85; (iii) all strains apart from 
84/85. Rates per source for both patients and staff sources count patient 
and staff carriers equally, and are taken directly from (Lidwell et al., 1970), 
while rates per patient source are derived from data therein and assume that 
the only sources for all acquisitions are patients. 
per source were obtained by the authors and are shown in table 5.4 
Lidwell and co-workers, (1970) The aim of this study, which was con-
ducted in two distinct phases, was to examine the effect of physically sep-
arating pre-operative and post-operative patients, although the same staff 
attended all patients. Carriers of tetracycline resistant strains of S. aureus 
were put in side-rooms or isolation cubicles when possible. A single multi-
resistant S. aureus strain (type 84/85) became established on the ward 
during the study, which was acquired by over 20% of patients who stayed 
for 5-6 weeks. 
Though the raw data are not presented in this paper, and no information 
is given about patient antibiotic use, the average numbers of carriers of 
different strains present are given, as are the acquisition rates. Acquisition 
rates per 1000 patient days per patient source can be calculated from these 
(table 5.5). 
On the basis of the typeable strains, the authors estimated the proportion 
of acquisitions that were spurious (due to false negative swabs) to be about 
16%. 
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Strain 
Any 
Tetracycline-resistant 
Acquisition rate per 1000 patient days 
per patient source per patient or staff source 
6.41 2.78 
12.05 5.20 
Table 5.6: Nasal acquisition rates per source for S. aureus. Data from 
Lidwell et al. (1971). 
Lidwell and co-workers, 1971 This study of two 29-bed medical wards 
was intended to examine the effect of nursing patients in 4-bed rooms, in-
stead of an open-plan "Nightingale" ward. 
The total nasal carriage frequency of S. aureus increased with time 
spent in the ward, as did carriage of multiply-resistant and to a lesser extent 
penicillin-resistant strains. The frequency of carriage of strains sensitive to 
all antibiotics decreased slightly with the length of stay. 
Of 257 apparent acquisitions, the authors considered about 20% to be 
spurious, based on a consideration of phage types and antibiograms. 
The authors calculated acquisition rates per patient source and per pa-
tient or staff source (excluding those considered spurious). These are shown 
in table 5.6. 
The authors also presented a multiple-regression analysis to determine 
the factors influencing the rate of nasal acquisition of S. aureus. Apart 
from patient age (and after accounting for a lower acquisition rate for pa-
tients during their first week in the ward), the only significant explanatory 
variables for the acquisition of tetracycline-resistant strains were antibiotic 
use: patients who weren't carrying S. aureus strains who had received an-
tibiotics (apart from penicillin) acquired strains at a rate of 20 acquisitions 
per 1000 patient-days faster than those who received only penicillin; and S. 
aureus carriers who received no antibiotics acquired tetracycline resistance 
significantly more slowly (27 acquisitions/lOOO patient-days) than carriers 
who received antibiotics. 
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5.4.5 Other studies 
Little useful data can be gleaned from the other major studies listed. Shooter 
and co-workers (1963) report colonization rates with tetracycline-resistant 
staphylococci ranging from 6 per 1000 days patient days in a post-operative 
division of a ward, to 2.8 in the pre-operative side, but no figures are given to 
allow a colonization rate per source to be estimated. Selwyn (1965) presents 
insufficient data to enable estimates of acquisition rates to be made. In the 
study by Burke and Corrigan (1961) patients were swabbed on admission 
and discharge, but the lengths of patient stays were not reported, so no 
estimates of acquisition rates are possible. Interpretation of the results of 
this study is further confused by the extraordinarily high level of S. aureus 
carriage amongst patients entering the ward (79%). This suggests either an 
extremely unusual patient population or unreliable laboratory results. 
In one of the few recent studies of this kind applicable to MRSA, Talon 
and co-workers (1995) took nasal, surgical wound, and tracheal swabs from 
patients on admission and then at weekly intervals. The aim of this study 
was to examine the effect of mupirocin treatment on acquisition, but during 
the first four months no interventions were made. During this period 31 
out of 99 untreated patients acquired nasal S. aureus. Most of these were 
caused by MRSA strains of three distinct RFLP types, while MSSA strains 
caused only sporadic cases. However, no length of stay data are given and 
the size of the ward is not specified. Estimates of acquisition rates are not 
possible without further information. 
5.5 Discussion 
Parameter estimates obtained from these studies are summarized in ta-
ble 5.7. This table also presents estimates of the Ro value for different 
wards and strains based on the estimated per-source colonization rate. For 
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an endemic infection, Ro can usually be estimated by the reciprocal of the 
proportion of susceptibles at the endemic equilibrium (Anderson and May, 
1991). In this case, however, this formula will not hold because of the impor-
tance of the constant admissions of colonized patients to the ward. Instead, 
in table 5.7 it is estimated as the product of colonization rate per-source, 
mean length of patient stay, and the number of susceptibles given that all 
patients except the index case are uncolonized. Although these are crude 
estimates, they do give an illustration of the range of values found on differ-
ent wards. These can be related to observed transmission patterns on the 
wards. 
Thus, in the study by Williams and co-workers (1959), frequency of car-
riage of resistant strains increased rapidly with length of stay. A strikingly 
different pattern was seen in the study by Parker and co-workers, with only 
a gradual increase in the frequency of resistance with length of stay (fig-
ure 5.2). This difference occurred despite the fact that similar numbers 
of patients received antibiotics in both studies (45-50% and 43% respec-
tively), and only slightly higher rates of acquisition per source were found 
for penicillin-resistant strains in the former study as were found for multiply-
resistant strains in the latter. The fact that the estimated Ro in the former 
study is about twice the value of that for multiply-resistant strains in the 
latter, however, reflects the markedly different dynamics. In addition to the 
slightly higher acquisition rate per source, the longer-length of stay, and the 
larger ward size account for the increased value. The high immigration rate 
of patients colonized with penicillin-resistant in the former study also has 
an important influence on the ward dynamics. 
The very low transmission rates reported in the study by Lidwell and 
co-workers (1966) for drug-sensitive and penicillin-resistant strains can per-
haps be explained in part by the very high levels of antibiotic use (most 
patients took antibiotics prophylactically). The transmission rate for the 
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tetracycline-resistant strains wa.'l considerably higher, but still low compared 
to other studies. It is not clear why this should be so. 
The results from the 1963 and 1967 studies by Lidwell and co-workers 
(1970) are particularly interesting, as they provide evidence that different 
multiply-resistant strains may have large differences in their transmissibili-
ties. Thus, the endemic strain on the ward appeared to be between three and 
four times more transmissible than other tetracycline-resistant strains, and 
was reported by the authors to be dispersed by carriers far more profusely 
than other strains. This strain had a wide range of antibiotic resistance, 
but it is not clear if this was the cause of its enhanced transmissibility, or 
whether there were larger fitness costs associated with the other resistant 
phenotypes, or if other factors accounted for the difference. 
5.6 Summary 
Antibiotic treatment causes the suppression of drug-sensitive strains, leav-
ing carriage sites free for colonization with new strains, and drug-resistant 
strains in particular. There is evidence that carriers of sensitive strains are 
colonized at a slower rate than non-carriers. 
Although it has been argued that antibiotic therapy in non-carriers does 
not increase the acquisition rate of staphylococci, there is strong evidence to 
contradict this. However, while in almost all cases the percentage of carriage 
S. aureus strains that are resistant has been to found to increase with the 
length of stay of patients on wards where significant numbers of antibiotics 
are used, the overall carriage frequency of S. aureus has been found to 
both increase and decrease with time (Lidwell et al., 1966, 1970). Increases 
may be attributed to both antimicrobial therapy increasing the chances of 
non-carriers acquiring strains, and simply due to increased contact rates 
found in hospital wards; hospital staff in contact with patients typically also 
have higher carriage rates than members of the general public (Casewell and 
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Ref. strain acquisition rate LOS ward size 1VJ 
/ source / day (days) 
(Williams et al., 1959) penicillin-resistant 0.0043 14.9 25 1.54 
(Parker et al., 1965) sensitive 0.0025 (no antibiotics) 
0.0015 (antibiotics) 
0.0026t (all patients) 11.5 20 0.57 
penicillin-resistant 0.0026 (no antibiotics) 
0.0016 (antibiotics) 
0.0020t (all patients) 11.5 20 0.44 
multi-resistant 0.0012 (no antibiotics) 
0.0052 (antibiotics) 
0.0038t (all patients) 11.5 20 0.83 
(Lidwell et al., 1966) sensitive 0.000017 15* 33 0.0082 
penicillin-resistant 0.00011 15* 33 0.0528 
tetracycline-resistant 0.00063 15* 33 0.30 
(Lidwell et al., 1970) 84/85 (1963) 0.0076 15* 22 2.41 
84/85 (1967) 0.011 15* 22 3.61 
other tet-resistant (1963) 0.0027 15* 22 0.86 
other tet-resistant (1967) 0.0030 15* 22 0.94 
(Lidwell et al., 1971) all strains 0.0028 15' 29 1.17 
tetracy line-resistant 0.0052 15* 29 2.18 
Table 5.7: Ro estimates from the reviewed studies. Ro is calculated as the product of the patient length of stay, acquisition 
rate per source, and [ward size -1]. 
* indicates data not available, so value given is a guess. 
In the study by Parker and co-workers (1965) acquisition rates obtained depend on whether patients have taking antibiotics 
or not. 43% of patients did take antibiotics, but the numbers on the ward at anyone time who had taken antibiotics are 
unknown. 
t These estimates of total acquisition rates are based on the assumptions that one strain provides complete protection against 
the acquisition of another, and that all apparent acquisitions detected in the first post-admission swab are in fact spurious. 
Strain 84/85 in (Lidwell et al., 1970) was resistant to penicillin, tetracycline, erythromycin and neomycin. 
Hill, 1986). Decreases may be attributable to antibiotic therapy suppressing 
sensitive flora. 
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Chapter 6 
Antibiotic resistance models 
6.1 Introduction 
In this chapter the basic model of chapter 2 is adapted to allow for two 
strains: antibiotic-resistant and antibiotic-sensitive. The impact of changing 
antibiotic prescribing rates and the duration of antibiotic courses is investi-
gated, again within the context of a single ward. As these changes to the 
model entail an increase in model complexity, to simplify the analysis the 
host-vector framework is dropped, and patients and carers are considered 
to mix homogeneously. Again, the model is constructed with an organism 
which usually behaves as a commensal (such as S. aureus) in mind. Thus, 
antibiotic treatment is assumed to be unrelated to the presence or absence 
of the organism. 
6.1.1 Previous models 
Models are beginning to shed some light on emergence and spread of drug-
resistance resistance (Levin et al., 1999). A menagerie of mathematical mod-
els simulating the spread and evolution of drug-resistance has been devel-
oped and applied in diverse settings. These include anthelmintic resistance 
(Barnes et al., 1995), fungicide resistance (Gubbins and Gilligan, 1999), vi-
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ral (Frost and McLean, 1994), as well as bacterial resistance (Blower et aZ., 
1996). 
To date the emphasis has been on community transmission and selection, 
and deterministic approximations to stochastic systems. Most of this work 
has also concentrated on drug-resistance occurring in the organisms which 
the drug use is intended to control, and successful treatment is assumed to 
completely eradicate the pathogen. In contrast, most of the antibiotic pres-
sure on bacteria capable of colonizing humans will affect bacteria behaving 
as commensals, and the effect of treatment is usually to temporarily suppress 
their numbers. Consequently, much of the work on drug-resistance is not 
directly relevant to the problem of drug-resistance in bacteria responsible 
for most nosocomial infections. 
Much of the modelling of relevance to nosocomial infections has con-
centrated on the competitive interactions between antibiotic resistant and 
sensitive strains. Krus and Rvachev (1971) first presented a very simple 
deterministic model of the spread of resistant and sensitive strains in an iso-
lated population. This work was extended by Massad and co-workers (1993) 
who presented a model intended to be more appropriate to a hospital ward, 
but which nonetheless still ignored stochastic effects and considered an iso-
lated population. As well as cross-infection, this model allowed for direct 
emergence of resistant organisms through mutations and plasmid transfer of 
resistance factors. 
Austin and co-workers (1997) considered a model of the competitive 
interactions of sensitive and resistant strains of commensal bacteria. The 
spread of resistance was explicitly related to antibiotic consumption, where 
antibiotic treatment was assumed to be independent of the colonization 
status of the host. Again, however, the main focus was on community spread 
and equilibrium conditions. Also, individuals were assumed to be initially 
uncolonized, antibiotic use was assumed to eradicate sensitive strains, and 
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stochastic effects were ignored. 
Bonhoeffer and co-workers (1997) used a deterministic model to explore 
different antibiotic treatment protocols, and concluded that cycling antibi-
otics could never be an effective strategy. While this conclusion may be 
justified for transmission in the community, the model is not applicable to 
hospital populations. Their conclusion relies on the property of the model 
that withdrawal of antibiotics leads to a slow decline of resistant strains, 
while reinstating their use results in a rapid increase in their numbers. In 
a community setting this conclusion seems reasonable. On a hospital ward, 
however, patient turnover is rapid, stochastic effects are crucial and fade-
outs of resistant strains not only would be expected to happen, but have 
in fact been repeatedly observed to occur after changes in antibiotic policy 
(see chapter 5). It is also far from certain that reinstating the use of the 
antibiotic should lead to a rapid rise of resistant strains. This will depend 
on their immigration rate into the ward, which in turn may be reduced by 
screening of incoming patients. In the same paper the authors also con-
sidered treatment with a combination of antibiotics to be, in most cases, 
optimal. Again, it is important to stress the limitations of the model. Only 
one species of bacteria was considered, and this was treated as if it were an 
obligate pathogen. There was no consideration of the additional selection 
pressure exerted by the extra antibiotic use this could lead to on the nor-
mal flora of patients. For most of the bacteria important for nosocomial 
infections, however, such incidental chemotherapy will represent the vast 
majority of their exposure to antibiotics. Furthermore, in most cases such 
treatment is likely to be insufficient to eradicate the commensals, but will 
provide strong selection pressure for resistance to the antibiotics. In other 
words, such multiple-antibiotic therapy may in fact exacerbate the resistance 
problem. 
Austin and co-workers (1999) considered a similar deterministic model. 
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Antibiotics were assumed not to affect transmission, but to act only by re-
ducing the persistence of sensitive strains, and to select for resistant mutants 
(or pre-existing resistant strains). Patients were assumed to be uncolonized 
on admission. As the authors make clear, these assumptions would be ap-
propriate for an upper respiratory tract infection, for example, rather than 
an organism that usually behaves as a commensal such as MRSA or VRE. 
Multiple resistance and combination antibiotic therapies were considered. 
The authors reach only the tentative conclusions that both rotation of an-
tibiotics and combination therapy may be effective. 
In another study Austin and co-workers (1999b) used prevalence data 
on an leU to fit a deterministic host-vector model of a similar form to that 
used in chapter 2. Simulations of the stochastic process were then used 
to obtain confidence intervals. However, no attempt to estimate the effect 
of antibiotic therapy on transmission was made. In this model colonization 
with VRE was assumed to lead to a reduced discharge rate. No justification 
of this assumption is given in the text, though it was reported that VRE-
positive patients had a mean stay of 10.9 days, and VRE-negatives only 7.0 
days. But if patients are assumed to become colonized at some constant rate 
). and discharged at a rate Il, then the expected length of stay of those who 
become colonized will be 1/ p greater. On this basis, it might be thought 
that lengths of stays of VRE-positives are actually shorter than those of 
VRE-negatives. More plausibly, the high proportion of patients who were 
colonized on admission, the timing of antibiotic therapy, and the incubation 
period before VRE becomes detectable may all act to bring the means closer 
together. 
Levin and colleagues (1997) considered a simple stochastic model of com-
mensal sensitive and resistant bacteria interacting only by transmission to 
and from an assumed environmental reservoir, and not directly with each 
other. In this model there is no threshold effect and any level of treatment 
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retains some resistant organisms. This is a consequence of two assumptions. 
First, all hosts are assumed to carry some resistant bacteria provided that 
there are some in the environment, though this number may be very low. 
Second, the numbers of resistant and sensitive organisms in the environment 
are treated as a ratio, and fadeout is not a possibility. Their main conclu-
sions were that even very low fitness costs for resistant bacteria would cause 
a big decline in numbers in the absence of antibiotics within a decade or 
less, but that if resistant bacteria were still present, then reinstating the 
use of antibiotics would be likely to lead to a rapid rise in resistance. For 
the reasons mentioned above this model is not directly applicable to hospi-
tal populations, but may perhaps be best thought of as a representation of 
bacteria normally found in the faecal flora in large populations. 
Sebille and her colleagues have modelled the spread of an antibiotic re-
sistant pathogen in an intensive care unit (ICU), initially in a deterministic 
framework (Sebille et at., 1997), but also using a stochastic individual-based 
approach (Sebille and Valleron, 1997). Their model again considered the 
interactions between sensitive and resistant strains and simultaneously as-
sumed vector-borne transmission by carers. Handwashing was accounted for 
by considering that staff had a pre-set probability of washing their hands be-
fore patient contacts. Different immigration rates of sensitive and resistant 
strains were allowed for, and antibiotic use was considered to be indepen-
dent of the initial colonization status of patients. Their model also allowed 
for direct patient-to-patient transmission, as well as staff-to-staff transmis-
sion. Antibiotic treatment was modelled by assuming that each course of 
treatment had some probability of eliminating strains sensitive to the drug, 
rather than increasing the chance of acquisition. This model was used by 
the authors to explore the effects of three different levels of handwashing 
compliance (including compliance that varied according to the number of 
colonized patients) on a lO-bed ICU with 30 carers. In the stochastic treat-
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ment, the model output presented is limited, and intended to be illustrative 
of of the model's potentialities, rather than representative of the full range 
of behaviour possible. This approach, however, is the closest to the mod-
elling framework used here, and seems to capture the essential aspects of 
the dynamics of most nosocomial infections, though is somewhat more elab-
orate than the models developed here, for which different models are used 
to address antibiotic selection for resistant strains and the effect of carer 
handwashing behaviour. 
Recently Lipsitch and co-workers (2000) also presented a model using 
a similar framework, though without the carers and presented only in a 
deterministic formulation. Like Sebille's model, this had the important im-
provement on other models that individuals were allowed to be colonized on 
admission. Antibiotic use was assumed to be independent of colonization 
status, so this model is appropriate for the most common causes of hospital 
infections. It was assumed that antibiotic use completely cleared carriage 
of sensitive strains. The authors showed how elimination of the sensitive 
strains had the result that, at the individual level, an antibiotic would be 
positively associate with carriage of bacteria resistant to other antibiotics 
(and not the current one), though negatively associated at the population 
level. In this model, if the resistant strain could be maintained, the authors 
found the counterintuitive result that changes in the transmission rate (com-
mon to both resistant and sensitive strains) affected only the prevalence of 
the resistant strain. 
Others models have also explicitly looked at within-host dynamics of 
drug-resistant bacteria as a function of antibiotic treatment (Austin et ai., 
1997; Steward et ai., 1998), ignoring between-host transmission. 
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6.2 Model for drug-resistant Staphylococcus au-
reus: methods 
From the review in chapter 5, it appears that acquisition of antibiotic-
resistant S. aureus in hospital wards can be attributed to the suppression 
of the sensitive bacterial flora and its replacement with resistant organisms 
acquired from other patients, and to a lesser extent from hospital staff. For 
MRSA, staff carriage is usually found to be rare and its main importance is 
likely to be the occasional introduction (or re-introduction) of MRS A into 
the patient population. For this reason colonized HCWs are not considered 
as a source for the acquisition of organisms by patients. Below a simple 
model that incorporates this behaviour is presented. 
6.2.1 Two strain model: sensitive and resistant strains 
To reduce model complexity no explicit assumptions about transmission 
routes are made here, and HCWs are thus omitted from the model. This 
is in accordance with the philosophy that a model should be as simple as 
possible, but sufficiently complex to answer the questions of interest. 
The same assumptions regarding lengths of patient stays and homogene-
ity are made as made in chapter 2. The following additional assumptions are 
also made to account for the interactions of antibiotic-resistant and sensitive 
S. aureus strains with each other and with the antibiotic: 
1. Two strains are considered: one resistant and one sensitive to antibi-
otics. Patients have some probabilities, a and a', of already carrying 
these when admitted to the ward. Only one strain can be carried at a 
time. 
2. When challenged by a resistant strain, patients taking antibiotics are 
assumed to have an increased risk of becoming colonized compared to 
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those not taking antibiotics. For un colonized patients the ratio of the 
probabilities of becoming colonized is a, while for patients colonized 
with sensitive strains it is as. 
3. Patients who are already colonized with one strain are assumed to have 
a reduced probability of becoming colonized when challenged with an-
other strain compared to uncolonized patients. The ratios of probabil-
ities in the absence of antibiotics are: s for resistant strain challenges 
on patients colonized with sensitive strains, and r for sensitive strain 
challenges on patients colonized with resistant strains. 
4. Patients colonized with sensitive strains taking antibiotics are assumed 
to lose carriage of those sensitive strains when taking antibiotics at a 
rate pyA. 
5. All patients colonized with resistant strains are assumed to contribute 
equally to the chance of other patients becoming colonized with these 
strains. For sensitive strains, however, only those patients not taking 
antibiotics are assumed to contribute. This assumption is made be-
cause of the very low levels of sensitive strains found in carriers taking 
antibiotics (fig 5.1). 
6. Patients are assumed to be prescribed antibiotics at a rate 4;, indepen-
dently of colonization status. The duration of antibiotic use is assumed 
to follow a negative exponential distribution with mean L. 
7. The cost ofresistance (ifit exists) is manifest by a reduced colonization 
probability for patients not taking antibiotics when challenged with 
a resistant strain, compared to the probability of colonization when 
challenged with a sensitive strain. This is reflected in the transmission 
parameters for the sensitive and resistance strains, (38 and (3R· SO 
(3R $ (38· 
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x $ Xa 
Uncolonized IlL Uncolonized 
+ ~sy t Ilya 
Y $ Ya 
S colonized IlL S colonized 
sp R (y '+)h' )+ t r~ s y + 3s PR(y '+y') 
Y' $ y~ 
R colonized ilL R colonized 
antibiotic use 
Figure 6.1 : Flow diagram of the model for resistant strains (y' and y~) and 
antibiotic-sensitive strains (y and Ya), illustrating per capita rat s of flow 
from each compartment. Admission and discharge rates are not shown, but 
we assume that patients not taking antibiotics are discharged at a rate /-l, 
and those taking antibiotics at a (generally lower) rate /-la. All discharge 
are matched by admissions. A fraction (I of these are assumed to be initially 
colonized with the sensitive strain, and go into the compartment y, and a 
fraction (I' go into the compartment y' (Le. carry the resistant strain). The 
rest, (1 - (I - (II), go into th uncolonized compartment x. It is assumed 
that none are ini tially taking antibiotics. 
8. In the absence of antibiotics, the rate at which strain are lost from 
patients is assum d to be very small compared to the rate at which 
patients are discharged from the ward, and can th refore be ignored. 
Parameters are summariz d in table 6.1 and the model is illustrated 
schematically in figure 6.1. 
Deterministic formulation 
Th model described above is formulated in stochastic t rms, and the stochas-
tic version remains t he primary interest. However, it can be instructive to 
first consider the properties of the deterministic analogue of the model. In 
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CJl 
00 
Parameter Meaning Default value Range Reference(s) 
f3s colonization rate with sensitive strains 0.001 0.0002 ... 0.02 A,B 
f3R colonization rate with resistant strains f3s f3s/2 . .. 2f3s A 
</> antibiotic prescribing rate 0.25 0.1. .. 1.0 C 
L mean length of antibiotic treatment 5 3 ... 10 C 
j.£ discharge rate 0.1 0.2 ... 0.05 C 
j.£a discharge rate during antibiotic treatment 0.02 0.0 ... j.£ C 
a proportion of new admissions 0.3 0.2 ... 0.4 A,B etc 
colonized with sensitive strains 
a' proportion of new admissions 0.05 0.01 ... 0.15 A,B etc 
colonized with resistant strains 
s reduction in f3 R if colonized 0.667 0.4 ... 1 D 
with sensitive strain 
r reduction in f3s if colonized s no data 
with resistant strain 
a multiplier for f3R if taking antibiotics 6 1. .. 8 A 
as as a, but for patients colonized a no data 
with sensitive strains 
j.£ya rate of loss of sensitive strains 0.03 E 
during antibiotic therapy 
Table 6.1: Parameters and their default values for the two strain model. All rates are in units of days-l. Sources for the 
default parameter values are given. Reference codes are: A (Parker et ai., 1965); B (Lidwell et al., 1966); C (own data 
collected during study described in chapter 3); D (Williams et ai., 1959)[derived from 95% risk ratio]; E (Aly et at., 1970). 
discussing this formulation of the model, the convention of talking about 
it as if it were a stochastic system is adopted. Strictly speaking, for the 
deterministic system individuals or probabilities have no meaning. The ter-
minology is retained to enable connections to be drawn to the stochastic 
system. 
The model can be expressed as follows: 
dx 
-
dt 
dy 
= dt 
dy' 
= dt 
dXa 
- = dt 
dYa 
dt 
dy~ 
dt 
-f1sxy - f1RX{Y' + y~) - ¢X + {I/L)xa - J.lX 
+ (J.lno + J.lana)(1 - a - a') 
(6.I) 
f1sxy + rf1sY'y - sf1RY{Y' + y~) - ¢y + {I/ L)Ya - J.lY (6.2) 
+ (J.ln + J.lana)a 
f1RX{Y' + y~) + sf1RY{Y' + y~) - rf1sY'y - ¢Y' + {I/ L)y~ (6.3) 
- J.lY' + (J.lno + I-Lana)a' 
J.lyaYa - af1RXa{Y' + y~) + ¢x - (I/L)xa - J.laXa (6.4) 
-J.lyaYa - as f1RYa{Y' + y~) + ¢y - (I/L)Ya - J.laYa (6.5) 
as f1RYa{Y' + y~) + af1RXa {Y' + y~) + ¢y' - {I/ L)y~ {6.6} 
, 
- J.laYa {6.7} 
where na = Xa + Ya + y~ and no = x + Y + y'. Since no + na is assumed 
to be a constant (n), only five of the above equations are independent. 
For notational convenience, the dependence of the transmission rate on n 
is not shown, and has been absorbed into the constants f1. When considering 
the effects of changing n, therefore, it should be borne in mind that the f1s 
will also need to change. 
Stochastic framework 
The stochastic version of the deterministic model described by equations 6.2-
6.7 is derived in the same manner as described in chapter 2. There are 
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now six compartments, and since the population size is assumed to remain 
constant, the state of the systems is uniquely determined by the numbers 
in any five of these. There are now 28 possible transitions between these 
compartments. These are listed in table 6.2. 
The behaviour of this model was explored with simulation studies, using 
a program written in C++ (available on request from the author). Ex-
periments investigating the invasion of resistant strains were performed by 
introducing one patient colonized with a resistant strain into a ward at equi-
librium with regard to the sensitive strain and antibiotic use. This condition 
was satisfied by running the simulation for a (simulated) period of 500 days 
before introducing the resistant strain. Persistence of resistant strains was 
investigated by introducing resistant strains and sampling only from those 
simulation runs where the resistant strain was present after a sufficiently 
long "burn-in" period. 
Apart from (J', which was set to 0 in these experiments, and ¢ which 
was typically varied, the default parameters from table 6.1 were used unless 
stated otherwise. 
6.3 Results 
6.3.1 Deterministic results for the two strain model 
In this model antibiotic treatment is independent of the colonization status 
of the patients, and the proportion of patients taking antibiotics at anyone 
time, Pa, is given by 
Pa = /-La + ¢ + 1/ L (6.8) 
So, in the absence of any bacterial strains, the equilibrium values of x 
and Xa (denoted x~ and x:,o)are given by 
Xo = n{1 - Pa) (6.9) 
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Transition 
y-+y+1,x-+x-1 
Y -+ Y + 1, y' -+ y' - 1 
y' -+ y' + 1, x -+ x-I 
y' -+ y' + 1, y -+ y - 1 
y~ -+ y~ + 1, Xa -+ Xa - 1 
y~ -+ y~ + 1, Ya -+ Ya - 1 
Ya -+ Ya - 1, Xa -+ Xa + 1 
Xa -+ Xa + 1, x -+ x-I 
Ya -+ Ya + 1, Y -+ Y - 1 
y~ -+ y~ + 1, Y' -+ Y' - 1 
Xa -+ Xa - 1, x -+ x + 1 
Ya -+ Ya - 1, Y -+ Y + 1 
y~ -+ y~ - 1, Y' -+ Y' + 1 
x-+x-1,y-+y+1 
x -+ x-I, y' -+ y' + 1 
Xa -+ Xa - 1, x -+ x + 1 
Xa -+ Xa - 1, y -+ y + 1 
Xa -+ Xa - 1, y' -+ y' + 1 
y -+ y - 1, x -+ x + 1 
y -+ y - 1, y' -+ y' + 1 
Ya -+ Ya - 1, x -+ x + 1 
Ya -+ Ya - 1, y -+ y + 1 
Ya -+ Ya - 1, Y' -+ Y' + 1 
Y' -+ Y' - 1, x -+ x + 1 
Y' -+ Y' - 1, Y -+ Y + 1 
y~ -+ y~ - 1, x -+ x + 1 
y~ -+ y~ - 1, Y -+ Y + 1 
y~ -+ y~ - 1, Y' -+ Y' + 1 
Description 
transmission (sensitive strain) 
transmission (sensitive strain) 
transmission (resistant strain) 
transmission (resistant strain) 
transmission (resistant strain) 
transmission (resistant strain) 
loss of sensitive strain 
start antibiotics 
start antibiotics 
start antibiotics 
stop antibiotics 
stop antibiotics 
stop antibiotics 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
discharge 
Rate 
f3sxyflt 
rf3sy'yflt 
f3RX(Y' + y~)flt 
sf3RY(Y' + y~)flt 
asf3Rxa(y' + y~)flt 
asf3RYa(Y' + y~)flt 
J-lyaYa flt 
<pxflt 
<pyflt 
<pyflt 
(xa/ L)flt 
(Ya/L)flt 
(y~/ L)flt 
J-lxcr flt 
J-lxcr' flt 
J-laxa(1 - cr - cr')flt 
J-laxacrflt 
J-laxacr' flt 
J-ly(1 - cr - cr')D.t 
J-lYcr' flt 
J-laYa(l - cr - cr')D.t 
J-laYacr flt 
J-laYacr'D.t 
J-ly'(l - cr - cr')D.t 
J-lY' cr flt 
J-lay~(l - cr - cr')flt 
J-la y~ cr fl t 
J-laY~cr' D.t 
Table 6.2: Stochastic transitions in the two strain model. All other transi-
tions occur at o(D.t). 
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(6.10) 
(6.11) 
In the absence of constant immigration for sensitive or resistant strains (a = 
a' = 0), a sensitive strain will only be able to become established on the 
ward given a single index case if its basic reproduction ratio, Rylo* is greater 
than 1. Here, Rylo* represents the number of secondary cases caused by the 
index case when no other strains are present on the ward and x and Xa are 
at their equilibrium values. 
Intuitively, this can be calculated as the product of the time the index 
case spends on the ward, T, and the rate, C, at which other patients are 
colonized by this index case. Since sensitive strains are assumed to only 
contribute to the spread of the organism when their hosts are not taking 
antibiotics, only the mean time spent in compartment y is needed. Let To 
represent this quantity, then 
1 
To = -",- +PrTO 
,/,+J.t 
(6.12) 
where Pr is the probability of moving from y to Ya and returning to y, 
and is given by 
which gives 
To = 1 + LJ.ta + LJ.tya 
J.t + (¢ + J.t)(LJ.ta + LJ.tya) (6.13) 
During this time susceptibles become colonized at a rate f3sx5. Combin-
ing the two gives 
R - f3s(1/L+J.ta+J.tya) n(J.ta+l/L) 
ylo* - [J.t/L + (¢ + J.t)(J.ta + J.tya)] (J.ta + ¢ + I/L) (6.14) 
So Rylo* is a decreasing function of the prescribing rate ¢, and as ¢ ~ 00, 
RyIO* ~ O. For a sufficiently high value of ¢ a sensitive strain will not be 
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able to invade. Three effects are responsible for this: firstly, patients are 
assumed not to be susceptible to strains sensitive to antibiotics they are 
taking; secondly, antibiotic treatment is assumed to clear carriage of sensi-
tive strains at a rate f.Lya; thirdly, patients colonized with sensitive strains 
are assumed not to cause any transmission during antibiotic therapy due to 
the suppression of the resident organisms. 
In a similar manner, the corresponding basic reproduction ratio for a 
resistant strain, Ry' 10*, can be shown to be 
R _ f3R(¢+l/L+f.La) n(f.La+ 1/ L + a¢) 
y'lo* - (¢f.La+f.L/L+f.Lf.La) (f.La+¢+l/L) (6.15) 
Differentiating this with respect to ¢ shows that this is an increasing 
function of ¢ provided that f.La :::; f.L and a ~ 1. When these conditions hold 
(as they usually will), increasing ¢ will increase the chance of a resistant 
strain invading. 
Two distinct effects are responsible for this increase: firstly if a > 1 pa-
tients taking antibiotics will become colonized faster than those who aren't; 
secondly, if f.La < f.L, patients taking antibiotics spend longer on the ward, 
providing more opportunity for a resistant strain to spread. If f.La = J-L only 
the first effect occurs, and the increase of Ry'lo* with Pa is linear, as shown 
in figure 6.2. 
In a hospital setting, for S. aureus, the situation described here with 
(1 = 0 is generally not realistic. In most wards a significant proportion of ad-
missions will be carrying sensitive strains (though neonatal wards represent 
an important exception). 
If Rylo* > 1, then, at the equilibrium, the numbers of susceptibles are 
reduced to a number x; such that each patient colonized with a sensitive 
strain causes exactly one more case. Hence 
where x~ is given by 6.10. 
x* 
Rylo* ~ = 1 
xo 
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(6.16) 
6 Tr===~========~========~~--~--~--~---t 
. - .. Sensitive strain , default parameters 
-- Resistant strain , default parameters 
. . . . . Resistant strain, constant dischar e rate 
5 
4 
2 
... ... 
O +----.----.--,. - ---.--,---. ----,. ---. --. ~-~· -r·~-~·=-~-~-~~~--~--~----+ 
o 0.1 0.2 0.3 0.4 0.5 0.6 0.7 O.B 0.9 
P , proportion of patients taking antibiotics 
a 
Figure 6.2: R y1o* (dash-dot ted line) and RY'lo> (solid line) for default param-
eter values. Also shown (dotted line) is RY'lo' assuming J.la = J.l = 0.1 (Le. 
constant patient discharge rate). For the default parameters Pa = 0.53. 
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This gives 
* p(¢ + P)(Pa + Pya) 1 
X = -(LPya + LPa + 1) !3s 
Again, a = a' = 0 is assumed. 
Then, from (6.8), y* = (1 - Pa)n - x*, and from (6.6) 
¢y* y* = --..:....::..-----:--
a Pya + P + I/L 
and x~ = Pan - y~. 
(6.17) 
More commonly a -=I 0, and even when Rylo* < 1 the constant influx 
of sensitive strains will cause y to stabilize at some level y*, obtained by 
setting equations 6.2,6.3,6.5 and 6.6 to zero and solving. Figure 6.3 shows 
the prevalence, y* In, as a function of Pa for two assumptions about the 
discharge rates of patients taking antibiotics. 
It is useful to define the basic reproduction ratio for a resistant strain, 
given that the sensitive strain is present and at its equilibrium value y*. This 
number, Ry' Iy*' then represents the number of secondary cases of resistant 
strains caused by one individual colonized with a resistant strain introduced 
when the ward contains only sensitive-strains at equilibrium levels. Ry'ly* 
can be calculated in a similar manner to Rylo* and is given by 
R _ (¢ + 1/ L + Pa)(!3RX* + s!3RY* + as!3RY: + a!3Rx~) 
y'ly* - ¢Pa + (r!3sY* + J1.)(J1.a + 1/ L) (6.18) 
Here y*,y:,x*, and x~ are the equilibrium values in the absence of the 
resistant strain, as given above. 
Figure 6.4 shows the relative contribution of the different compartments 
to new cases caused by the index case. For the range of parameter values 
considered here, at the beginning of an outbreak most of the new cases are 
likely to come from patients undergoing antibiotic therapy. Since antibiotic 
treatment is assumed to be independent of colonization status, this suggests 
that in an outbreak situation, where the resistant strain would not persist 
in the absence of antibiotics, the influx of sensitive strains may not be im-
portant in determining the chance of an outbreak. Figure 6.5 emphasizes 
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P I proportion of patients taking antibiotics 
a 
Figure 6.3: Equilibrium preval nces for sensitive strains (y* In) with im-
migration (0' = 0.3). Solid line uses default parameter values, except for 
cp. The dotted line assumes J.1.a = J.1. = 0.1 (i.e. constant patient discharg 
rate), but otherwise uses the same parameters. For the default parameters 
Pa = 0.53. In both cases, Rylo* :::; 0.2. 
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4 
2 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 
P , proportion of patients taking antibiotics 
a 
Figure 6.4: Ry'lv.' indicating the contribution of the different compartments 
due to one primary case colonized with a resistant strain. Apart from </J, 
default parameters are used throughout. At the default value of </J, Pa = 0.53. 
this point: when the basic reproduction ratio for the resistant strain is near 
one, the presence of sensitive strains make very little difference to its value. 
Even if sensitive strains are assumed to offer complete protection against 
acquiring resistant strains for patients not taking antibiotics (8 = 0), Ry'lv. 
is not substantially reduced. 
6.3.2 Stochastic results for the two strain model 
Figure 6.6 illustrates the model's behaviour following the introduction of 
one patient colonized with a resistant-strain into a ward at equilibrium with 
regard to antibiotic use and the sensitive strain. The proportion of patients 
taking antibiotics at anyone time (Pa) is increased from 0 to 0.8 by varying </J, 
the prescribing rate. For low values of Pa, when Ry'lv* is much smaller than 
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Figure 6.5: Dependency of reproduction numbers on antibiotic use in the two 
strain model. Solid line: Ry'jo*, Dotted line: Ry'jy*' Dot-dashed line: Ry'jy* 
with r = s = 0, so in the absence of antibiotics one strain cannot replace 
another. Otherwise, apart from </1, default parameters are used throughout. 
At the default value of </1, Pa = 0.53, 
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one (less than about 0.5), though there are sporadic outbreaks, the frequency 
of these decreases rapidly with outbreak size. In contrast, when Ry'ly* is 
substantially higher than one, although there is still a high probability of no 
transmission occurring, when there are just one or two secondary cases there 
is now also a high probability that many more patients will subsequently be 
colonized. Thus as Ry'ly* increases above one, the frequency of there being 
exactly 1,2,3 ... cases actually decreases, as the chances of there being a 
large outbreak and quasi-endemicity being reached increase. In the region 
where Ry'ly* is close to 1, an intermediate behaviour is observed. 
For Ry'ly* much smaller than one, sporadic outbreaks will still occur. 
For example, when Ry'ly* = 0.53, following the admission of one colonized 
patient into a ward free of the strain, in more than 7% of cases five or more 
transmission occur, and more than ten OCCur in one admission in 50. In 
contrast, when Ry'ly* is much greater than one, if five secondary cases occur 
it is almost certain that 10 secondary cases will OCCur unless an intervention 
is made to reduce the transmission. In the former case, even without any 
intervention, the strain is likely to be eliminated before many more patients 
are colonized. 
6.3.3 Quasi-stationary distributions 
Figure 6.7 shows how the mean number of patients colonized with a resistant 
strain changes with time, following the introduction of one colonized case 
on day O. 
If a long time has elapsed since the introduction of the resistant strain, 
then it can be assumed that, if it is still present on the ward, the distribution 
of the number of patients colonized with it will be well-described by the 
quasi-stationary distribution, that is the stationary distribution conditional 
on non-extinction of the epidemic. Figure 6.8 shows the approximate quasi-
stationary distributions obtained from the simulation runs, by conditioning 
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on non-extinction, and sampling either 75 or 150 days after the introduction 
of the resistant strain. 
For comparison, also shown on figure 6.7 are the corresponding quasi-
stationary distributions for the stochastic SIS epidemic model with basic 
reproduction ratio, Ro, set equal to Ry'ly*. These distributions were obtained 
as the left eigenvalues of the matrix obtained by deleting the first row and 
column from the matrix A, where A is taken from the Kolmogorov forward 
equations for the SIS model: pi = pA. Here p(t) is the row vector of state 
probabilities, where the ith component gives the probability of there being 
i infecteds at time t (Nasell, 1999). 
Clearly, they show excellent agreement with the simulation results. This 
suggests that despite the additional complexity, the quasi-stationary be-
haviour of the current model behaves essentially like the stochastic SIS 
model, but governed by Ry'ly* instead of Ro. 
Adopting Nasell's terminology for the SIS model, the behaviour of the 
model in three distinct regions is considered: Ry'ly* distinctly greater than 
one; Ry'ly* distinctly less than 1; and Ry'ly* in a transitional region between 
the two, and near the threshold value of one (Nasell, 1999). 
• Ry'ly* distinctly less than one 
In this case the quasi-stationary distribution is approximated by a ge-
ometric distribution. Following the introduction of one colonized case 
carrying the resistant strain into a ward previously free of this strain, 
the mean number of patients colonized with this strain decreases mono-
tonically to zero . 
• Ry'ly* ~ 1 
The quasi-stationary distribution is approximated by a truncated nor-
mal distribution. The mean number of colonized patients stays close 
to One at first, before decreasing slowly due to fadeouts. 
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• Ry'ly* distinctly greater than one 
The quasi-stationary distribution is approximated by a normal distri-
bution. Although in a large number of cases fadeout will occur shortly 
after the introduction of the index case, there is a rapid increase in the 
mean number of colonized patients; this reaches a plateau at a quasien-
demic level close to the deterministic endemic level. Since fadeout is 
certain this must eventually decrease to zero. However, the rate at 
which the mean decreases itself decreases with Ry'ly*; for large values 
fadeouts are very rare, and the mean remains almost constant with 
time. 
6.3.4 Extinction times and intensity 
Figure 6.9 shows times to extinction from the introduction of one colonized 
patient, and its dependency On RY'ly" shown on a logarithmic scale. Ry/IY' 
was changed by changing the prescribing rate <p. 
When the default parameters are used the mean time to extinction in-
creases faster than exponentially with Ry/IY" The mean increases much 
faster than the median since it is dominated by the very long persistence in 
a small proportion of simulation runS. The mean time to extinction is also 
shown as a function of Pa, the proportion of patients taking antibiotics at 
anyone time. When patients taking antibiotics are discharged at a slower 
rate, the time to extinction becomes very sensitive to this number; this re-
sults from the dependency of Ry/IY' on Pa, as shown in figure 6.2. When the 
discharge rate for patients taking antibiotics is the same as that for other 
patients Ry/IY' increases only linearly with Pa, and the time to extinction 
increases only exponentially with both. In contrast to the quasi-stationary 
distributions, times to extinction do not depend solely On Ry1IY" For the 
same Ry/IY' values, longer extinction times are seen when the discharge rate 
of patients taking antibiotics is lower. This shouldn't be surprising; in the 
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SIS model, the expected time to extinction is found to be inversely propor-
tional to the removal rate of infecteds (the recovery rate, or discharge rate 
in the case of hospitals wards) (Nasell, 1999). 
Figure 6.10 shows similar graphs for the colonized patient days (inten-
sity) following the introduction of one patient colonized with a resistant 
strain. It shows a similar relationship, but the greater rate of increase with 
RY'ly* when patients taking antibiotics have a reduced discharge rate is more 
apparent. 
Figure 6.11 shows how colonized patient days, the mean time to extinc-
tion, and the quasi-stationary distribution are related. Colonized patient 
days can be closely approximated by the product of the mean time to ex-
tinction and the quasi-stationary mean (for the SIS model), particularly for 
larger values of RY'ly* when most of the colonized patient days will come 
from outbreaks that persist for a long time, and will therefore be closer to 
the quasi-stationary distribution. 
Times to extinction from the quasi-stationary distribution are shown in 
figure 6.12. As for the stochastic SIS model, these have a negative exponen-
tial distribution, regardless of the value of Ry'ly*' 
Figure 6.12 shows times to extinction following the withdrawal of an-
tibiotics. In all cases this has the effect of reducing the value of Ry'ly* to 
0.17. For values of RY'ly* distinctly less than one a similar distribution of 
times to fadeout is seen. Here, the mean time to extinction is reduced from 
102 when RY'ly* = 0.53 to 48 days. For values of RY'ly* distinctly greater 
than one the distribution of times to extinction from the quasi-stationary 
appears to approach gamma distribution as Ry'ly* increases. In this case, 
the mean time to extinction was reduced from 7860 days for RY'ly* = 2.36 
to 160 days. Only in this case (Ry'ly* distinctly greater than one) is there 
likely to be a good chance that results of an intervention are statistically 
significant at conventionally accepted levels. In this case, there is 5% chance 
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that a fadeout in the number of resistant strains will occur within 400 days 
without an intervention, but in almost all cases fadeout will have occurred 
by this time when the indicated intervention is made. 
When RY'ly* is close to the threshold value the times to extinction fol-
lowing the reduction in RY'ly* have a bimodal distribution. In this case the 
mean extinction time was reduced from 198 days when RY'ly* = 1.14 to 103 
days. 
6.4 Discussion 
The value of any model depends on the validity of its assumptions, and 
(as in most biological models) many of this model's assumptions may be 
questioned. Of particular interest are the assumptions made regarding an-
tibiotic usage. Estimates of durations of courses and prescribing rates were 
based on data collected in the observational study described in chapter 3. 
However, a far larger set of data on antibiotic use was collected in a re-
cent study by Bradley et al. (1999), and this is presented in figure 8.8 in 
chapter 8. Some qualitative aspects are accurately captured by the model, 
others aren't. Clearly many patients do go through repeated courses of an-
tibiotics, and patients' longer stays are associated with antibiotic use. The 
time before a patient takes antibiotics however has a negative exponential 
distribution in the model, but a bimodal distribution in the data in fig-
ure 8.8, with a large proportion of patients taking antibiotics within 2 days 
of being admitted, and the other peak occurring about 12 days later. Du-
ration of one course of antibiotics is (surprisingly) reasonably approximated 
by the negative exponential distribution in these data, but again there is 
in fact a bimodal distribution, with the main peaks at 1 day and a smaller 
peak at 5 to 7 days. For the study described in chapter 3 the negative expo-
nential distribution also seems like a reasonable approximation. In both sets 
of data (as in the model) distributions of durations of antibiotic treatments 
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Figure 6.6: A: Frequencies of 0, 1, 2 ... secondary cases of the resistant strain, 
following the introduction of one patient colonized with this strain intro-
duced to a ward at equilibrium. B: cumulative frequencies for three RY'ly* 
values. Each bar indicates the probability of the indicated number of sec-
ondary cases or more. For each value of Pa the results are based on 10,000 
simulation runs. Apart from ¢, the default param ters were used. 
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(Pa = 0.25); centre, RY'IY. = 1.135 (Pa = 0.5); bottom, RY'IY. = 2.356 
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introduction of the index case (by which time resistant strain fade out had 
occurred in over 48% of the runs). For the first two cases, samples are based 
on the 3.4% and 21.7% of runs not reaching extinction 75 days after the 
introduction of the resistant strain. Apart from 4>, the default parameters 
were used. 176 
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have long tails, and a large number of very short durations of antibiotic use. 
Of course, other wards may have very different patterns of antibiotic usage. 
Another difference is that the model has the Markov property. Thus, in 
the model a patient who has just finished one course of antibiotics and not 
been discharged is as likely to undergo another course or be discharged as a 
newly admitted patient. However, of the 290 patients episodes in figure 8.8, 
antibiotics were taken in 234. In 211 of these the patients weren't discharged 
during or immediately after antibiotic treatment; subsequent mean length 
of stay was only 13.2 days (compared with a mean length of stay of 25.2 
for new admissions), and only 57 of the patients who weren't discharged 
immediately had subsequent courses of antibiotics at a later date during 
the same episode. If the Markov property did hold a similar proportion 
of these 211 patients should have had further courses of antibiotics as that 
found in new admissions and lengths of stays should have been similar. This 
suggests that, for this ward at least, it might be more appropriate to include 
a new compartment in the model to represent patients who have completed 
a course of antibiotics. 
Of course, on other wards the picture could be different, and such a 
modification carries the cost of further increasing model complexity. How-
ever, since a disproportionate amount of colonization should occur amongst 
patients who have taken antibiotics, length of stay on the ward following 
antibiotic therapy is likely to be an important factor for the persistence of 
resistant strains on the ward. 
Other models have been of a similar form to that used here, but have 
simplified the analysis by using only three compartments: one for un col-
onized patients; and one for those colonized with each of the two strains 
(for example Austin and Anderson, 1999; Lipsitch et al., 2000). Antibiotics 
are then assumed to act for a fixed proportion of the time for each patient 
class. This has the advantage that the system reduces to two independent 
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equations and solutions are readily found. It has the disadvantage that cor-
relations between antibiotic use and colonization status are lost, and these 
can have important effects on the dynamics of the system. In situations 
where a large proportion of each individual's time is spent taking antibi-
otics, as is likely on many hospital wards, the effects will be particularly 
important. 
6.5 Conclusions 
• Models for the spread of antibiotic resistance in the community will 
not be appropriate for hospitals. The important difference is that in 
hospitals there will be a constant influx of new hosts colonized only 
with sensitive strains, and these will rapidly replace resistant strains in 
the absence of antibiotic pressure. Furthermore, the small populations 
will mean that stochastic effects are important and fadeouts cannot be 
neglected. Here, it has been shown that changes in antibiotic policies 
can lead to large changes in the prevalence of resistant strains. More-
over, these changes can occur on a fast timescale, and rapidly lead to 
extinction of resistant strains, contrary to predictions of deterministic 
models. Previous arguments based on deterministic model results that 
claim that cycling of antibiotics will never be a good strategy cannot 
be applied to hospital wards. Antibiotic policies suggested by models 
that consider only the effect of antibiotics on obligate pathogens may 
be more likely to select for resistance in commensals, and therefore 
exacerbate the problem. Great care is therefore needed in the inter-
pretation of models, and should be exercised in indicating their range 
of applicability. 
• The model is very sensitive to the persistence of patients undergoing 
antibiotic therapy. Thus, if such patients have reduced discharge rates, 
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big increases in the basic reproduction number for the resistant strains 
can occur. This is because most of the patients who become colonized, 
at least in the early stages of an outbreak, are those who have taken 
antibiotics. For the same reason, length of stay following antibiotic 
therapy will also have a large impact on transmission; the longer it 
is, the greater the basic reproduction number. The assumptions made 
here about length of stay following antibiotic treatment were mathe-
matically convenient, but probably unrealistic on most wards. More 
realistic models that aim to make quantitative predictions should pay 
particular attention to this. 
• Colonization with sensitive strains may significantly reduce the chance 
of an individual becoming colonized with resistant S. aureus strains 
in the absence of antibiotics. When antibiotics are taken, however, 
the numbers of sensitive strains are reduced to such low numbers that 
such interference is unlikely to be important. Because of this, the 
fact that most transmission is likely to be associated with antibiotic 
therapy, and the relatively low numbers of patients colonized with 
sensitive S. aureU8 strains, models that ignore sensitive strains may 
be adequate for many purposes. Nonetheless, as shown by Lipsitch and 
co-workers (2000), consideration of sensitive strains and the role they 
play in preventing colonization with other strains can explain apparent 
paradoxes in colonization patterns. It is also likely that patients who 
have taken antibiotics are likely to be more susceptible to colonization 
with sensitive strains (as well as with resistant strains) due to the 
reduced numbers of the rest of the flora. 
• All the models mentioned in this chapter consider only different strains 
of the same species of bacteria. Thus patients who don't carry these 
are considered to be the same as patients who have had their sensitive 
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flora suppressed or removed through antibiotic therapy. For S. aureus 
however, experiments have shown that other bacteria, such as CNS, 
can also reduce the risk of acquiring new S. aureus strains. When the 
antibiotics also suppress these (see figure 5.1), it may be more appro-
priate to model treated patients in a separate class. This would also 
allow lengths of stays following antibiotic treatment to be modelled 
explicitly. 
• A major conclusion of this work is that not only the prevalence of 
antibiotic therapy on a ward are important, but also the timing. The 
effect of reduced discharge rates for patients taking antibiotics not only 
increases the basic reproduction number for the resistant strain, RY'ly*' 
thus increasing the chance of transmission, and the quasi-endemic 
level, it also increases the persistence of such a strain on the ward, 
over and above the increase that can be attributed to the change in 
Ry'ly*' Consequently, an effective strategy to reduce resistant strains 
would be to discharge patients who have taken or are taking antibiotics 
promptly when this is possible . 
• Because of stochastic effects, in many circumstances it can be difficult 
to interpret the results of interventions that result in the elimination 
of a resistant strain from a ward, as fadeout may have occurred by 
chance. Simulation results of extinction times from quasiequilibrium 
both with no intervention, and with an intervention to reduce the ba-
sic reproduction number can aid in the interpretation of these results, 
as well as in the design of studies. In particular, they suggest that 
unless the basic reproduction number is significantly higher than one 
and the effect of the intervention is large, then the variability of extinc-
tion times will be so large that, for most possible results of effective 
interventions, one would have little confidence that the results didn't 
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occur by chance. 
• One consequence of this model, and all models like these, is that 
the amount of resistance will have a non-linear relationship with the 
amount of antibiotic consumption. Thus, given the choice, it may be 
a better strategy to have two wards with equal levels of antibiotic use 
rather than one with twice the level and one with none at all. This 
is an immediate consequence of the threshold effect. If both wards 
prescribe antibiotics below the threshold where long-term persistence 
can occur, only sporadic outbreaks in each will be possible. Doubling 
these levels, however, may enable long-term persistence of the resistant 
strains, resulting in many more patients becoming colonized. 
• Despite its moderate complexity, the model explored here has fairly 
simple behaviour. It can usefully be considered to be an extension 
of the simple SIS model. Indeed, the quasistationary distributions 
are essentially the same as those from the corresponding SIS model. 
Times to extinction from the quasistationary distribution, however, 
now depend on parameters relating to antibiotic consumption as well 
as the "recovery rate". 
• The model presented here has a large number of parameters. In this 
case, only simplified versions of this model were considered where some 
of these were set to zero or chosen to equal each other, reducing the pa-
rameter space. Exploring the full parameter space would be a difficult 
task and would be getting ahead of available data (though chapter 8 
shows how many of the unknown parameters may be estimated). One 
of the major goals of this work has been to show that much of the 
model's behaviour can be characterized by derived quantities. In this 
case it was shown that some of the most important aspects of the 
model's behaviour can be understood by consideration of the quasis-
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tationary distributions, and the mean time to extinction. The form of 
the quasistationary distribution in turn can be approximated using the 
basic reproduction ratio for the resistant strain, and through this the 
effect of different parameters can be determined. Simulation studies 
showed that the former was approximated well by that for the simpler 
SIS model, but with the Ro replaced by RY'ly*. Such approximations 
may be important for further developments, including determining op-
timal antibiotic policies and investigating the interactions of a number 
of wards. 
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Chapter 7 
A comparison of growth 
kinetics between 
methicillin-resistant and 
methicillin sensitive S. 
aureus strains 
This chapter describes a study comparing growth kinetics between collec-
tions of MRSA and MSSA strains. The intention is to examine whether 
there are obvious fitness costs associated with the methicillin-resistance. 
7.1 Background: the fitness cost of resistance 
Most mutations that make significant changes to the physiology of a cell 
would be expected to be deleterious {Maynard Smith, 1989}. Mutations 
conferring resistance to antibiotics should be no different in the absence of 
antibiotics. In vitro studies have borne out this intuition, with maladaptive 
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pleiotropic effects accompanying mutations conferring resistance to viruses 
in Escherichia coli (Lenski, 1988), rifampicin in Bacillus subtilis (Cohan 
et al., 1994) and streptomycin resistance in E. coli (Schrag and Perrot, 1996). 
These studies showed that this initial "cost" of resistance is subsequently 
reduced through one or more compensatory mutations. 
Significant variations in the initial costs are seen, caused in part by the 
resistance genes themselves, but mostly by variations in the genetic back-
ground. Increasing the antibiotic use should increase the cost that a resis-
tant organism is capable of supporting in the absence of antibiotics while 
still persisting. Consequently, hospitals, with their exceptionally high con-
centration of antibiotic usage, might by expected to playa disproportionate 
role in the selection of resistance: even resistance genes that carry a high fit-
ness cost in the absence of antibiotics may persist for long enough to enable 
the reduction in the cost to occur. 
Generally, very little is known about what makes one bacterial clone 
a better competitor than another. Most laboratory experiments aimed at 
investigating fitness and fitness costs have relied on in vitro competition ex-
periments between strains (when two or more strains are grown together) or 
simply on studies of growth kinetics (see for example Lenski et al., 1998). For 
S. aureus, interpretation of competition experiments may be complicated by 
the fact that different groups of strains are able to inhibit production of ex-
tracellular proteins in other groups (Guangyong et al., 1997). Competitive 
fitness may therefore not be hierarchical, but instead depend on prevalences 
of other strains in the environment. 
To avoid these complications, growth kinetics of S. aureus strains grown 
in isolation were studied. For a commensal such as S. aureus the two impor-
tant components of fitness are (i) ability to spread to new hosts (ii) ability 
to persist on hosts (in hospital populations this can have an important affect 
on the admission rate of colonized patients; many patients are readmitted 
188 
at varying times after discharge). In general, trade-ofl's may be expected 
between these two factors, but higher growth rates may be expected to be 
associated with both factors, and represent an obvious starting point when 
looking for any costs associated with resistance. 
7.2 Growth rate studies on MRSA and MSSA 
7.2.1 Method 
Bacterial strains 
s. aureus strains used in this study are listed in table 7.1. 
All the London strains in this table correspond to those described in 
chapter 3. The molecular typing results in that chapter were used to choose 
strains that were epidemiologically unrelated. The Polish strains in table 7.1 
have also been typed previously using a variety of molecular and phenotypic 
methods (Trzcinski et al., 1997). Again, strains chosen for inclusion were 
shown by the typing results to be epidemiologically unrelated. The remain-
ing strains listed came from a variety of sources and had only been typed 
using antibiograms. On the basis of these results, and by considering the lo-
cation and date of recovery, strains were selected that were thought unlikely 
to represent single clones. MSSA strains isolated from adult population 
have been shown to come from a large number of distinct clones (Kobayashi 
et al., 1995). For those strains coming from neither London nor Poland, it 
was therefore assumed that two MSSA strains isolated from patients in the 
same hospital were unlikely to be related, unless there was information to 
the contrary. When choosing between two epidemiologically related strains 
to include in the analysis, the choice was always made randomly (by coin 
flipping). 
Some additional growth rate measurements were performed to test whether 
observed growth rates were consistent at three levels: between different runs 
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using the same strains (tested with repeated runs of strains B28, B29, and 
reference strain ATCC25923); between different isolates of the same strain 
obtained from the same patients on different occasions (strains B2 and B29); 
and between different isolates of the same strain (as defined by typing results 
in chapter 3) obtained from different patients where there appeared to have 
been transmission (strains B10 and B13, and strains B28 and B29). 
Culturing of bacterial strains 
All strains were inoculated on to brain heart infusion (BHI) agar plates 
and incubated overnight at 37°C. Cells from one colony of each strain were 
suspended in phosphate buffered saline and diluted to an optical density at 
600nm (OD6oo) of 0.1 ± 15% using a microplate reader (EMS Reader MF, 
Labsystems, Finland). Once at the correct OD, 1111 of each suspension was 
added to 200 III of Tryptic Soy Broth (TSB, Difco laboratories, Detroit) in 
each of three wells on the 96-well plate. In addition to the strains listed 
in table 7.1 the type strain (ATCC25923) was added to three wells of each 
plate as a control. 
Growth conditions and measurements 
Using the microplate reader the cells were incubated at 37°C, shaking every 
10 minutes. OD6oo readings were taken from each well every 10 minutes 
over a period of 10 hours. 
7.2.2 Statistical methods 
Exponential phase growth rates for each well were taken to be the maxi-
mum growth rates observed over any 90 minute period. The growth rates 
were estimated by taking the gradient of the least squares line through the 
In(OD600) readings. The lag period was then estimated as the time from 
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Strain ID Isolated from 
MRSA strains 
B28 Hospital patient 
K1678 Hospital patient 
M38 Hospital 
M19 Hospital patient 
M15 Hospital patient 
M22 Hospital patient 
M61 Hospital 
M141 Hospital 
M152 Hospital 
M138 Hospital 
M146 Hospital 
M120 Hospital 
M129 Hospital 
M1l2 Hospital 
M128 Hospital 
M93 Hospital 
M95 Hospital 
MllO Hospital 
M88 Hospital 
MSSA strains 
D10 Hospital patient 
B22A Hospital staff 
B30A Hospital staff 
B20A Hospital staff 
B35 Hospital staff 
B3A Hospital patient 
B7 Hospital patient 
M49 Hospital 
M8 Community 
M57 Hospital 
M43 Hospital 
M94 Hospital 
M3 Community 
M87 Hospital 
M1 Community 
B16 Hospital patient 
B21 Hospital patient 
M36 Hospital 
M75 Hospital 
Location Year 
London 
Poland 
Warwick 
Poland 
Poland 
Poland 
Warwick 
Bulgaria 
Bulgaria 
Bulgaria 
Bulgaria 
Bulgaria 
Bulgaria 
Bulgaria 
Bulgaria 
Ipswich 
Ipswich 
Bulgaria 
Rugby 
London 
London 
London 
London 
London 
London 
London 
Warwick 
Coventry 
Warwick 
Warwick 
Ipswich 
Coventry 
Rugby 
Coventry 
London 
London 
Warwick 
Rugby 
1998 
1990-1992 
1999 
1990-1992 
1990-1992 
1990-1992 
1999 
1996 
1998 
1996 
1997 
1995 
1995 
1994 
1995 
1999 
1999 
1994 
1999 
1998 
1998 
1998 
1998 
1998 
1998 
1998 
1999 
1998 
1999 
1999 
1999 
1998 
1999 
1998 
1998 
1998 
1999 
1999 
Resistance Pattern 
C,E,M,P 
D,M,P,T,To 
C,E,M,P 
Ch,Cl, D, E,G, K, L,M,P,Sp,St,T,To 
D,M,Mu,P, To,T 
D,G, K,M, Mi, P,St,T,To 
C,M,P 
Ch,D,E, G,K,M,P,T,To 
D, Mh,P,T 
G,P, K, M, To 
Cl,E, G,K,L,M,P,To 
M,P,St 
E, G,K,N,Mh,P,St,to 
G,P, K, M, To 
E,G, K, Mh,P,St,To 
E, G,K,M,P,To 
E,G,K, Mh,P,Su,To 
Ch,G,K,M,St,To 
C,E,M,P 
P 
P 
P 
P 
P,k 
P 
P 
D,T 
C,P 
st 
P 
d,D, f,T 
D,P,T 
P 
Table 7.1: Strains used in the growth rate experiment. Antibiotic re-
sistance codes: A, amikacin; C, ciprofloxacin ; Ch, Chloramphenicol; 
Cl,clindamycin; D, doxycycline; E, erythromycin; F, fusidic acid;G, gentam-
icin, K kanamycin;L, lincomycin; M, methicillin (homogeneous resistance; 
Mh, methicillin (heterogeneous resistance); Mi, minocycine;Mu, mupirocin; 
N, neomcyinjP, penicillin, R, rifampin, Sp, Spiramcyin; St, streptomycin;Su, 
sulphamethoxazolej T, tetracyclinej To, tobramycin. Lower case indicates 
intermediate resistance. 
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starting incubation until the start of the 90 minute period with the maxi-
mum growth rate. 
A two-level nested analysis of variance (mixed model) was then used to 
study the differences in growth rates and lag periods between the groups of 
MRSA and MSSA strains, and between the individual strains (Sokal and 
Rohlf, 1994). 
In addition to the MRSAjMSSA comparison (the purpose of the exper-
iment) a number of other exploratory comparisons between different sub-
groups of strains were performed. Such additional comparisons were per-
formed between tetracycline-resistant and tetracycline-sensitive strains, and 
between antibiotic sensitive strains (or those resistant to penicillin only) and 
multiply-resistant strains (classified as those with four or more distinct re-
sistance mechanisms). Mean growth rates and lag periods were compared 
using two-tailed t-tests. Growth rate parameters were also examined for 
linear trends with the time since isolation, and with the number of distinct 
antibiotic resistance mechanisms identified. 
As consistency checks, comparisons of growth rate parameters between 
pairs of isolates were made using two-tailed t-tests. 
7.2.3 Results 
Mean growth rates and lag periods are listed in table 7.2. In all cases the 
straight lines fitted to the In(OD600) values over 90 minute periods showed 
an excellent fit to the data, with all coefficients of determination (R2 values) 
for the lines of maximum slope exceeding 0.996. This indicates that growth 
rates were measured over periods of exponential growth. 
Tables 7.3 and 7.4 summarize the analyses of variance for the growth rate 
data and the lag period data. Though a slightly higher mean growth rate 
was found in the MRSA strains, the data provide no evidence to reject the 
null hypothesis that MRSA and MSSA strains have the same growth rates. 
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MRSA strains MSSA strains 
mean growth mean mean growth mean 
Strain rate(SD) lag(SD) Strain rate (SD) lag (SD) 
B28 0.093(0.002) 6.7(0.6) B10 0.078(0.004) 6.7(0.6) 
K1678 0.092(0.002) 17.7(1.5) B16 0.055(0.003) 17.7(1.5) 
MllO 0.085(0.004) 7.7(1.2) B20A 0.081(0.002) 7.7(1.2) 
M1l2 0.089(0.003) 13.7(0.6) B21 0.096(0.003) 13.7(0.6) 
M120 0.090(0.001) 7.7(1.5) B22A 0.078(0.003) 7.7(1.5) 
M128 0.084(0.003) 12.3(2.9) B30A 0.090(0.003) 12.3(2.9) 
M129 0.088(0.002) 10.0(2.0) B35 0.078(0.001) 10.0(2.0) 
M138 0.087(0.007) 11.3(0.6) B3A 0.089(0.003) 11.3(0.6) 
M141 0.091(0.007) 9.3(0.6) B7 0.076(0.003) 9.3(0.6) 
M146 0.090(0.004) 18.3(5.9) Ml 0.068(0.003) 18.3(5.9) 
M152 0.091(0.006) 17.3(1.5) M3 0.104(0.004) 17.3(1.5) 
M19 0.070(0.005) 12.0(0.0) M36 0.066(0.001) 12.0(0.0) 
M22 0.053(0.002) 7.3(0.6) M43 0.070(0.002) 7.3(0.6) 
M38 0.090(0.005) 17.3(4.7) M49 0.067(0.007) 17.3(4.7) 
M61 0.089(0.003) 10.7(0.6) M57 0.108(0.005) 10.7(0.6) 
M88 0.094(0.003) 20.7(0.6) M75 0.071(0.002) 20.7(0.6) 
M93 0.056(0.004) 13.3(1.2) M8 0.089(0.002) 13.3(1.2) 
M95 0.079(0.002) 14.3(0.6) M87 0.063(0.003) 14.3(0.6) 
M15 0.091(0.005) 20.3(0.6) M94 0.084(0.001) 20.3(0.6) 
MRSA mean: 0.084 15.9 MSSA mean: 0.079 13.1 
Table 7.2: Mean growth rates and lag periods of MRSA and MSSA strains, 
based on OD600 readings from cell cultures in three wells for each strain. 
Lag periods were estimated as described in the text, and are expressed as 
multiples of 10 minutes. Growth rates give the maximum gradient of the 
In(OD6oo) readings plotted against time (expressed in units of ten min-
utes). Assuming OD600 is proportional to the number of cells present, then 
the doubling period (in minutes) is given by 10 x In2 (or 6.93) times the 
reciprocal of the growth rate. 
Source of variation df SS MS Fs P-value 
MRSA/MSSA 1 0.000688 0.000688 1.365 0.25 
Among strains 36 0.0182 0.000504 36.276 3.63 xlO-35 
Within strains (between wells) 76 0.00106 1.39 xlO-5 
Table 7.3: ANOVA table for MRSA and MSSA growth rates. The within 
strain variance (1.39 x 10-5 ) represents only 7.7% of the total, while the 
estimated among strain variance (0.00016) accounts for 90.5% of the total. 
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Source of variation df SS MS Fs P-value 
MRSA/MSSA 1 233.06 233.06 4.45 0.042 
Among strains 36 1886.07 52.39 12.09 1.67 x 10-19 
Within strains (between wells) 76 329.33 4.33 
Table 7.4: ANOVA table for MRSA and MSSA lag periods. The within 
strain (between well) variance (4.33) represents 18.4% of the total, while 
the estimated among strain variance (16.019) accounts for 68.1% of the 
total. The difference between the estimated lag periods of MRSA and MSSA 
strains, though small, is just significant at the 5% level. 
Clearly, there is considerable variation in growth rates between the strains, 
which accounts for over 90% of the total variance. Minimal difference is seen 
between wells with the same strain. 
The estimated lag periods of the MRSA strains were, on average, almost 
20 minutes longer than those of the MSSA strains. Again, there was large 
variation between the strains, and more variation between the individual 
wells containing the same strains than was seen for the growth rates. Though 
the MRSA/MSSA classification explained a relatively small proportion of 
the differences in lags compared to the strain classification, the difference 
was just significant at the 5% level. 
The results of the consistency checks found that for all three strains 
where repeated runs were made, there was no evidence to reject the null 
hypothesis that growth rates were consistent between runs (for all three 
pairwise comparisons P > 0.1). Similarly, there was no evidence for any 
difference in growth rates between isolates B2 and B29, which typed identi-
cally in chapter 3, and had been obtained from the same patient on different 
occasions (P = 0.68). Comparing growth rates between strains typing iden-
tically but isolated from different patients also gave similar results (P = 0.41 
for isolates B28 and B29, and P = 0.094 for B10 and B13). Overall, though 
large differences in growth rates were found between different strains, there 
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was no reason to reject the hypothesis that isolates that were directly epi-
demiologically related had the same growth rates. 
No significant trends were found between growth rates or lag periods 
and time since isolation (P = 0.83 and P = 0.87 respectively). Similarly 
no significant linear relationship was detected between growth rates or lag 
periods and the number ofresistance mechanisms (P = 0.32 and P = 0.87). 
Tetracycline-resistant strains had, on average, slightly lower growth rates 
than tetracycline-sensitive strains, but again the difference was non-significant 
(P = 0.16) as was the difference in lags between the two groups of strains 
(P = 0.92). There were, however, only a few strains resistant to tetracycline. 
Comparing isolates with four or more distinct resistance mechanisms 
with those with zero or one, the less resistant strains did have slightly 
higher mean growth rates (0.082 compared to 0.079), but this difference 
was far from being significant (P = 0.60). There was a more pronounced 
difference in the mean lag period between the multiply-resistant strains and 
the sensitive strains (13.59 compared to 16.27), though again this was not 
significant (p = 0.13). 
7.2.4 Discussion 
The main conclusion from the growth rate experiments is that there is con-
siderable heterogeneity in growth rate parameters between different strains, 
and these parameters seem to be stable properties of the strains. There was 
no evidence to suggest that MRSA strains had different mean growth rates 
to MRSA strains, although there was some evidence for a small difference 
in the lag periods associated with these groups of strains, with the MRSA 
strains having, on average, slightly greater lags (though many MRSA strains 
had shorter lag periods than many MSSA strains). Other factors, such as 
years since isolated and number resistance mechanisms present, did not help 
explain any of the heterogeneity between the strains. 
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Although these differences in lags were significant at the 5% level, the 
variation between the strains accounts for much more of the overall variation 
than the small differences between the MRSA and MSSA groups. Only 
tentative conclusions about differences in the length of the lag phase between 
MRSA and MSSA should be drawn. The experimental protocol was designed 
more to measure the maximum growth rate rather than the duration of the 
lag phase. Consequently, no attempt was made to standardize the growth 
phase of the cells used to inoculate the growth medium in the microplate 
wells at the start of the experiment, and estimates of the lag may therefore 
be biased by the initial status of the cells (there are, however, no reasons 
for thinking that there should be systematic differences between MRSA and 
MSSA strains, both of which were treated identically once recovered from 
the frozen samples). Since MRSA and MSSA strains are not, however, 
generally treated identically from isolation, it is possible that systematic 
differences may arise as a result of their history of subculturing. Also, the 
strains examined are not by any means a random sample of all MRSA and 
MSSA strains, with many of them coming from just a few locations. A 
different selection of strains may have produced very different results. 
Perhaps the one reason for attaching any weight to these comparisons is 
that the one other study which attempted to compare the in vitro growth 
rates and lag periods of MRSA and MSSA reached a similar conclusion 
(Mizobuchi et al., 1994): no differences were found in growth rates in expo-
nential phase, but the growth of MRSA was much slower in the lag phase. 
Parameter estimation 
The growth curves sometimes showed irregularities in the later growth stages. 
Because of this they were not analysed by fitting the full range of data to 
standard forms for growth curves as these irregularities would have led to 
a reduction in the accuracy with which the maximal growth rates and the 
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lag period were measured. Growth rates were estimated using only data 
from the 90 minute period where the maximum growth rate occurred in 
each well. This period was chosen to be long enough to prevent stochastic 
fluctuations and/or measurement errors from dominating, but short enough 
so that growth was accurately described by an exponential curve over the 
period. In fact, all of the final fitted straight lines to the log-transformed 
data had coefficients of determination (r2 values) greater than 0.996. In-
spection of the fitted lines indicated that the lines with maximal slopes gave 
better estimates of the exponential growth rates than did lines with maxi-
mal r2 values, though in most cases identical, or near-identical, results were 
obtained. 
The estimation of the lag period is somewhat arbitrary, and may lead 
slower growing strains to have apparently higher lags, since there will be 
a greater region over which growth is exponential and to which a straight 
line segment may be fitted to the data. Although there was a small negative 
association between growth rate and lag period (product-moment correlation 
coefficient r = -0.18) this was not statistically significant (P = 0.26). 
The cost of resistance 
Clearly in vitro studies such as this can at best be a poor substitute for in 
vivo studies in human hosts, and the growth rate is but a single component 
of a strain's fitness. 
However, experiments like this are easy to carry out. As Mizobuchi et al. 
(1994) found, there was no evidence of fitness cost of methicillin-resistance 
manifesting itself in a reduced growth rate, though there was some evidence 
for an increased lag period. 
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Chapter 8 
Fitting models to data 
8.1 Introduction 
This chapter deals with the problem of how to fit simple transmission mod-
els, such as that described in chapter 2, to hospital data using Markov Chain 
Monte Carlo (MCMC) methods. 
The hospital data are assumed to come from studies where all patients 
are swabbed, with the possible exception of a number of "non-consenters" , 
where it is assumed that non-consent occurs at random. The data then 
consist of a series of patient swabs indicating the presence or absence of a 
given pathogen, and in some cases also a strain type. 
Where data consist only of clinical isolates for pathogens normally be-
having as commensals (such as MRSA and VRE) more complex models, 
accounting for both transmission and for progression from colonization to 
infection, are required. The methods presented here are therefore not ap-
propriate for such data-sets. Modified MCMC-based methods, however, are 
likely to be valuable tools for the analysis of such data. For community-
acquired infections they have already been used to estimate incidence rates 
for subclinical Haemophilus influenzae type b (Hib) infection in the com-
munity, using only clinical infection data (Auranen, 2000). 
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In the past little formal analysis has been carried out on data arising 
from such transmission studies of nosocomial pathogens. Typically, only 
summary statistics are presented. In the best cases authors have made 
meticulous attempts to estimate acquisition rates per source (for example 
Lidwell et ai., 1966, 1971). Sometimes these acquisition rates have been 
related to the antibiotic consumption of patients acquiring the strains. In 
doing this authors are forced to develop sets of ad hoc rules for determining 
the times of acquisition (Lid well et al., 1966), and for assigning the acquisi-
tion of strains to specific sources. For example, for acquisitions having more 
than one possible source, Lidwell et al. (1971) assumes the same distribu-
tion of sources as for acquisitions where the source can be unambiguously 
located. In contrast, Jernigan et al. (1996) used a panel of independent ob-
servers who considered temporal and spatial factors along with staff contact 
patterns to assess the "most likely" sources. Sometimes the process can 
seem even more arbitrary. Shooter et al. (1963), for example, assumed the 
true source was always the nearest. 
Earlier studies also had the disadvantage that they depended on phage 
typing. This technique is unable to type many strains and is not as effec-
tive at grouping outbreak-related strains as DNA-based techniques (Tenover 
et al., 1994) . However, even if one can be almost certain of the identity of 
strains colonizing two or more patients, these can only ever be observed at 
a finite number of time points, and there will inevitably be uncertainty in 
the underlying process being observed. Further uncertainty is likely to arise 
due varying sensitivities of sampling and culturing methods. 
Two attempts have been made to fit hospital data to models. Firstly 
Austin and co-workers (1999b) used prevalence data on an leu to fit a de-
terministic host-vector model of a similar form to that used in chapter 2. 
Simulations of the stochastic process were then used to obtain confidence 
intervals. No attempt to estimate the effect of antibiotic therapy on trans-
199 
mission was made. 
In another study, Bonten and co-workers (1998) cultured rectal swabs 
collected daily from patients on an ICU, and used a Cox proportional haz-
ards model to relate the acquisition rate of VRE to factors including antibi-
otic use, and what they termed the "colonization pressure". By this they 
meant the prevalence of VRE. An unfortunate consequence of their choice of 
model is that the hazard for acquiring VRE increases exponentially with the 
prevalence. Epidemiologically, this is meaningless. Nonetheless, the "colo-
nization pressure" still appeared to be the most important variable affecting 
VRE acquisition, with a weaker association with use of third-generation 
cephalosporins. 
One possible approach to dealing with such data would be to analyse 
the number of transmissions on each day using a generalized linear model to 
investigate the dependence of the number of transmission on factors such as 
the number of colonized patients, antibiotic use (see Becker, 1989, chap. 6). 
For infections where acquisition is clearly indicated by a show of symptoms 
this can be a powerful approach. For asymptomatic infections, however, 
arbitrary decisions again have to be made about the true acquisition times 
unless swabbing is sufficiently frequent to remove this uncertainty. Also, 
since patient swabs are usually taken weekly in this type of study, and in 
this time interval a high turnover of patients would be expected on most 
wards, the analysis of the number of acquisitions in any given time period 
will necessarily be complicated by the arrival of new, potentially colonized 
patients. There is also the problem of there being some patients for whom 
no swabs are obtained, which further complicates this method. 
Recently, however, methods for fitting data to stochastic epidemic mod-
els with missing data have been developed (Auranen et al., 2000; O'Neill and 
Roberts, 1999). Loosely speaking, these approaches work by using Monte 
Carlo methods to integrate over all possibilities for the unobserved process 
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that are consistent with the data. In this chapter, this approach is adapted 
to fitting simple single ward stochastic transmission models to data. 
In subsection 8.2.1 an approach suitable for a single strain is developed. 
Simulated data is used to test the approach in section 8.2.3, and also to 
illustrate the effects of different study designs on parameter estimates. 
In section 8.3.1 the method is extended to allow for the transmission 
of multiple strains on a ward, and different assumptions regarding the im-
migration of strains. In section 8.3.3 this is then used to estimate a single 
transmission parameter for the S. aureus transmission data collected in the 
study described in chapter 3. 
Finally, section 8.4 shows how this approach can easily be extended to 
cope with more complex models. This is illustrated with a preliminary 
analysis of a large VRE data-set in section 8.4.2, where acquisition of VRE 
is related to antibiotic consumption. 
8.2 Single strain model 
8.2.1 Methods 
A Bayesian data augmentation approach is used, where the unobserved times 
of acquiring the organism (the latent event times, which constitute the aug-
mented data) are included in the set of model unknowns, with posterior 
distributions to be derived (see, for example Green, 1995). Each accepted 
set of values for the augmented data thus constitutes one possible realisa-
tion of the epidemic process, and the acquisition times are parameters to 
be estimated. Because the number of acquisitions is itself an unknown the 
dimension of the model changes, and an MCMC sampling algorithm with 
reversible jump extensions is required to explore the joint posterior distribu-
tion of all model unknowns (augmented data and model parameters) (Green, 
1995). 
201 
The overall model is hierarchical in nature, with three levels: the observa-
tional model, the transmission model, and the prior model. The observation 
model determines the likelihood of the observed data (the patient swabs) 
for a given realisation of the epidemic process, and the transmission model 
the likelihood of the realisation given the model parameters. 
Because swab and patient-presence data are typically available on a daily 
basis, colonization statuses are assumed to remain constant during anyone 
day. 
The following notation is used: D represents the observed data, which 
consists of the set of swab results S = {8ij}, and the timing of patient stays, 
{Wij} . Here 8ij is the result of the swab taken on day j for patient i, and 
is equal to one if the result is positive, and zero otherwise. Wij is equal 
to 1 if patient i is present on the ward on day j, and zero otherwise (it is 
assumed that patients are not readmitted). The time in days is represented 
by t, where 0 ~ t ~ T. The augmented data A consist of the set {Cij}, 
where Cij represents the assumed (though generally unknown) colonization 
status of patient i on day j, and is equal to 1 if the patient is colonized and 
present on the ward on that day, and zero otherwise. From this and {Wij} 
the latent event times (colonization times) {T}, the number of colonized and 
susceptible patients at time t, y(t) and x(t), and the colonization statuses 
of each patient on admission {ad can be derived in an obvious manner. For 
example, the set of transmission days {T} gives the (unknown) days at which 
uncolonized patients become colonized (so Ti E {T} iff Ti = min{ T : Ci,T = I} 
and Wi,Ti- 1 = 1). The admission colonization status for patient i is given by 
ai = Cit, where t = min{t : Wit = I}. 
Transmission model 
Patient stays are assumed to be perfectly observed. Only transmissions and 
introductions of the organism need to be considered. 
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It is assumed that there is a single strain with which patients may be-
come colonized. Once colonized, patients are assumed to stay colonized for 
the rest of their stays on the ward. The mass action model for transmission 
is assumed, so the instantaneous rate at which any uncolonized patient be-
comes colonized is Ay(t), for some constant rate A. This model is effectively 
the same as that presented in chapter 2 with the detection rate, set to 0, 
and without explicit consideration of the vectors (inclusion of vectors into 
the model does not greatly affect the dynamics as the timescale at which 
they become colonized and "recover" is short compared to that for patients). 
Each patient is assumed to have some probability, a, of already carrying the 
strain when admitted to the ward. 
The transmission model defines the likelihood of a given set of values for 
the augmented data given the model parameters. This is given by 
L = exp (-A loT y(t)X(t)dt) II Ay(L) 
o tE{T} 
(8.1) 
where L is the time just before t. The likelihood of the set of admission 
colonization statuses, {ai}, is just 
II aa; (1 - a)l-a; 
i 
Since in practice event times are only resolved at the level of days, L is 
taken as t - 1. The total log likelihood of the data is then given by 
1 = -A L y(t)x{t) + A L y{L) + L ai Ina + (1 - ai) In(l - a). (8.2) 
t=O ... T tE{T} i 
Observation model 
Patients' colonization statuses are assumed to be determined by a number 
of arbitrarily timed swabs. There is assumed to be some probability, e, of 
recovering the organism from a swab taken from a colonized patient. 
For each patient i, for each day of their stay j, observed colonization 
status is given by bij . Here bij is arbitrarily taken to be 1 if the patient is 
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known to be colonized on that day, 0 if the patient is known to be uncolonized 
(only possible if ~ = 1), and -1 if the colonization status is unknown. 
The observation model defines the probability of the observed data (the 
swab results) D, for a given set of values in the augmented data. This is 0 
if :3i, j such that Si,j = 1 and Cij = 0, since false positives are assumed not 
to occur. Otherwise it is given by 
II eij (1 - Ol-Si j . 
ij (cij=l, si}ES) 
In the case where ~ = 1, so there is no uncertainty in the swab data, this 
is simply equal to one if the observations are consistent with the augmented 
data, and zero otherwise. 
Posterior inference 
Conditionally on the realization of the latent process, A, and on ~, the ob-
served data D is independent of the model parameters {A, a}. The joint 
posterior density of A, a, ~, A and D is thus given as the product of obser-
vation model, the transmission model and the prior model: 
p(D, A, A, a,~) = p(D, AlA, a, ~)p(A, a,~) (8.3) 
p(DIA, Op(AIA, a)p(A, a,~) (8.4) 
The joint posterior density of A, a, ~ and A is then explored numerically 
using an MCMC sampling approach outlined below. 
Implementation 
For simplicity, only the special case where the probability of colonization 
on admission, a, is known is treated here. In practice a is easy to estimate 
from admission swabs and is not the primary interest. Similarly, a swab 
sensitivity of 100% is assumed for the moment, so ~ = 1. Although in 
practice it is clearly not possible to achieve such a sensitivity, it is also not 
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particularly useful to consider an individual colonized if they harbour only 
a few cells of the infectious organism, since then the risk of infecting others 
will be negligible. Effectively, therefore, a positive swab is treated as the 
definition of colonization with the organism. 
Metropolis sampling was used (see, for example Gamerman, 1997, and 
references therein). A proposal for a new value for A was chosen by draw-
ing a proposal for In A from the proposal distribution N(ln Ac , a~) (the log 
transformation allows the proposal to be drawn from the whole real line). 
Here Ac is the current value of A, and a~ is the proposal variance, which acts 
as a tuning constant: too large and too few moves are accepted; too small, 
and the new values are too close to the old ones for the Markov chain to 
mix well. If In A * is the proposed value, then this value is accepted into the 
sample with probability 
* . [ p(AIA*)P(A*)A*] 
a(Ac, A ) = mm 1, p(AIAc)p(Ac)Ac 
Here p(AIA) is the probability of the augmented data for given A, p(A) 
is the prior density for A, and the final A term in both denominator and nu-
merator of the acceptance ratio is needed since the proposal is for In A rather 
than A. These terms are the Jacobians for this change of parameterization. 
If the new value is not accepted the old value, Ac , is retained in the 
sample. 
Updates to the augmented data Let A* represent the proposed aug-
mented data, and Ac the current augmented data. 
A proposal A * is accepted as the new state of the augmented data with 
probability 
a(Ac, A *) = min(l, A) 
where 
A = [p(DIA*)P(A*IA)] 11 
p(DIAc)p(AcI A) P (8.5) 
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In this case, since it is assumed that there are no false negative swabs, 
p(DIA *) is equal to one if the augmented data are consistent with observed 
data (the swab results), and zero otherwise. Assuming that initially Ac is 
consistent with D then p(DIAc) must always be equal to one, since only 
consistent data can be accepted. IIp is the proposal ratio: the ratio of the 
density of a proposal for a move from A * to Ac, q(A * -+ Ac) , to the density 
of the proposal for the reverse move, q(Ac -+ A *). 
To see that see that the Markov chain defined above has the required 
stationary distribution (i.e. equation 8.3) it is sufficient to show that the 
detailed balance equations are satisfied, and that the chain is irreducible. 
For the updates to the model parameters, this is standard (see, for exam-
ple Gamerman, 1997). For the updates to the augmented data, first assume 
without loss of generality that A < 1, and consider a move to another fea-
sible state, A*, so that p(DIA*) = 1. Then, from equation 8.5, and writing 
p(Ac -+ A *) as the probability of updating the augmented data from Ac to 
A*: 
where 
so 
p(Acl>.)p(Ac -+ A*) = q(Ac -+ A*)p(A*I>')IIp 
II _ q(A* -+ Ac) 
p - q(Ac -+ A*) 
p(Acl>.)p(Ac -+ A *) = p(A *1>.)q(A * -+ Ac) 
Since A < 1, the acceptance ratio for the reverse move is one, and 
the right hand side is equal to p(A *1>.)p(A * -+ Ac), showing that detailed 
balance is satisfied. Irreducibility is also required to show that the chain has 
the desired stationary distribution. However, providing that all moves that 
update the augmented data are reversible, with the acceptance ratio defined 
above, new updating moves can be added until this condition is satisfied. 
Similar considerations are required in the choice of updating moves as are 
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needed when choosing the proposal variance: if the moves are too small the 
chain will have a high autocorrelation, but if too large, few of them may be 
accepted, again resulting in poor mixing. 
Three sorts of changes to the augmented data are used here. When 
updating the augmented data one of these types was chosen at random. 
In the first move type only event times are updated. Thus for patients 
who become colonized in the current set of augmented data, but for whom 
there is uncertainty as to the exact colonization date, the day on which they 
are assumed to acquire the organisms may change. This move is carried 
out on all such patients simultaneously. Suppose that when updating the 
acquisition time for patient i, there are ni possible days on which the strain 
may have been acquired. Because of the assumption that once colonized a 
patient remains colonized for the duration of their stay, these ni days are 
necessarily contiguous. One of these ni days is selected uniformly, and in A * 
patient i is made colonized from the selected day to discharge. This move 
doesn't change the dimension of the augmented data and hence IIp = 1. 
The second type of move updates the actual transmission events. This is 
needed since any of the patients whose final colonization status is unknown 
may have become colonized following their final negative swab. For this 
move, only one patient is updated at a time, so a single transmission event 
is changed. A decision is first made whether to add or remove a transmission 
event. 
When adding a transmission event a patient i is selected uniformly from 
me possible patients in the current augmented data whose final colonization 
status is unknown, but who don't become colonized in Ac. One of the 
ni days during which their colonization status is unknown is then selected 
at random, and in the proposed augmented data A * they are made to be 
colonized from this day until discharge. 
When removing a transmission event a patient j is selected. To be a 
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candidate for transmission event removal j must currently be assumed to be 
colonized in Ac , but have no positive swabs (so in D the final colonization 
status is unknown). A * is then updated by making the patient uncolonized 
during each day of their stay. 
The proposal ratio for adding a transmission event for patient i is then 
given by 
where m~ is the number of candidate patients for removal in Ac. When 
removing a transmission event the proposal ratio is 
, 
II _ me 
P - (me + 1) 
All patients who are swabbed are assumed to have an admission swab, so 
there is no uncertainty as to whether or not they are colonized on admission. 
However, for patients for whom no swabs are taken it is not known whether 
they were colonized on admission or not. Since the augmented data must 
integrate over all the possibilities for the unobserved process consistent with 
the observed data, a third move type is required which changes the admission 
colonization status of these unobserved patients. This move chooses an 
unswabbed patient at random who in Ac is assumed to be uncolonized 
throughout their whole stay. This patient is then made colonized throughout 
their stay in the proposed augmented data, A * . The reverse move simply 
chooses one such unswabbed patient who is assumed colonized on admission 
in Ac and makes them uncolonized. The proposal ratio for the forward move 
is given by 
Ue IIp =--
Ve + 1 
where U e is the number of unswabbed patients who are currently assumed 
to never become colonized in A c , and Ve is the number of un swabbed patients 
currently assumed to be colonized on admission. The proposal ratio for the 
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reverse move is given by: 
n=~ 
p U c + 1· 
Irreducibility can easily be shown in this case (though when considering 
the multi-strain model in section 8.3 it is more difficult to ensure). Ape-
riodicity follows from irreducibility, since some states will clearly have a 
periodicity of one. 
The algorithm was implemented in a C++ program (available on request 
from the author). Convergence was assessed primarily through the use of 
the Raftery-Lewis diagnostic (Rafter and Lewis, 1992), as implemented in 
CODA (Best et al., 1995). A sufficient number of samples were recorded 
from a single chain to estimate the 2.5th percentile ( ±0.005) with a prob-
ability of attaining this accuracy of 0.95, as calculated with the Raftery-
Lewis diagnostic. An initial "burn-in" period was used where all samples 
were discarded. The length of this burn-in was taken to be at least that 
recommended by the Raftery-Lewis diagnostic. 
8.2.2 Test data 
Simulated data were generated from a single-strain model of a 20 bed hos-
pital ward with mean length of stay of 10 days and>' = 0.00263 (giving a 
value of Ro of 0.5.), where 20% of patients were assumed to be colonized on 
admission. 
Two sets of data were generated corresponding to 30 and 500 days of 
surveillance. In both cases the MCMC algorithm was used to estimate >. 
under four different scenarios (assuming that C1 was known). First, full data 
were assumed. This corresponds to swabbing each patient every day of their 
stay. Second, all patients were assumed to be swabbed on admission and 
then at weekly intervals. The third and fourth scenarios were identical to 
the second, except that 10% and 50% of patients respectively were assumed 
to be non-consenters, and provide no swabs. Non-consenters were chosen 
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at random, and the observed colonization status, bij for patient i on day j 
was coded either as 0 for uncolonized, 1 for colonized, and -1 for unknown 
colonization status. The rules for assigning these values are based on the 
transmission model and the assumption that ~ = 1. If there is any negative 
swab for patient i on day j, then for all j' < j, bij' = O. Similarly, a positive 
swab on day j means that for all j' > j, bij' = 1. If there are positive swabs 
for patient i on days j1 and 12 (JI < h) and JI ::; j ::; 12 then bij = 1. 
However, if there is a positive swab on day j2, and the previous swab was 
negative and taken on day j1, then for j1 < j < 12, bij = -1. Patients for 
whom no swabs are taken will clearly have unknown colonization status on 
each day. 
8.2.3 Single strain model results 
Figure 8.1 shows the posterior densities obtained for the eight sets of simu-
lated data using the single strain model. 
8.3 Multiple strain models 
Real data from a single hospital ward often includes typing information that 
shows that two or more strains of the same organism were in fact circulating 
among the patients. The section describes the extensions that need to be 
made to the model to account for this, and for the introduction of new 
strains. In this section it is assumed that all the circulating strains have 
an identical transmission rate, A, although modifications to allow different 
strains to have different transmission rates are straightforward. 
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Figure 8.1: Posterior densities obtained from simulated transmission data 
corresponding to one 20 bed ward over 30 days (top) , and 500 days (bottom). 
Priors in all four cases were r(O.OOl,O.OOl). The vertical dashed line shows 
the value of ). used when generating the data (0.00263). 
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8.3.1 Methods 
Observation model 
The observation model is identical to that described in section 8.2.1 except 
that patients may now be colonized with anyone of M different strains. 
Strains are now indexed by integers between 1 and M. When patient i is 
colonized on day j, bij is now set to the index number of the strain. 
Transmission model 
The transmission model is also identical to that described in section 8.2.1 
except that patients may now be colonized with anyone of the M strains. 
Since once colonized patients are assumed to remain colonized, it is assumed 
that patients can only be colonized with a single strain during their stay on 
the ward. 
Yr (t) now represents the number of patients colonized with strain r at 
time t, and y(t) still represents the total number colonized. The set of trans-
mission days {T} is now partitioned into M sets Ul, ... , U M corresponding 
to the transmission days for each strain. Since each strain is assumed to 
be equally transmissible the likelihood of the observed transmission data (if 
fully observed) is now given by: 
L = exp (->.IoT y(t)X(t)dt) IT II >'Yk(L) 
o k=l tEUk 
(8.6) 
Implementation 
When considering multiple strains, it also becomes important to explicitly 
consider their introduction to the ward. Here it is assumed that the typing 
methodology used has sufficiently high resolution, and that there are enough 
distinct strains, so that each unique strain type identified on the ward is 
introduced by exactly one patient (although more than one patient may, of 
course, be colonized with that strain at the beginning of the observation 
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period). The assumption that admission swabs are taken for all swabbed 
patients is now relaxed, so in some cases there may be uncertainty as to 
which patient introduces a strain. Consequently, a new update move for the 
augmented data needs to be introduced. This move first chooses a strain 
at random for which there is uncertainty as to the true introducer, then 
selects uniformly one of the feasible introducers of the strain from amongst 
(i) those patients who are known to carry the strain at some point, but whose 
admission colonization status is unknown, and (ii) those patients who are 
never swabbed and also never colonized in the current augmented data. In 
A * the newly selected introducer is colonized from their admission with the 
selected strain. Before a decision is made whether to accept this move a not, 
all the acquisition times are updated as described previously. The purpose of 
this last move is to increase the number of problems for which the algorithm 
is irreducible and to allow a simpler form for the proposal ratio. 
The proposal ratio for this move, which is its own reverse, is 
IT = 1 + ni 
p 1 +nj 
when both patients i and j are known to become colonized ni and nj are the 
number of days during which patients i and j have unknown colonization sta-
tus. If i and/or j are unswabbed patients, then the numerator/denominator 
is replaced by one. 
As well being able to introduce strains which are seen on the ward, 
patients for whom no swabs are taken may also introduce strains which 
never appear in swabs. To account for this, the move that changes patients' 
colonization status on admission is retained with the same proposal ratio, 
but only for patients who have no swabs at all. Since introductions for all 
strains observed on the ward are catered for by the previous move, this 
move now makes patients colonized on admission with a strain M + 1. This 
appears only in the augmented data, and represents all unobserved strains. 
This strain may also be acquired by other patients in the augmented data. 
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Although several patients may introduce strain M + 1 in the augmented data, 
conceptually these should be thought of as separate introductions of different 
unobserved strains. The likelihood calculation for the augmented data will 
still be valid, though the sampled augmented data need to be interpreted 
with care: the number of acquisitions of this strain in the augmented data 
should be interpreted as the number of acquisitions of any unobserved strain, 
rather than any particular strain with one introducer. For an organism such 
as S. aureus which a high proportion of patients might be expected to carry 
on admission and for which interferencejbioexclusion is important, failing 
to take this into account would result in an overestimate of the number of 
susceptible patients. 
In general the above moves are not sufficient to ensure irreducibility 
of the chain, as figure 8.2 demonstrates. Similar deadlock situations to 
that shown in the figure can occur if there are two candidate patients who 
may each be the introducers of one of two strains. Once one scenario is 
chosen, a deadlock situation is reached where other possible scenarios cannot 
be reached. Further moves would need to be introduced to resolve such 
deadlocks or the assumption that one patient can only carry one strain 
would need to be relaxed. However, for many data, the above rules will be 
sufficient to ensure irreducibility. For example, if there are no gaps in the 
observed chain of transmission of anyone strain, and either the introducers 
of each strain are known, or the candidate introducers of one strain are 
not also candidate introducers for another strain, then such deadlocks will 
be avoided. In the latent process, patients of unknown colonization status 
can be made colonized with any strain consistent with the data, and all 
feasible latent processes will be explored. Attention here is restricted to 
such data where these moves do ensure irreducibility. For the more general 
case, additional moves need to be added. However, choosing moves that 
ensure the chain is irreducible and mixes well may not always be an easy 
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3 
4 strain 8 5 strain 8 
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6 
Figure 8.2: One example where "deadlock" could occur with the set of 
moves in section 8.3.1. Patients are indicated by the lines, and discharges 
by arrowheads. Solid lines indicate periods when patients are known to 
be colonized, and dashed lines periods when their colonization status is 
unknown. Assuming no other patients are present, since only one patient 
can introduce each strain, to be consistent either patient 3 or patient 6 
must be colonized with strain A in the augmented data. Suppose patient 
3 is colonized with A in the current augmented data, so patient 6 must be 
colonized with strain B. With the existing updating moves, there is no way 
to now move to the situation where patient 3 is colonized with strain B, and 
patient 6 with strain A. 
task. 
8.3.2 Application to Staphylococcus aureus data 
Figure 3.6 shows the transmission data collected in the study described in 
chapter 3, with strain types indicated by numbers. Solid coloured lines 
indicate periods when patients were known to be colonized or not colonized 
with S. aureus. Strains are indicated by the circled numbers. Green lines 
indicate periods where patients are deduced to be uncolonized on the basis of 
the swab data. Black lines indicate periods of unknown colonization status. 
For one patient (in bed 12), a series of positive swabs was followed by a 
large number of negative swabs, with no positive swabs for the remainder 
of the study. This observation apparently refutes the model. However, 
since the model should be thought of as a tool rather than a conjecture, 
rather than changing it for a less wieldy one, the data are changed instead. 
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Thus this patient is split into two. From the beginning of the study to the 
mid-point of the period of unknown colonization status (indicated by the 
dashed pink line), the patient is assumed to be colonized. From this point 
onwards, until discharge, the patient is treated as a new patient, assumed to 
be uncolonized1. Similarly, another patient (in bed 1), had positive swabs for 
two different strain types, the second of which was identical to one isolated 
from another patient. This contradicts the assumption that patients can 
only be colonized with one strain at a time. To cope with this, only the 
acquired strain was considered. 
8.3.3 Staphylococcus aureus results 
Figure 8.3 shows the smoothed posterior density for)' when a diffuse prior 
(r(O.OO1,O.OO1)) is assumed. This gives a mean colonization rate of 0.00145 
per colonized patient per day, with a 95% credible interval of [0.0002, 0.0040]. 
The estimate for Ro is then given as product of A, the mean length of 
stay, and the number of susceptible patients. From data obtained for all 
patients stays in 1997, mean length of stay on the ward was 10.01 days 
CI: [9.49,10.87]. The ward has 15 beds, with nearly 100% bed occupancy. 
Assuming that all 14 patients are susceptible, and using the mean length of 
stay gives an Ro value of 0.203 with 95% CI [0.028,0.56]. 
The informative prior r(2,0.0015) was then used, based on estimates 
from chapter 5. In these studies A only once took a value exceeding 0.01, 
and had a mode in the region of 0.003. Figure 8.4 shows the smoothed 
posterior density obtained using this prior. The data modify the prior only 
slightly, by increasing the confidence that A takes a value below about 0.01, 
but also reducing the support for very low values. The mean (and 95% 
CI) for the posterior are now 0.00437 [0.0011,0.0077]. This corresponds to 
1 An alternative approach would be to simply allow the swab sensitivity to be less than 
100% 
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Figure 8.3: Posterior density for transmission parameter .A for the S. aureus 
transmission data. The diffu e prior r(O.OOl,O.OOl) was used, and 25,000 
iterations were made, with a thinning of 25 (i.e. storing ev ry 25th value). 
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Figure 8.4: Smoothed posterior density (solid line) for transmission param-
eter >. for the S. aureus transmission data. The broken line shows the prior, 
r(2,0.0015). 20,000 iterations were made, with a thinning of 25. 
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a mean Ro value of 0.51, with 95% CI [0.15,1.08]. This suggests there is 
still a high degree of confidence that Ro is below the critical value, but also 
suggests that there is non-negligible chance that it lies in the transitional 
region between which quasiendemicity and rapid fadeouts occur. 
8.4 Application to VRE data 
In section 8.2.1 and 8.3.1 above, simulated transmission data, and data 
from a month long study on a single ward were used to estimate a single 
transmission parameter. With minor modification the algorithms could have 
been used to also estimate the proportion of patients who were colonized on 
admission. In general, however, interest lies in determining what factors 
affect transmission rates, and by how much. For the spread of antibiotic-
resistant bacteria in hospitals, for example, the most important questions 
are: how much does antibiotic use affect the transmission of bacteria between 
patients, and what difference do infection control activities make? Below, 
simple extensions to the model are made to allow such estimates to be made, 
and preliminary estimates are made for the effect of six different classes of 
antibiotic treatment on the acquisition of strains of VRE, based on a subset 
of data from a 16 month study in a haematology unit. 
It is a preliminary analysis because the data are preliminary, based on 
initial typing of a single isolate from each patient. 
8.4.1 VRE study description 
Data concerning the transmission of VRE were obtained from the study de-
scribed in detail by Bradley et al. (1999). In brief, this was a prospective 
three-phase sequential study where colonization with VRE was established 
by rectal swabs from consenting patients (90-95% of all patients) on a three 
ward haematology unit. In the first phase (four months) ceftazidime (a third 
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generation cephalosporin) was used as the first-line treatment for febrile neu-
tropenic episodes; in the second phase (8 months) piperacillin/tazobactam 
was used instead; and in the third phase (4 months) ceftazidime was used 
as the first line antibiotic again. Bradley and co-workers also collected ex-
tensive data on patient antibiotic use for all consenting patients, recording 
antibiotics used on most days of each patient's stay. Frequencies of dif-
ferent combinations of antibiotics used are summarized in table 8.4.1, and 
table 8.4.1 shows total antibiotic use during the whole study. Glycopeptide 
use did not change significantly throughout the study, while ceftazidime use 
was close to zero in phase two, and piperacillin/tazobactam use close to zero 
in phases one and three. In the second and third phases there was also an 
intensive education programme to improve hygiene on the wards. A sur-
vival analysis showed that acquisition rates of VRE decreased significantly 
in phase two, and then returned in phase three to a value only slightly lower 
than that seen in phase one (Bradley et at., 1999). 
Preliminary PFGE typing has since been carried out on the isolates, and 
the analysis here is made on the results. 
Data description and modelling assumptions 
The data analysed here come only from the largest ward under study, which 
had 18 beds. Figure 8.6 shows colonization statuses for each patient on each 
day they were on the ward, based on the assumption that patients could 
both lose and acquire strains, and that there were no false negative swabs. 
The figure shows that once a positive VRE swab was obtained, the patient 
typically remained colonized for the rest of their stay. When subsequent 
negative swabs were obtained, later swabs were often positive again. Be-
cause of this, the assumption that once a patient was colonized with VRE 
they remained colonized for the rest of their stay was considered adequate. 
Figure 8.7 shows the data based on this assumption, including available in-
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Figure 8.5: VRE transmission on a haematology ward. Data from study by 
Bradley et al. (1999) with preliminary PFGE typing results. A. See text 
for study details. Number of patients who are colonized (red), uncolonized 
(green) and of unknown colonization status (blue). B Colonized patients 
classified by the PFGE strain type of the patient's first positive isolate. 
Black olonized with unique strain; red- strain 1; orange-strain 2; pink-
strain 3; yellow- strain 5. 
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Antibiotics 
None 
Piperacillin/tazobactam 
Ci profloxacin 
Ceftazidime 
Teicoplanin & ceftazidime 
Teicoplanin & piperacillin/tazobactam 
Flucloxacillin 
Teicoplanin 
Metronidazole 
Erythromycin 
Imi/Merpoenem 
Teicoplanin & ciprofloxacin 
Teicoplanin & ciprofloxacin 
patient days 
2810 
298 
225 
210 
183 
176 
167 
104 
73 
69 
62 
56 
56 
Table 8.1: Antibiotic combinations, and the number of patient days for 
which they were observed for those used for more than 50 patient days. 
Data from study by Bradley et al. (1999) 
Antibiotic 
Teicoplanin 
Ceftazidime 
Piperacillin/tazobactam 
ciprofloxacin 
Metronidazole 
Flucloxacillin 
Gentamicin 
Erythromycin 
patient days 
1091 
807 
760 
610 
550 
347 
326 
250 
Table 8.2: Antibiotic used, and the number of patient days for which they 
were observed for those used for 250 patient days or more. Data from study 
by Bradley et al. (1999) 
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Class Antibiotics Patient days 
A None 2810 
B Ceftazidime + glycopeptide 418 
C Ceftazidime without glycopeptide 371 
D Piperacillin/tazobactam + glycopeptide 449 
E Piperacillin/tazobactam without glycopeptide 396 
F Glycopeptide (without ceftazidime & pip.jtazo.) 523 
G Other antibiotics 1046 
Table 8.3: The seven mutually exclusive antibiotic classes, and the number 
of patient days for which they were observed. Except for A, other unlisted 
antibiotics were also used simultaneously for some of the patient days in 
each class. Teicoplanin accounted for most of the glycopeptide use, but 155 
patient days of vancomycin use were also observed. Data from study by 
Bradley et al. (1999) 
formation on the PFGE type of the strains recovered from each patient, 
which in most cases is just the PFGE type of the first positive isolate. The 
rules used here to assign the colonization status for each patient are the same 
as those used for the simulated data as outlined in section 8.2.2. Figure 8.5 
uses this information to show how total numbers colonized with each strain 
changed during the three phases of the study. A large proportion of the 
colonized patients gave isolates with unique PFGE types (indicated in black 
in figures 8.5 and 8.7). These present important difficulties of interpreta-
tion. While strains with identical PFGE types can be assumed to share a 
common source, strains of unique types may represent either pre-existing 
flora, endogenous sensitive flora that has acquired the transposon contain-
ing the vancomycin resistance gene as a result of transmission from other 
patients, or it may be due to the transmission of strains which are present 
but undetected in other patients (Chadwick et al., 1997). The effect of an-
tibiotic therapy may be both to change the chance of a patient acquiring the 
transposon or particular strain, and also to change the chance of detecting 
such a strain if it is present. 
The fact that apparent acquisitions of strains of unique type continues 
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in phase two, but decreases as the number of colonized patients decreases 
suggests that selection of pre-existing resistant flora as a result of antibiotic 
use is unlikely to be the sole explanation. If this were the case a much 
faster response to the change in antibiotic therapy would be expected. The 
observed data are probably accounted for both by transmission and selection 
of pre-existing flora. While it would be possible to fit a model that allowed 
for both processes, this has not been done yet and the analysis presented here 
ignores the possibility of transmission of these strains, and they are treated 
as if they were all attributable to pre-existing flora. For the other strains, 
the multi-strain transmission model is first used to compare transmission 
rates in three periods. This is then modified to allow the transmission to 
also depend on the antibiotics being taken by the susceptible patients. Other 
possible transmission models are considered in the discussion. 
Transmission model with antibiotic-dependent susceptibilities 
The transmission model is identical to that described in section 8.3.1, except 
that the instantaneous acquisition rate is assumed to depend on the antibi-
otics which a susceptible patient is currently taking. There are too many 
possible combinations of antibiotics to treat each one individually (270 dif-
ferent combinations were used, if a distinction is made between oral and 
intravenous administration) and synergistic effects are likely, so there is no 
obvious way to combine the effects of two or more antibiotics taken together. 
Instead, combinations of antibiotics are assigned to classes. For example, in 
the current analysis seven different classes are considered (table 8.3). 
The likelihood of the observed transmission data (if fully observed) is 
now given by: 
(8.7) 
where Ad is now the rate at which susceptible patients in antibiotic class 
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d become colonized due to one colonized patient, Xd(t) is the number of 
patients in antibiotic class d at time t. There are assumed to be Q transmis-
sions, and .Ar is the transmission rate corresponding to the antibiotic class 
of the patient becoming colonized in the rth transmission . 
Immigration assumptions 
In order to completely specify the likelihood it is necessary to specify the 
probability of each patient being already colonized when admitted to the 
ward. The approach described in section 8.3 might seem to be appropriate 
here. For the strains which colonize several patients, exactly one patient 
should be required to introduce the strain. Patients who have no swabs 
may also be assumed to have some probability of introducing other strains 
of unique PFGE type to the ward. This probability then becomes another 
parameter of the model. This approach would work well for the third part of 
the study, where a strain previously not seen on the ward is introduced, and 
spreads rapidly to other patients. However, in the first part of the study 
several patients were already colonized with the predominant ward strain 
when admitted. This is almost certainly due to those patients acquiring the 
strains during previous episodes on the unit. Out of 283 patients, 125 had 
two or more episodes on the ward during the study. There were 91 episodes 
where patients who were colonized with VRE on their previous episode were 
readmitted, and in 53 of these they were again found to be colonized; in 21 
cases no swabs were taken; and in the remaining 17 episodes only negative 
swabs were recorded. Because of this constant recycling of patients through 
the ward, the assumptions of section 8.3 are no longer valid. A full model for 
the data should specify the probability of a patient being colonized with a 
given strain on admission to the ward, given their colonization status when 
leaving the ward during the previous episode and the time interval between 
the two. The most obvious assumptions for such a model would be to assume 
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this probability was very small if the patient was uncolonized at the end of 
the last stay, and decreased exponentially at some rate ( if the patient was 
colonized at the end of the previous episode. ( is then another parameter 
to be estimated from the data, though one about which there is extensive 
prior information. 
The preliminary analysis presented here ignores these complications, and 
treats each patient episode as a new patient. Previous patient episodes on 
the unit are, however, accounted for in the following way: patients who are 
found to be colonized during the current episode, and who have no negative 
swabs before the first positive swabs for this episode are assumed to have 
been already colonized on admission if they were known to be colonized at 
the end of their previous episode. Also, patients with strains of unique types 
were assumed to introduce these to the ward. 
Once these episodes have been accounted for, there were four remaining 
episodes where it is possible that the patient was colonized on admission 
with strain 1 (the predominant strain during phase 1). These episodes are 
dealt with on a case-by-case basis. 
• Episode 59: The patient was found to be colonized on the first swab 
taken, which was on the eighth day of stay. This patient was not a 
previous in-patient on the unit, and was therefore assumed to acquire 
the strain during this episode. 
• Episode 140: The patient was found to be colonized on the first swab 
taken, which was on the third day of stay. At the end of their previous 
stay on the ward their colonization status was unknown, but many 
other patients were colonized with strain 1 on the ward at this time. 
This patient was therefore assumed to be colonized on admission. 
• Episodes 124 and 283: Both patients were found to be colonized with 
strain 1 on their previous episodes, but no swabs were taken for the 
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above-mentioned episodes. These episodes were treated in the same 
way as patients who had no previous exposure to the ward, and it is 
assumed that they are not colonized on admission with strain 1. 
Previously colonized readmitted patients with no swabs or only negative 
swabs were treated in an identical manner to patients with no previous 
episodes. 
There is assumed to be some constant probability that patients are ad-
mitted with strains of unique type. This probability is taken from the 222 
admissions to the ward whose colonization status on admission could be de-
duced as described above. Of these 28 (13%), were assumed to be colonized 
with VRE on the basis of the assumptions outlined above. 
To make the data consistent with the model two further assumptions are 
required. First, the patient who becomes colonized during episode 325 must 
be assumed to be colonized on admission (the same patient was previously 
on the ward, and left with unknown colonization status). This is because 
there are no possible patient sources on the ward at this time. 
Finally, there is one patient episode that is inconsistent with the model: 
the patient in episode 703 acquired strain 1 during their stay. This patient 
was not a previous in-patient on the unit, so this cannot be an apparent 
acquisition due only to a false negative swab. Not only were there no other 
patients who harboured this strain present on the ward prior to this acquisi-
tion, there were no other patients of unknown colonization status who could 
feasibly have been colonized with this strain. In fact there were no patients 
of unknown colonization status during the period when the strain could have 
been acquired. This acquisition therefore cannot be accounted for by this 
simple model. To account for it the model would have to modified to allow 
for cross-infection from other wards (presumably through a carer acting as a 
vector), direct transmission from a colonized carer, or colonization resulting 
from a reservoir of VRE in the form of environmental contamination On the 
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ward. For the purposes of fitting this model however, the episode is simply 
divided into two. During the first one, lasting from the admission date to the 
midpoint of dates where the patient had unknown colonization status, the 
patient is assumed to be uncolonized. During the second one, the patient is 
assumed to be colonized "on admission". 
Simulation details 
In all cases diffuse priors, r(O.OOl, 0.001), were used for all parameters. In 
the first run colonization rates for the three phases were allowed to vary 
independently. In the second run, colonization rates in phases one and 
three of the study were constrained to be equal, but the rate in the second 
phase was allowed to vary independently. Finally, colonization rates were 
allowed to vary for individual patients according the antibiotics they were 
taking at the time, where antibiotic treatment was deemed to fall into one 
of seven classes (see table 8.3). 
8.4.2 VRE results 
Figure 8.9 shows posterior densities when the colonization rate A was allowed 
to vary according the phase of the study. Phases one and three clearly seem 
to have markedly higher values than phase two. There is little evidence 
that phase one and three have different transmission rates, despite the fact 
that in phase three there was an intensive education programme aimed at 
improving hygiene on the ward. The survival analysis, which ignored the 
effect of there being different numbers of susceptibles (Bradley et al., 1999) 
showed a slightly lower rate of acquisition in phase three than in phase 
one. The opposite conclusion here arises because of the different numbers of 
colonized patients initially present in phase one and three, and the different 
immigration rates of colonized patients. Both of these were greater in phase 
one than in phase three. Because estimates for phase one and three were so 
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Figure 8.6: VRE colonization statuses on the ward assuming patients can 
lose as well as acquire VRE during their stays. Key: red-colonized; green-
uncolonized; blue-unknown. Where patients spent time on other wards 
during their episode, they have been split into two episodes in the figure. 
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Figure 8.7: VRE colonization statuses assuming that patients who acquire 
VRE remain colonized for the rest of their stays. Key: green- uncolonizedj 
blue-unknown; black- colonized, unique strain; grey-colonized, unknown 
strain. Other colours indicate strains as determined by the PFGE typ-
ing: red- strain 1; orange-strain2; pink-strain 3; yellow- strain 5. Patients 
spending time on other wards during their episodes ha.ve been split into two 
episodes in the figure. 
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Figure 8.8: Antibiotic courses of patients. Key: green-no antibi-
otics; blue-ceftazidime, no glycopeptide; purple--ceftazidime & gly-
copeptide; yellow-piperacillin/ tazobactam l no glycopeptide; orange-
piperacillin/tazobactam & glycopeptide; red- glycopeptide, no ceftazidime, 
no pip./tazo.; black-other antibiotic(s). 
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similar, a single colonization rate was then specified for them. The results of 
this parameterization are shown in the lower panel of figure 8.9. The mean 
(and 95%CI) for the first and third phase is 0.0037 [0.0025,0.0042], and for 
the second 0.0014 [0.00062,0.0024] 
The mean length of patient stay during the study on this ward was 25.2 
days. Since this was an 18 bed ward, this gives a mean value of Ro for the 
first and third phases of 1.59, with 95% credible interval [1.07,1.80]. In the 
second phase of the study this was reduced to 0.60 [0.27,1.01]. Note that 
the mean length of stay here is large. More typical wards have about half 
this length of stay, and because of the resulting reduction in Ro wouldn't be 
expected to have a VRE problem even if transmission occurred at a similar 
rate to that seen here. 
Figures 8.10 and 8.11 show the posterior densities for the colonization 
rate when it is allowed to vary according to the antibiotic class of each sus-
ceptible patient. In this case, the same parameters were used for all three 
phases of the study. The large uncertainties in the colonization rates for pa-
tients taking different antibiotics reflect the fact that there were relatively 
few patient days of observation for each antibiotic class, except for the one 
corresponding to no antibiotics. The mean colonization rate for patients 
not taking antibiotics, 0.00093 [0.00046,0.0016], is clearly much lower than 
all the estimates for patients taking antibiotics. The largest of these cor-
responds to joint ceftazidime and glycopeptide use, (0.0145,[0.0078,0.023]), 
with a slightly lower value when the glycopeptide was not used simultane-
ously (0.0099, [0.0043,0.017]). Piperacillin/tazobactam use without a gly-
copeptide gave the lowest acquisition rate (0.0046, [0.0015,0.0092]), which 
was increased slightly when glycopeptides were used simultaneously (0.0071, 
[0.0027,0.014]. Glycopeptide use with ceftazidime and piperacillin/tazobactam 
gave a lower rate (0.0058[0.0021,0.011]) than use of other antibiotics (0.0081, 
[0.003,0.015]). 
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8.5 Discussion 
8.5.1 Simulated data 
The results suggest that relatively little information is gained by taking daily 
instead of weekly swabs. In practice, the situation may be complicated by 
the detection of very short-term carriage, when a newly arrived strain is 
present in enough numbers to be detected, but not to become established 
(Cookson et al., 1989). This phenomenon was not included in the model 
used for generating the data. With real data, more frequent swabs would 
have a greater chance of correctly identifying such carriage as transient. 
With weekly swabs, for each swab there is a large chance that a patient will 
be discharged before a second swab can be made to determine if the carriage 
does persist. 
A surprising result is that even with very low levels of patient consent 
good estimates can be obtained. It is not clear, however, if this will still 
be the case in a situation where there are multiple strains or when there 
are large uncertainties attached to initial colonization status. Low consent 
rates can also introduce significant bias if the assumption that non-consent 
occurs at random doesn't hold. 
Given these caveats, however, the results do show when planning such 
studies different designs are likely to have radically different efficiencies. 
For example, taking daily swabs from all patients for 30 days requires 
nearly as many swabs as taking weekly swabs from 50% of patients over 
500 days, but provides much less information about the transmission rate. 
Such studies are time-consuming and expensive. In large part this is due to 
laboratory work needed to type the isolates obtained. Also, because of the 
large stochastic fluctuations it can be difficult to distinguish even quite large 
effects from chance. Analysis of simulated data may therefore help in the 
design of such studies. However, because of the size of the stochastic fluc-
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tuations associated with such hospital epidemics, even large well-designed 
studies may be unable to show effects significant at conventionally accepted 
a values. Adopting a Bayesian approach, and taking prior information from 
previous studies into account, could provide a more productive and rational 
framework for analysing such studies. 
The simulation studies suggest that the best approach might be to take 
fewer swabs from each patient, but extend the study over a longer period 
of time or several wards. If transient carriage is not important, taking only 
admission and discharge swabs from patients is likely to be sufficient. 
Most studies have used weekly swabs, but Parker et al. (1965) tried 
taking twice-weekly swabs. The main difference they found was that in-
creased transmission was found this way, as more transient colonization was 
included. For VRE data some studies have used daily swabs (Bonten et at., 
1998). Though very time-consuming, expensive, and tiresome for the pa-
tient, this would remove most of the uncertainty with the data (provided 
swabs were obtained from each patient) and analysis using a generalized 
linear model might be a more productive approach. 
8.5.2 Staphylococcus aureus data 
The large credible interval obtained in the estimates of the transmission rate 
reflects the short duration of the study and low consent rate. However, the 
estimate is consistent with the pattern of MRSA transmission seen on the 
ward, which is characterized by sporadic cases of cross-infection. When such 
"clusters" are spotted by infection control staff it is likely that an interven-
tion will be made. This was seen during the study described in chapter 3 
when alcohol handscrub was placed at the end of every bed. However no 
subsequent increase in hand washing frequency was observed when this hap-
pened. It is likely that on a ward such as this outbreaks will be self-limiting, 
provided reasonable levels of hygiene are maintained. 
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The Bayesian approach provides a natural way to incorporate informa-
tion from previous studies by specifying an informative prior. In many cases 
this is necessarily a subjective process, but by subjecting data to a "com-
munity of priors" the degree to which previous beliefs are modified by the 
new data can be examined. 
In this case, a prior was elicited from previous studies, most of which 
were conducted more than 30 years ago. Consequently, the relevance of such 
estimates for contemporary wards and strains is questionable. 
Such limited data can only justify fitting the simplest of models. In prac-
tice, though, this model has severe limitations. Firstly, since the population 
will never (or almost never) be completely susceptible, Ro is of relevance 
only as an upper bound. In chapter 6 an effective Ro value for resistant 
strains was introduced, where the effect of patients colonized with sensitive 
strains was accounted for. However, when all the strains behave identically, 
as assumed here, then if the ward can be assumed to be observed at equi-
librium, the mean number of secondary cases arising from each case can 
at most be one. Long-term stability of anyone strain will not be possi-
ble (in the model), due to the constant influx of new strains with identical 
behaviour to those present. 
To account for observed patterns of behaviour where a single strain 
becomes endemic to a ward requires a model that differentiates between 
the strains. Amongst the most important differences are likely to be the 
antibiotic-resistance patterns. Antibiotic data were collected during this 
study, but there are too few transmissions for it to be usefully applied. In 
particular, there was no observed transmission of MRSA during the study 
period. 
Note that when assessing the effect of different numbers of beds on the 
transmission dynamics, it will not be valid to simply substitute the number 
of beds in the above calculation. The reason for this is that as the size of 
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the ward increases, A would be expected to decrease. 
Again, as mentioned above, the assumption that once a patient is col-
onized they remain colonized is contradicted by data. In the present case, 
colonization of a patient was deliberately eliminated. Transient carriage by 
patients may also be important. However, if the former is rare and can be 
treated on case-by-case basis, and the latter is unimportant for transmis-
sion, then this may still be a useful working assumption. The assumption 
that patients are not simultaneously colonized with two or more strains is 
also contradicted by the data. The fact that carriage of multiple strains has 
been found to be rare in other studies (for example Shinefield et at., 1974), 
suggests that this too may still be a convenient, if incorrect, assumption. In 
the current study, swabs from multiple sites of each patient were taken, and 
all colonies of differing morphologies were cultivated, but only two patients 
were identified as carrying more than one strain. 
8.5.3 VRE data 
These are the most interesting results, and represent the first attempt to 
fit data relating antibiotic use to the spread of resistance to a dynamic 
model. Uncertainties are still large but may be reduced when full typing 
data becomes available, and all three wards are combined. 
8.5.4 The effect of antibiotics 
Carmeli and co-workers conducted a meta-analysis of 20 studies relating 
VRE acquisition to antecedent vancomycin usage (Carmeli et al., 1999). 
They found that studies that used patients harbouring vancomycin-susceptible 
enterococci as controls found a stronger association between use of the an-
tibiotic and VRE acquisition when compared to those studies that used 
patients not acquiring VRE as controls. They also found, when analysing 
these latter studies, if only those studies that adjusted for length of stay 
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were included, only a weak and non-significant association was found with 
vancomycin treatment and VRE acquisition. This seems to contradict con-
ventional view that the emergence ofVRE "mainly results from the extensive 
use of glycopeptides" (Mouthon and Mainardi, 1996). 
Again, however, there is the problem that drug use is likely to be highly 
correlated with length of stay, so this may obscure the effect of antibiotic 
use. In chapter 5 it was argued with reference to S. aureus acquisition that 
simple logistic regressions are likely to be of limited value when investigating 
the effect of antibiotic use because of this association. In the VRE data 
considered in this chapter, for example, figure 8.8 shows that all but one 
of the patients who stayed longer than 20 days received antibiotics. The 
appropriate tool is survival analysis, but with asymptomatic infections there 
will usually be large uncertainties regarding the true acquisition times. This 
can limit the applicability of such techniques. The methods in the present 
chapter overcome these problems by allowing for all possible acquisition 
times in the unobserved data, and simultaneously making inferences about 
model parameters and the unobserved process. In all six of the antibiotic 
classes, the patient acquisition rate was found to be well above that for 
patients not taking antibiotics. Some of this increase, however, may simply 
be due to the fact that patients taking antibiotics are contacted by carers 
almost twice as frequently as those who aren't (see chapter 3). 
Another study overcame the problems inherent in routine hospital data 
by giving healthy volunteers oral glycopeptides. Using non-selective me-
dia, VRE could be found in 14 out of 22 subjects after three weeks of gly-
copeptide treatment, while none of the pre-treatment screens were positive 
(Van der Auwerea et al., 1996). When using a selective medium containing 
vancomycin VRE could only be recovered from 11 out of 40 healthy un-
treated volunteers. This study clearly suggests that glycopeptides do select 
for VRE, at least when orally administered. 
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The study by Carmeli et al. (1999) also suggests that resident antibiotic-
sensitive enterococci may playa important role in inhibiting acquisition of 
VRE in the absence of antibiotic treatment. Vancomycin might be expected 
to select for enterococci by killing resident susceptible enterococci, leaving a 
vacant niche for the VRE. This could explain why there was a stronger as-
sociation between vancomycin use and VRE acquisition when controls were 
those colonized with sensitive enterococci. Cephalosporins, however, are not 
active against enterococci, and might be expected to select for the resident 
enterococcal population, inhibiting acquisition of VRE. The results obtained 
in this chapter suggest that this is not the case, with the highest acquisition 
rates being found for patients taking cephalosporins. This may be because 
the effect of the cephalosporin depends on the response time of the endoge-
nous flora to the antibiotic pressure. During treatment with a cephalosporin, 
endogenous enterococci should initially increase in numbers. If competition 
between strains is principally through competition for attachment sites as 
suggested for S. aUTeus (Bibel et al., 1983), rather than direct, then dur-
ing this period any incoming enterococci should also be able to increase in 
numbers. This period of growth in the enterococcal population may also 
provide excellent conditions for the spread of the transposon containing the 
resistance gene. The lowest acquisition rates were found amongst patients 
taking piperacillin/tazobactam and glycopeptides. This is also a little para-
doxical, as both drugs should be active against sensitive but not resistant 
strains, and therefore might be expected to select for VRE. It should be 
noted, though, that acquisition rates for patients taking these drugs were 
still much higher than the corresponding rate for patients taking no antibi-
otics. In other words, it appears that they do increase the risk of acquiring 
VRE, but not as much as cephalosporins do. It may be the case, as was 
found with the interference experiments with S. aUTeus described in sec-
tion 5.4.3, that the interference caused by other bacteria species making up 
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the faecal flora is at least as important as that attributable to enterococci 
themselves. 
8.5.5 Model selection 
The approach taken here provides a framework for fitting a whole family of 
epidemiologically meaningful models. In the present case this was illustrated 
by fitting a simple transmission model where the rate that patients become 
colonized depends on the number of colonized patients on the ward at that 
time (the mass action assumption). Clearly many other assumptions are 
possible and many interesting questions can be framed in terms of choosing 
between competing models. 
For example, the effect of antibiotics may change the chance of a patient 
becoming colonized, may change the chance of a colonized patient colonizing 
other patients, or the effect could be some combinations of the two. Patients 
are treated with many different combinations of antibiotics, and there are 
many ways that these could be accounted for in a model. The mass action 
assumption that each new colonized individual provides a constant addi-
tional risk should also be examined. If, for example, the acquisition rate 
were to remain constant providing there was at least one colonized patient 
on the ward, different conclusions might be drawn about the transmission 
process. 
Most importantly, the strains of unique PFGE types need to be con-
sidered, and the colonization status of a patient on admission to the ward 
needs to be related to their colonization status on departure in their previ-
ous episode. A fuller treatment should also make allowance for incubation 
periods. The delayed effect of antibiotic therapy due to suppression of en-
dogenous flora may also be important. Other factors that may be worth con-
sidering include: heterogeneities in the transmissibilities of different strains; 
and the effect on transmission of diarrhoea in colonized patients. 
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The Bayesian approach used here provides an attractive framework for 
doing this. When full typing information becomes available further work 
will need to concentrate on the problems of model selection and assessment. 
Clearance of VRE carriage 
It was assumed when looking at the VRE data that once a patient became 
colonized they remained colonized for the rest of that episode. Other studies 
have shown low clearance rates of VRE carriage. Unsurprisingly, clearance 
rates appear to be closely related to the number of organisms present. Green 
et at. (1991) found that 7 out of 21 subjects with more than 107 CFU jml of 
VRE in their stool specimens had persistent colonization, while 0 out of 4 of 
those with less than 104 CFU jmls had persistent colonization. If antibiotic 
therapy increases the numbers of resistant organisms given that they are 
already present, then an important aspect of antibiotic therapy may be to 
increase persistence in colonized hosts. In most hospital wards, inclusion of 
this effect may not be important, since length of hospital stay is typically 
short compared to the rate of loss of carraige. However, when considering 
transmission in long-term care settings, and looking at the problem at a 
hospital level where many of the patient episodes are readmissions, the effect 
could be important. 
A high rate of "loss" ofVRE was also found in the study by Van der Auw-
erea et al. {1996}. One week after the last dose of glycopeptide the authors 
found that amongst patients given a low dose of teicoplanin 78% of samples 
were VRE negative. 64% had been positive after three weeks of glycopeptide 
treatment. Note, however, that unlike the studies by Bradley et at. (1999) 
and Green et at. (1991), in this case there was no enrichment step, and spec-
imens were not inoculated directly onto glycopeptide-containing agar, so a 
lower sensitivity for the detection of VRE would be expected in this case. 
Both of these latter studies have much lower rates of loss. 
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Admission of colonized patients 
A particularly interesting aspect of these data is the importance of readmis-
sions of colonized patients. Patients were frequently readmitted soon after 
they were discharged from the ward. The effect of this is to decrease the rate 
of loss of strains from the ward. In phase one of the study, in those patients 
for whom initial colonization status on admission could be established, 14 
out of 53 were colonized. In phase two the corresponding figure was 12 out 
of 129, but this decreased from 10 out of 59 in the first four months of phase 
two, to only 1 out of 70 in the second four months. In phase three only 2 
out of 40 were colonized on admission. This suggests that the assumption 
of a constant probability that new patients are colonized with unique VRE 
strains on admission cannot be justified. A full model that allows for acqui-
sition of the transposon and relates patients' colonization statuses to those 
of previous episodes would be needed to account for this. 
As well as decreasing the rate at which VRE was lost from the ward, 
the same effect could explain why hospitals see gradually increasing levels 
of resistant organisms following their introduction. Since a large number 
of patient episodes are likely to be readmissions, a gradual increase in the 
proportion of patients colonized on admission would be expected. The rate 
of this increase would depend on the proportion of patient episodes that 
are readmissions, the time interval between readmissions, the rate of loss of 
resistant organisms in the absence of antibiotics, and also transmission in 
the community if this is important. 
Environmental contamination 
The role of environmental contamination in the transmission of VRE re-
mains contentious, and it has proved difficult to disentangle animate and 
inanimate reservoirs (Weber and Rutala, 1997). Environmental contami-
nation is frequently found in the rooms of colonized patients, particularly 
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those with diarrhoea, but high levels of hand contamination of healthcare 
workers are also reported (Bonilla et al., 1997). To demonstrate that envi-
ronmental contamination is important for the transmission of VRE requires 
doing more than showing that organisms can be found surviving on fomites; 
it also requires showing that transmission is reduced by reducing the level 
of environmental contamination. Since colonized patients are almost cer-
tainly also an important reservoir, the reduction is likely to be partial at 
best, and because of stochastic effects and associated large uncertainties, 
evidence from any single study is likely to be inconclusive. 
If there is a high level of contamination of fomites, it seems highly likely 
that there will be at least some transmission attributable to this reservoir. 
This could be demonstrated by observing acquisition of a strain by a patient 
which no current patients on the ward harboured. In practice, however, it 
is difficult to exclude all other patients as potential reservoirs, especially as 
there may also be HCW-borne transmission from contacts with colonized 
patients on other wards. HCWs would also need to be excluded as potential 
sources. 
More important, though, is an assessment of the importance of this 
reservoir compared with the reservoir of colonized patients. Highly detailed 
studies such as the one described above may help to answer this question 
by considering, for example, whether patients have an increased risk of ac-
quiring strains carried by previous occupants of their rooms or beds. Such 
analyses, however, would inevitably be complicated by the fact that if such 
an association were found alternative explanations could be equally plausi-
ble. Most importantly, neighbouring patients would be expected to have a 
greater chance of being colonized with a strain harboured by a departed pa-
tient. Such spatial correlations may arise solely from carer contact patterns, 
rather than environmental contamination or airborne spread. 
A more conclusive demonstration of the importance of such environ-
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mental contamination would depend on interventional studies. Studies that 
compare both carer and patient hand contamination after contact with col-
onized patients and surfaces should also be valuable. Without such studies, 
the role of environmental contamination must remain largely a matter of 
speculation. 
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Chapter 9 
Conclusions 
This chapter summarises the main conclusions from the previous chapters, 
their implications for hospital infection control, and considers directions for 
future work. 
9.1 An overview of the main results 
9.1.1 Chance 
Simulation results from chapter 2 suggest that chance (stochastic) effects 
are likely to be extremely important for hospital epidemics, particularly 
for ward-level outbreaks. Huge variation in the course of outbreaks occurs 
even when the underlying processes are in every way identical. For many 
scenarios it was found that almost any sensible measure of the scale of 
a ward's problem is likely to be highly unpredictable, with similar wards 
having widely differing outcomes. 
Such stochastic effects are almost never considered in outbreak reports, 
but a consideration of them may profoundly modify any interpretation of 
observed outcomes. 
The large reporting biases likely in this literature, together with the 
huge heterogeneity in source data that theory predicts, suggest that such 
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retrospective reports may contribute little to our knowledge, other than the 
information that what was observed is possible. Attempts at the study 
of hospital epidemics should consider whether effects usually attributed to 
interventions may not equally well have occurred by chance. 
9.1.2 Length of stay and detection rate 
Model results in chapter 2 showed that decreasing the lengths of patients' 
stays could result in both increases and decreases in the total colonized 
patient days. This was a consequence of two opposing processes: shorter 
lengths of stays result in more introductions of the pathogen into the ward, 
but less opportunity for its spread. Which effect dominates depends on 
the transmissibility of the pathogen (or the susceptibility of the patient 
population) and the prevalence of colonization amongst new admissions. 
For a highly transmissible strain, decreasing length of stay should decrease 
colonized patient days. For a strain of low transmissibility the effect of 
more introductions can dominate. In both cases total colonized patient days 
increase linearly (or almost linearly) as the proportion of patients colonized 
on admission increases. 
Assuming that known carriers of the pathogen are removed, isolated, 
or cleared, increasing the detection rate of the pathogen is equivalent to 
decreasing the length of stay for carriers. Consequently, for a highly trans-
missible strain increasing the detection rate can results in big reductions in 
colonized patient days, while only small effects are seen when transmissibil-
ity is lower. 
Decreasing the proportion of patients bringing the pathogen into the 
ward (by admission screening, for example) is likely to be a good strategy in 
all settings. Increased surveillance should be more effective in settings (or 
with strains) where there is a lot of transmission. 
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9.1.3 Handwashing 
Simulation results from chapter 2 suggest (if hand-borne transmission is 
as important as is widely believed) that the spread of a pathogen will be 
highly sensitive to handwashing frequency. For parameter values chosen to 
be representative of a general medical ward, effective handwashing frequen-
cies as low 30 or 40% were found sufficient to eliminate almost all patient 
colonization, leaving only sporadic and self-limiting outbreaks. 
Handwashing frequencies in this range are in fact commonly observed, as 
was the case in the observational study described in chapter 3. Handwashing 
frequency was found to vary greatly with contact type, with hand washes 
least likely for simple touches, and most likely for invasive or semi-invasive 
procedures. Also in agreement with other studies (for example Pittet et ai., 
1999) was the observation that doctors washed their hands far less frequently 
than other carers, even after adjusting for the contact type. Surprisingly, 
once differences in carer type had been accounted for, little heterogeneity 
in the handwashing behaviour of carers was seen. Heterogeneity between 
observation periods was, however, significant, but did not seem to be linked 
to ward activity levels, staffing levels, or the presence of senior staff. 
The implications for control are that, away from wards with highly sus-
ceptible patients (such as ICUs, burns units, and neonatal units), fairly 
modest and achievable hand washing frequencies may be sufficient to pre-
vent sustained outbreaks. Lower grade (types 1 and 2) contacts were found 
to be far more frequent than high grade (type 3) contacts and far less likely 
to be followed by handwashes, but are not necessarily associated with lower 
risk of transmission of organisms to carers' hands (Wong, 2000). Efforts at 
increasing compliance might therefore usefully be directed at emphasising 
the importance of handwashing after these simpler contacts, as well as at 
improving the consistently poor performance of doctors. 
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9.1.4 Contact patterns: ward teams, named-nurses, patient-
carer ratios 
The common assumption in epidemic models of homogeneous mixing (that 
each individual is equally likely to contact every other individual) is rarely 
likely to be found in practice, and the consequences of departures from 
this assumption should be considered. In the observational study of the 
surgical/medical ward, only the nurse team structure (two nurse teams, 
each with primary responsibility for one side of the ward) was found to 
be an important source of structure in the contact patterns. Results from 
chapter 4 suggest that this team structure has the potential to reduce the 
burden of infection in a ward, but the effect is small and only likely to 
become evident at levels of separation between the two halves of the ward 
far greater than those observed. 
On the ICU, however, 60% of each patient's contacts came from the sin-
gle nurse assigned to them at that time. Chapter 4 results show that-as 
has been suggested elsewhere (Austin et ai., 1999b)-this structuring should 
be a highly effective control measure, becoming more so as the fidelity of 
a carer to their patient increases. Interestingly, the results are sensitive to 
the carer-patient ratio, with the colonized patient days and time to extinc-
tion both increasing as staffing levels decrease. No such dependency is seen 
when there is only homogeneous mixing. Reports that link decreased carer-
patient ratios with higher infection rates usually attribute the association 
to lower hand washing rates among busier staff. These results show that 
the structure of contact patterns can also be important. They predict that 
on wards such as ICUs, where staffing patterns similar to these are seen, 
infection rates should go up when staffing levels go down, even when hand-
washing frequency is unchanged. In fact, in chapter 3 no link between three 
different measures of nursing workload and handwashing frequency could 
be found. Others, however, have found such a link (Pittet et al., 1999), 
250 
using the number of hand washing opportunities as a proxy for staff work-
load. Measuring ward-activity is not simple, though. For example, type 3 
contacts are likely to take much longer than simple touches, so when many 
carers are performing these invasive procedures a crude count ofthe number 
of hand washing opportunities would falsely suggest a period of low activity. 
Because these contacts are likely to be associated with higher handwash-
ing frequencies, a spurious association between low ward activity and high 
handwashing frequency could arise. 
Increased staffing levels in high risk areas and contact patterns typical 
of an leU may therefore be an effective control measure, whether or not 
hand washing frequency does go down as workload goes up. Indeed, one of 
the reasons for the effectiveness of closing wards to new admissions may be 
just this change in carer-patient ratios. 
9.1.5 Contact pattern heterogeneity: the importance of high 
risk patients 
Large heterogeneities in patient-carer contact rates were seen, with signif-
icant variation between observation periods and between patients. Simu-
lation results in chapter 4 suggest that such heterogeneity in contact rates 
would result in modest increases in transmission. However, antibiotic use 
and having had an operation in the last 24 hours were both strongly linked 
with higher contact rates; each was associated with nearly a doubling of the 
rate. Both of these factors might themselves be expected to be independent 
risks for becoming colonized or infected. When higher patient contact rates 
are associated with greater susceptibility, the simulation results show that 
the ability of the pathogen to persist is greatly enhanced. A small group of 
high-risk patients may account for much of the spread and persistence. 
Theoretical consideration suggest that as a control measure, separating 
such high risk patients from low risk patients is likely to exacerbate the 
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problem, and the best option may be to mix such patients together. If-as 
seems likely-100% hand washing compliance cannot be achieved, a more 
focussed approach that emphasises hand decontamination before and after 
contacts with high risk patients may be an effective control strategy. 
9.1.6 Transmission rates 
The S. aureus transmission data collected as described in chapter 3 and 
analysed further in chapter 3 provided only limited information on trans-
mission patterns. No cases of MRSA cross-infection were seen, despite there 
being three MRSA colonized patients on the ward for most of the time. 
In contrast, two cases of MSSA cross-infection were observed. It is possi-
ble that MSSA cross-infection is more frequent than has been previously 
thought (see, for example Casewell and Hill, 1986), but simply less likely to 
be detected and less visible because of the multitude of strains and the fact 
that a single strain is unlikely to become endemic l . Analysed together, the 
data suggested that the S. aureus transmission rate observed in the med-
ical/surgical ward was unlikely to reach the critical level where long-term 
persistence becomes a possibility. This is consistent with the observation 
that the patterns of transmission in such wards are usually characterized 
by sporadic clusters of cases. During such outbreaks interventions-such as 
encouraging staff to wash their hands more-may be made to reduce trans-
mission. While these may indeed limit the spread, it seems likely-from 
these limited data-that most such outbreaks would rapidly fade out on 
their own. 
Considerations such as these again suggest that a targeted approach to 
infection control, that concentrates on preventing endemicity in high risk 
areas rather than fighting many sporadic outbreaks elsewhere, may pay div-
INeonatal units are an exception. Babies are highly susceptible to colonization, and 
MSSA strains sometimes do become endemic. 
252 
idends. 
9.1. 7 Antibiotics and the spread of resistance 
Chapter 5 reviewed studies relating transmission of resistant bacteria to 
antibiotic use. Surprisingly, those studies that used logistic regressions to 
relate the risk of acquiring resistant organisms such as MRSA or VRE to 
prior antibiotic use tended to find only weak associations, or no association 
at all once length of stay had been accounted for. Because length of stay and 
antibiotic use will usually be closely linked, the many studies that do not 
adjust for the former cannot be considered to contribute useful information. 
A variety of methods, however, were used in other studies to make infer-
ences about the rate of acquisition. These all found the rates to be greatly 
increased in patients taking antibiotics. It was argued that the high levels 
of antibiotic use and its close association with length of stay mean that the 
power of logistic regressions to detect any extra risk due to antibiotic use 
is likely to be very low, even if that extra risk is large. Further analysis 
of such data, and of simulation experiments, may be able to confirm this 
suspicion. Studies that report no link may not only be counter-intuitive, 
but also highly misleading if naively interpreted as providing evidence of no 
effect, rather than no evidence of an effect. The link between antibiotic use 
and the spread of resistant organisms may not be simple or always easy to 
detect, but the rarity of resistance genes before widespread antibiotic use, 
the fact that resistant bacteria are consistently found in greater numbers 
as antibiotic use increases, estimates relating acquisition rates to antibiotic 
use, and basic theoretical considerations all support the obvious conclusion: 
that antibiotic use is indeed amongst the most important determinants for 
the spread of antibiotic-resistant bacteria. 
Previous models relating antibiotic use and the transmission of resistant 
organisms were critically reviewed in chapter 6. It was argued that claims 
253 
that the cycling of antibiotics could never be an effective strategy were 
based on models inappropriate to hospital populations, and the conclusions 
unjustified. In particular, chance effects and patient turnover are important. 
A stochastic model of the spread of resistant bacteria in a hospital ward was 
presented, and simulation experiments showed that the elimination of an 
endemic resistant strain following withdrawal of antibiotics (or a change 
in antibiotic policy) could indeed be rapid. Away from endemic settings, 
however, any effect of a change in policy would be far harder to detect 
because of the large variability in periods required for elimination of the 
strain from the ward. In common with other models, a threshold effect was 
predicted, whereby long-term persistence does not occur below a certain 
level of antibiotic use, but becomes a possibility (though by no means a 
certainty) above that level. 
The model proved to be very sensitive to the assumptions regarding 
discharge rates for patients undergoing antibiotic therapy, suggesting that, 
where it is possible, rapid discharge of patients undergoing or having recently 
undergone antibiotic therapy may be effective at controlling the spread of 
resistant organisms. 
If transmission rates are enhanced by antibiotics as much as the data 
suggest, reducing antibiotic use-and particularly the density of antibiotic 
use-would be expected to make a large impact, particularly if it could be 
reduced below the critical level where long-term persistence is no longer 
possible. Again, a more focussed attitude to infection control that concen-
trated on preventing transmission to patients taking antibiotics might also 
be effective. 
9.1.8 The fitness cost of resistance 
Both theory and experiment suggest that a mutation conferring antibiotic-
resistance to a bacterium is likely to be associated with a fitness cost in the 
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absence of the antibiotic. Subsequent secondary mutations may then reduce 
this cost. Such a fitness cost could reduce a strain's ability to persist on 
host or colonize new hosts, and consequently hinder its ability to spread in 
hospitals and the community. 
In an attempt to see if there was any such cost associated with methicillin-
resistance in S. aureus a comparison of growth kinetics was made between 
MRSA and MSSA strains. No differences in maximal (exponential) growth 
rates were found, though there was a suggestion of an increased lag period 
in MRSA strains. Both MRSA and MSSA strains, however, exhibited great 
variability in both aspects of their growth curves. 
This experiment should not be considered as evidence for the lack of a 
fitness cost. To date, however, there is little evidence that any such cost 
does exist, although research in this area has been minimal. 
9.1.9 Fitting models to data 
Chapter 8 showed how model parameters could be estimated from detailed 
ward-level data using a Markov chain Monte Carlo (MCMC) approach. Such 
MCMC methods are computationally expensive and have only recently been 
applied to epidemic models, but have great potential for fitting stochastic 
models to data, particularly when the epidemic process is only partially ob-
served. In one of the examples it was shown how the approach could be 
used to make inferences about the effects of different antibiotics, and com-
binations of antibiotics, on the rate of acquisition of VRE strains amongst 
patients in a haematology unit. The results contradicted a previous meta-
analysis that suggested that glycopeptide use did not select for VRE, ,though 
provided support for the view that cephalosporin use was an important ad-
ditional risk factor for VRE acquisition. 
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9.2 Directions for future work 
Patterns of patient movement 
The work presented in this thesis has concentrated on transmission within 
single hospital wards. Clearly, other levels need to be considered. In par-
ticular, the transfer of patients and movement of carers between wards will 
be important for the dynamics within a hospital as a whole. Data are read-
ily available for these movements, and models of the likely consequences of 
these movements need to be developed and explored. 
Patterns of patient readmission are likely to be particularly important for 
long-term dynamics. If a colonized or infected patient colonizes on average 
0.5 other patients during a stay in a ward free of the pathogen, the pathogen 
will not become established in the hospital from a single episode. However, 
if each such patient has three episodes before being cleared of carriage, then 
an average of 1.5 patients will become infected in a susceptible population. 
A chain reaction is then possible, and a long-term increase in prevalence may 
occur in the hospital. If such readmissions are indeed important for the long-
term dynamics, then a number of possible control measures immediately 
suggest themselves. 
Antibiotic policies 
As suggested above, cycling of antibiotics has not been shown to be ineffec-
tive. Whether or not it works should depend on the time taken to eliminate 
a resistant strain when antibiotic use is changed, and the rate at which new 
resistant strains come into a ward. If the first rate is high and the second 
low, then cycling antibiotics could be an effective policy. Again, modelling 
work should shed light on this question. Stochastic optimization techniques 
may also allow optimal antibiotic policies to be identified. For this to be 
feasible it may be necessary to work with approximations of the epidemic 
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process suggested by the results of chapter 6. Multiply-resistant strains rep-
resent the other major problem, and their emergence and spread must be 
a major consideration when assessing all policies involving the use of more 
than one antibiotic. 
Transmissibility 
Transmissibility is amongst the most important of model parameters, yet 
very little is known about its determinants, and no attempts have been made 
to measure the transmission rate for different strains in different settings. 
The methods of chapter 8 show how such transmission rates could be 
measured, but there is also a need for further laboratory investigations com-
parable to those of Farrington et al. (1992). 
Further studies on the growth kinetics of S. aureus strains will also be 
of interest. As well as competition experiments, it would be interesting to 
compare kinetics of early MRSA strains to the more recent epidemic variety. 
In this way any change in the fitness cost of resistance could be explored. 
Repeating these experiments at temperatures slightly below 37°C, closer 
to the normal temperatures of the usual colonization sites of S. aureus, may 
also be worthwhile. 
Fittings models to data 
The analysis of the VRE data in chapter 8 represents just the beginning 
of what is possible with these data and methods. A lot of further work is 
required. In particular, the areas of model assessment and selection need 
attention, as a number of different models may be appropriate. Fitting 
different models should allow an evaluation of the consistency of the data 
with different assumptions regarding the underlying processes. For example, 
it is not clear how to interpret VRE strains of unique types. They may have 
been present in low numbers before antibiotic use and selected by treatment, 
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or they may represent strains that have acquired the resistance-conferring 
transposon by cross-infection from other patients. 
It should be possible to apply the same methods to many other hospital 
infection problems. For example, formal assessments of the effect of side-
room isolation on transmission of MRSA could be made, without the need 
for ad hoc assumptions. 
Assessing interventions 
Ward-level experiments are essential for the assessment of any suggested 
intervention, ideally with a cluster-randomized design. Mathematical mod-
els are important tools for proposing interventions and assessing the likely 
costs and benefits, and stochastic models allow an exploration of the ex-
pected variation in these costs and benefits. Models may not only help 
choose which interventions should be tested in controlled trials, they can 
also help in the design of the trials themselves. 
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Form CRl. Contact Recording Form 
Date: .... ...... ..... Start time: ............ .. .. . Stop time: ....... ........ ..... Beds being observed: 
Time Bed Carer Event detail Hand decontam. Contact Gloves Apron Finger 
No. No. (0 = observed; G = guessed) Type2 ./ or x if ./orxif swab id 
B A used used (if done} 
2 Contact types: 1 = simrnple touch; 2 = extensive touch; 3 = invasive/semi-invasive touch .. 
Form Ct. Shift Details 
Date: ...................... .. 
First shift Name ID Assigned to which Team Date of last 
beds/patien ts swab 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Second Name ID Assigned to which Team Date of last 
shjft beds/patients swab 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
J 
I 
Night shift Name ID As igned to which Team Date of last 
beds/patients swab 
1. 
2. 
3. 
Fonn Cl 
Form PI. Patient Details 
The following info will be recorded when each patient enters the ward, or at the start 
of the study for patients already present. 
Surname: .............................................................................................. .. 
First name: : ........ ...... ........... ......... ....................................................... .. 
Ho pita] number : ....................... .. 
Initial bed number: ..................... .. 
Named nurse: ...................................... . 
Consultant ................................................................ . 
Sex: ................ ............................ .. 
Date of birth: ............................... . 
Reason for hospitalisation: .................................................................. . 
Date admitted to ward: ................ . 
Time admitted to ward: ............... . 
Date of expected discharge from ward .......... .. 
Where patient admitted to ward from (e.g. another ward, nur ing home, home): 
If transferred from another ward 
Name of previous wards: ................................................................ .. 
Date admitted to this hospital: ....... 
Dates of last period of hospitalisation. From ............. To: .................... . 
Was there a ho pital-acquired infection during last hospitali ation? (YESINO) ............ . 
If YES, give details ......... .. 
Total number of days in hospital in last 12 months: ........ 
Consent for study obtained (YESINO) ........................ .. 
Today's date: ..................... .. 
Note : 
datafms2.doc 
Form PI 
Form P2. Daily Patient Details 
PatientID: ................................ . 
Intended Discharge date: .. ...................... .. Rea on for delay (if any): ................................ .. 
Actual Discharge date: ........................ .. 
Start date of information collection ....................... . 
Wound site: 1). 2). 3). 4). 
W d I oun status: 
Date 
Wound 1 
Wound 2 
Wound 3 
Wound 4 
Wound swabs (wound numbers and dates): 
Operation date: ....................... What was done: ........... ....... ..................... .... .......... .... .. 
Lines 
Type Start date Stop date Notes 
Observations: 
I Wound statu codes: A = wound clean and healing; B = suspicion of infection; C= Definite Infection.; 
D=Dressings not to be removed while patient on ward ; E = healed . 
Daily Patient Details ... continued PatientID: .. .............. ................ . 
RId egu ar . I d' fl'd d rugs mc u mg Ul s an . pumps 
Drugs being taken l. 2. 3. 4. 
Route 
Start date 
Stop date 
Drugs being taken 5. 6. 7. 8. 
Route 
Start date 
Stop date 
Durgs "as required" or once only 
Changes to above data or extra information 
Datarms3.doc Form P2 
